Her kan du finde en oversigt over alle ATC-koder. Det er ATC-koder fra SKS-browser der anvendes her.
| Kode | Tekst |
|---|---|
| M | Lægemiddelstofklassifikation ATC |
| MA | Fordøjelsesorganer og stofskifte |
| MA01 | midler mod sygdomme i mundhulen |
| MA01A | stomatologica |
| MA01AA | midler mod caries |
| MA01AA01 | natriumfluorid |
| MA01AA02 | natriummonofluorophosphat |
| MA01AA03 | olaflur |
| MA01AA04 | stannofluorid |
| MA01AA30 | midler mod caries, kombinationspræparater |
| MA01AA51 | natriumfluorid, komb. |
| MA01AB | antiinfektiva til lokal brug i mundhulen |
| MA01AB02 | hydrogenperoxid |
| MA01AB03 | chlorhexidin |
| MA01AB04 | amphotericin |
| MA01AB05 | polynoxylin |
| MA01AB06 | domiphen |
| MA01AB07 | oxyquinolin |
| MA01AB08 | neomycin |
| MA01AB09 | miconazol |
| MA01AB10 | natamycin |
| MA01AB11 | diverse antiinfektiva til lokal brug i mundhulen |
| MA01AB12 | hexetidin |
| MA01AB13 | tetracyclin |
| MA01AB14 | benzoxoniumchlorid |
| MA01AB15 | tibezoniumiodid |
| MA01AB16 | mepartrizin |
| MA01AB17 | metronidazol |
| MA01AB18 | clotrimazol |
| MA01AB19 | natriumperborat |
| MA01AB21 | chlortetracyclin |
| MA01AB22 | doxycyclin |
| MA01AB23 | minocyclin |
| MA01AB24 | octenidin |
| MA01AB25 | oxytetracyclin |
| MA01AB53 | chlorhexidin og cetylpyridinium |
| MA01AC | corticosteroider til lokal brug i mundhulen |
| MA01AC01 | triamcinolon |
| MA01AC02 | dexamethason |
| MA01AC03 | hydrocortison |
| MA01AC04 | prednisolon |
| MA01AC54 | prednisolon, kombinationer |
| MA01AD | andre midler til lokal behandling i mundhulen |
| MA01AD01 | adrenalin |
| MA01AD02 | benzydamin |
| MA01AD05 | acetylsalicylsyre |
| MA01AD06 | adrenalon |
| MA01AD07 | amlexanox |
| MA01AD08 | becaplermin |
| MA01AD11 | diverse midler til lokal behandling i mundhulen |
| MA02 | midler mod syrerelaterede forstyrrelser |
| MA02A | antacida |
| MA02AA | magnesiumforbindelser |
| MA02AA01 | magnesiumcarbonat |
| MA02AA02 | magnesiumoxid |
| MA02AA03 | magnesiumperoxid |
| MA02AA04 | magnesiumhydroxid |
| MA02AA05 | magnesiumsilicat |
| MA02AA10 | magnesiumforbindelser, kombinationspræparater |
| MA02AB | aluminiumforbindelser |
| MA02AB01 | aluminiumoxid |
| MA02AB02 | aluminiumhydroxid |
| MA02AB03 | aluminiumphosphat |
| MA02AB04 | dihydroxyaluminiumnatriumcarbonat |
| MA02AB05 | aluminiumacetoacetat |
| MA02AB06 | aloglutamol |
| MA02AB07 | aluminiumglycinat |
| MA02AB10 | aluminiumforbindelser, kombinationspræparater |
| MA02AC | calciumforbindelser |
| MA02AC01 | calciumcarbonat |
| MA02AC02 | calciumsilicat |
| MA02AC10 | calciumforbindelser, kombinationspræparater |
| MA02AD | kombinationer og complexer af aluminium-, calcium-, og magnesium-forbindelser |
| MA02AD01 | kombinationer af almindelige salte |
| MA02AD02 | magaldrat |
| MA02AD03 | almagat |
| MA02AD04 | hydrotalcit |
| MA02AD05 | almasilat |
| MA02AF | antacida og midler mod flatulens |
| MA02AF01 | magaldrat og midler mod flatulens |
| MA02AF02 | alm. saltkombinationer og midler mod flatulens |
| MA02AG | antacida og spasmolytika |
| MA02AH | antacida og natriumhydrogencarbonat |
| MA02AX | antacida, andre kombinationer |
| MA02B | midler mod mavesår og gastro-oesophageal reflux (gord) |
| MA02BA | H2-receptor antagonister |
| MA02BA01 | cimetidin |
| MA02BA02 | ranitidin |
| MA02BA03 | famotidin |
| MA02BA04 | nizatidin |
| MA02BA05 | niperotidin |
| MA02BA06 | roxatidin |
| MA02BA07 | ranitidinbismuthcitrat |
| MA02BA08 | lafutidin |
| MA02BA51 | cimetidin, kombinationspræparater |
| MA02BA53 | famotidin, komb. |
| MA02BB | prostaglandiner |
| MA02BB01 | misoprostol |
| MA02BB02 | enprostil |
| MA02BC | protonpumpe-hæmmere |
| MA02BC01 | omeprazol |
| MA02BC02 | pantoprazol |
| MA02BC03 | lansoprazol |
| MA02BC04 | rabeprazol |
| MA02BC05 | esomeprazol |
| MA02BC06 | dexlansoprazol |
| MA02BC07 | dexrabeprazol |
| MA02BC08 | vonoprazan |
| MA02BC09 | tegoprazan |
| MA02BC10 | fexuprazan |
| MA02BC11 | ilaprazol |
| MA02BC51 | omeprazol, kombinationer |
| MA02BC53 | lansoprazol, kombinationer |
| MA02BC54 | rabeprazol, kombinationer |
| MA02BD | komb. til bekæmpelse af heliobacter pylori |
| MA02BD01 | omeprazol, amoxicillin og metronidazol |
| MA02BD02 | lansoprazol, tetracyclin og metronidazol |
| MA02BD03 | lansoprazol, amoxicillin og metronidazol |
| MA02BD04 | pantoprazol, amoxicillin og clarithromycin |
| MA02BD05 | omeprazol, amoxicillin og clarithromycin |
| MA02BD06 | esomeprazol, amoxicillin og clarithromycin |
| MA02BD07 | lansoprazol, amoxicillin og clarithromycin |
| MA02BD08 | bismuth subcitrat, tetracyclin og metronidazol |
| MA02BD09 | lansoprazol, clarithromycin og tinidazol |
| MA02BD10 | lansoprazol, amoxicillin og levofloxacin |
| MA02BD11 | pantoprazol, amoxicillin, clarithromycin og metronidazol |
| MA02BD12 | rabeprazol, amoxicillin og clarithromycin |
| MA02BD13 | rabeprazol, amoxicillin og metronidazol |
| MA02BD14 | vonoprazan, amoxicillin og clarithromycin |
| MA02BD15 | vonoprazan, amoxicillin og metronidazol |
| MA02BD16 | omeprazol, amoxicillin og rifabutin |
| MA02BD17 | vonoprazan og amoxicillin |
| MA02BX | andre midler mod mavesår og gastro-oesophageal reflux (gord) |
| MA02BX01 | carbenoxolon |
| MA02BX02 | sucralfat |
| MA02BX03 | pirenzepin |
| MA02BX04 | methiosulfoniumchlorid |
| MA02BX05 | bismuthsubcitrat |
| MA02BX06 | proglumid |
| MA02BX07 | gefarnat |
| MA02BX08 | sulglicotid |
| MA02BX09 | acetoxolon |
| MA02BX10 | zolimidin |
| MA02BX11 | troxipid |
| MA02BX12 | bismuthsubnitrat |
| MA02BX13 | alginsyre |
| MA02BX14 | rebamipid |
| MA02BX15 | teprenon |
| MA02BX16 | irsogladin |
| MA02BX51 | carbenoxolon, kombinationer excl. psykoleptika |
| MA02BX71 | carbenoxolon, kombinationer med psykoleptika |
| MA02BX77 | gefarnat, kombinationer med psykoleptika |
| MA02X | andre midler mod syrerelaterede forstyrrelser |
| MA03 | midler mod funktionelle gastrointestinale forstyrrelser |
| MA03A | midler mod funktionelle gastrointestinale forstyrrelser |
| MA03AA | synt. anticholin.estere med tertiære aminogrupper |
| MA03AA01 | oxyphencyclimin |
| MA03AA03 | camylofin |
| MA03AA04 | mebeverin |
| MA03AA05 | trimebutin |
| MA03AA06 | rociverin |
| MA03AA07 | dicycloverin |
| MA03AA08 | dihexyverin |
| MA03AA09 | difemerin |
| MA03AA30 | piperidolat |
| MA03AB | syntetiske antikolinergika, kvarternære ammoniumforb. |
| MA03AB01 | benzilon |
| MA03AB02 | glycopyrron |
| MA03AB03 | oxyphenon |
| MA03AB04 | penthienat |
| MA03AB05 | propanthelin |
| MA03AB06 | otiloniumbromid |
| MA03AB07 | methanthelin |
| MA03AB08 | tridihexethyl |
| MA03AB09 | isopropamid |
| MA03AB10 | hexocyclium |
| MA03AB11 | poldin |
| MA03AB12 | mepenzolat |
| MA03AB13 | bevonium |
| MA03AB14 | pipenzolat |
| MA03AB15 | diphemanil |
| MA03AB16 | (2-benzhydryloxyethyl)diethylmethylammoniumiodid |
| MA03AB17 | tiemoniumiodid |
| MA03AB18 | prifiniumbromid |
| MA03AB19 | timepidiumbromid |
| MA03AB21 | fenpiverin |
| MA03AB53 | oxyphenon, kombinationspræparater |
| MA03AC | syntetiske antispasmodika, amider med tertiære aminer |
| MA03AC02 | dimethylaminopropionylphenothiazin |
| MA03AC04 | nicofetamid |
| MA03AC05 | tiropramid |
| MA03AD | papaverin og derivater |
| MA03AD01 | papaverin |
| MA03AD02 | drotaverin |
| MA03AD30 | moxaverin |
| MA03AE | serotoninreceptor antagonister |
| MA03AE01 | alosetron |
| MA03AE03 | cilansetron |
| MA03AX | andre midler mod funktionelle gastrointestinale forstyrrelser |
| MA03AX01 | fenpipran |
| MA03AX02 | diisopromin |
| MA03AX03 | chlorbenzoxamin |
| MA03AX04 | pinaverin |
| MA03AX05 | fenoverin |
| MA03AX06 | idanpramin |
| MA03AX07 | proxazol |
| MA03AX08 | alverin |
| MA03AX09 | trepibuton |
| MA03AX10 | isomethepten |
| MA03AX11 | caroverin |
| MA03AX12 | phloroglucinol |
| MA03AX13 | silikoner |
| MA03AX14 | valethamat |
| MA03AX15 | pebermynteolie |
| MA03AX30 | trimethyldiphenylpropylamin |
| MA03AX58 | alverin, kombinationer |
| MA03B | belladonna og derivater, usammensatte præparater |
| MA03BA | belladonna-alkaloider, tertiære aminer |
| MA03BA01 | atropin |
| MA03BA03 | hyoscyamin |
| MA03BA04 | belladonna, totalalkaloider |
| MA03BB | belladonna-alkal.semisynt.kvartern. ammoniumforb. |
| MA03BB01 | butylscopolamin |
| MA03BB02 | methylatropin |
| MA03BB03 | methylscopolamin |
| MA03BB04 | fentonium |
| MA03BB05 | cimetropiumbromid |
| MA03BB06 | homatropinmethylbromid |
| MA03C | antispasmodika i kombination med psykoleptika |
| MA03CA | syntetiske antikolinergika i kombination med psykoleptika |
| MA03CA01 | isopropamid og psykoleptika |
| MA03CA02 | clidin og psykoleptika |
| MA03CA03 | oxyphencyclimin og psykoleptika |
| MA03CA04 | otiloniumbromid og psykoleptika |
| MA03CA05 | glycopyrron og psykoleptika |
| MA03CA06 | bevonium og psykoleptika |
| MA03CA07 | ambuton og psykoleptika |
| MA03CA08 | diphemanil og psykoleptika |
| MA03CA09 | pipenzolat og psykoleptika |
| MA03CA30 | emepron og psykoleptika |
| MA03CA34 | propanthelin og psykoleptika |
| MA03CB | belladonna og derivater i kombination med psykoleptika |
| MA03CB01 | methylscopolamin og psykoleptika |
| MA03CB02 | belladonna, totalalkaloider og psykoleptika |
| MA03CB03 | atropin og psykoleptika |
| MA03CB04 | homatropinmethylbromid og psykoleptika |
| MA03CB31 | hyoscyamin og psykoleptika |
| MA03CC | andre antispasmodika i kombination med psykoleptika |
| MA03D | antispasmodika i kombination med analgetika |
| MA03DA | syntetisk antikolinergika i kombination med analgetika |
| MA03DA01 | tropenzilon og analgetika |
| MA03DA02 | pitofenon og analgetika |
| MA03DA03 | bevonium og analgetika |
| MA03DA04 | ciclonium og analgetika |
| MA03DA05 | camylofin og analgetika |
| MA03DA06 | trospium og analgetika |
| MA03DA07 | tiemoniumiodid og analgetika |
| MA03DB | belladonna og derivater i kombination med analgetika |
| MA03DB04 | butylscopolamin og analgetika |
| MA03DC | andre antispasmodika i kombination med analgetika |
| MA03E | antispasm. og antichol. i komb. med andre stoffer |
| MA03EA | antispasmodika, psykoleptika, analgetika i kombination |
| MA03ED | antispasmodika i kombination med andre stoffer |
| MA03F | propulsives |
| MA03FA | propulsives |
| MA03FA01 | metoclopramid |
| MA03FA02 | cisaprid |
| MA03FA03 | domperidon |
| MA03FA04 | bromoprid |
| MA03FA05 | alizaprid |
| MA03FA06 | cleboprid |
| MA03FA07 | itoprid |
| MA03FA08 | cinitaprid |
| MA03FA09 | mosaprid |
| MA03FA10 | acotiamid |
| MA04 | antiemetika og midler mod kvalme |
| MA04A | antiemetika og midler mod kvalme |
| MA04AA | serotonin (5HT3) antagonister |
| MA04AA01 | ondansetron |
| MA04AA02 | granisetron |
| MA04AA03 | tropisetron |
| MA04AA04 | dolasetron |
| MA04AA05 | palonosetron |
| MA04AA55 | palonosetron, kombinationer |
| MA04AD | andre antiemetika |
| MA04AD01 | scopolamin |
| MA04AD02 | ceriumoxalat |
| MA04AD04 | chlorbutanol |
| MA04AD05 | metopimazin |
| MA04AD10 | dronabinol |
| MA04AD11 | nabilon |
| MA04AD12 | aprepitant |
| MA04AD13 | casopitant |
| MA04AD14 | rolapitant |
| MA04AD51 | scopolamin, kombinationspræparater |
| MA04AD54 | chlorbutanol, kombinationspræparater |
| MA05 | galde- og leverterapi |
| MA05A | galdeterapi |
| MA05AA | galdesyrer og derivater |
| MA05AA01 | chenodeoxycholsyre |
| MA05AA02 | ursodeoxycholsyre |
| MA05AA03 | cholinsyre |
| MA05AA04 | obeticholsyre |
| MA05AA05 | ursodoxicoltaurin |
| MA05AB | galdevejspræparater |
| MA05AB01 | nicotinylmethylamid |
| MA05AX | andre galdepræparater |
| MA05AX01 | piprozolin |
| MA05AX02 | hymecromon |
| MA05AX03 | cyclobutyrol |
| MA05AX04 | maralixibatchlorid |
| MA05AX05 | odevixibat |
| MA05AX06 | elafibranor |
| MA05B | lever og lipotropica |
| MA05BA | leverterapi |
| MA05BA01 | argininglutamat |
| MA05BA03 | silymarin |
| MA05BA04 | citiolon |
| MA05BA05 | epomediol |
| MA05BA06 | ornithinoxoglurat |
| MA05BA07 | tidiacicarginin |
| MA05BA08 | glycyrrhizinsyre |
| MA05BA09 | metadoxin |
| MA05BA10 | phospholipider |
| MA05C | galde-præparater og lipotropica i kombination |
| MA06 | midler mod obstipatio |
| MA06A | midler mod obstipatio |
| MA06AA | blødgørende midler |
| MA06AA01 | paraffinolie |
| MA06AA02 | natriumdocusat |
| MA06AA51 | paraffinolie, kombinationspræparater |
| MA06AB | kontaktlaksantia |
| MA06AB01 | oxyphenisatin |
| MA06AB02 | bisacodyl |
| MA06AB03 | dantron |
| MA06AB04 | phenolphthalein |
| MA06AB05 | ricinusolie |
| MA06AB06 | sennes-glycosider |
| MA06AB07 | cascara sagrada |
| MA06AB08 | natriumpicosulfat |
| MA06AB09 | bisoxatin |
| MA06AB20 | kontaktlaksantia i kombination |
| MA06AB30 | kontaktlaksantia i komb. m. belladonna-alkaloider |
| MA06AB52 | bisacodyl, komb. |
| MA06AB53 | dantron, kombinationspræparater |
| MA06AB56 | sennes-glycosider, kombinationspræparater |
| MA06AB57 | cascara sagrada, kombinationspræparater |
| MA06AB58 | natriumpicosulfat, kombinationspræparater |
| MA06AC | volumendannende laksantia |
| MA06AC01 | ispaghula (loppefrø) |
| MA06AC02 | ethulose |
| MA06AC03 | sterculia |
| MA06AC05 | hørfrø |
| MA06AC06 | methylcellulose |
| MA06AC07 | triticum (hvedefibre) |
| MA06AC08 | polycarbophilcalcium |
| MA06AC51 | ispaghula, kombinationspræparater |
| MA06AC53 | sterculia, kombinationspræparater |
| MA06AC55 | hørfrø, kombinationspræparater |
| MA06AD | osmotisk virkende laksantia |
| MA06AD01 | magnesiumcarbonat |
| MA06AD02 | magnesiumoxid |
| MA06AD03 | magnesiumperoxid |
| MA06AD04 | magnesiumsulfat |
| MA06AD10 | mineralsalte i kombination |
| MA06AD11 | lactulose |
| MA06AD12 | lactitol |
| MA06AD13 | natriumsulfat |
| MA06AD14 | pentaerithrityltetranitrat |
| MA06AD15 | macrogol |
| MA06AD16 | mannitol |
| MA06AD17 | natriumphosphat |
| MA06AD18 | sorbitol |
| MA06AD19 | magnesiumcitrat |
| MA06AD21 | natriumtartrat |
| MA06AD61 | lactulose, kombinationspræparater |
| MA06AD65 | macrogol, kombinationer |
| MA06AG | klystermidler |
| MA06AG01 | natriumphosphat |
| MA06AG02 | bisacodyl |
| MA06AG03 | dantron, incl. kombinationspræparater |
| MA06AG04 | glycerol |
| MA06AG06 | olie |
| MA06AG07 | sorbitol |
| MA06AG10 | natriumdocusat, incl. kombinationspræparater |
| MA06AG11 | natriumlaurilsulfoacetat, inkl. kombinationspræparater |
| MA06AG20 | klystermidler, kombinationspræparater |
| MA06AH | perifere opioidreceptor antagonister |
| MA06AH01 | methylnaltrexonbromid |
| MA06AH02 | alvimopan |
| MA06AH03 | naloxegol |
| MA06AH04 | naloxon |
| MA06AH05 | naldemedin |
| MA06AX | andre midler mod obstipatio |
| MA06AX01 | glycerol |
| MA06AX02 | carbondioxid-dannende præparater |
| MA06AX03 | lubiproston |
| MA06AX04 | linaclotid |
| MA06AX05 | prucaloprid |
| MA06AX06 | tegaserod |
| MA06AX07 | plecanatid |
| MA06AX08 | tenapanor |
| MA06AX09 | elobixibat |
| MA07 | midler mod diarré og tarminflammation/-infektion |
| MA07A | intestinale antiinfektiva |
| MA07AA | antibiotika |
| MA07AA01 | neomycin |
| MA07AA02 | nystatin |
| MA07AA03 | natamycin |
| MA07AA04 | streptomycin |
| MA07AA05 | polymyxin B |
| MA07AA06 | paromomycin |
| MA07AA07 | amphotericin |
| MA07AA08 | kanamycin |
| MA07AA09 | vancomycin |
| MA07AA10 | colistin |
| MA07AA11 | rifaximin |
| MA07AA12 | fidaxomicin |
| MA07AA13 | rifamycin |
| MA07AA51 | neomycin, kombinationer |
| MA07AA54 | streptomycin, kombinationer |
| MA07AB | sulfonamider |
| MA07AB02 | phthalylsulfathiazol |
| MA07AB03 | sulfaguanidin |
| MA07AB04 | succinylsulfathiazol |
| MA07AC | imidazol-derivater |
| MA07AC01 | miconazol |
| MA07AX | andre intestinale antiinfektiva |
| MA07AX01 | broxyquinolin |
| MA07AX02 | acetarsol |
| MA07AX03 | nifuroxazid |
| MA07AX04 | nifurzid |
| MA07B | intestinale adsorptionsmidler |
| MA07BA | kul-præparater |
| MA07BA01 | aktivt kul |
| MA07BA51 | aktivt kul, komb. |
| MA07BB | bismuth-præparater |
| MA07BC | andre intestinale adsorptionsmidler |
| MA07BC01 | pectin |
| MA07BC02 | kaolin |
| MA07BC03 | crospovidone |
| MA07BC04 | attapulgit |
| MA07BC05 | diosmectit |
| MA07BC30 | andre intestinale adsorptionsmidler, kombinationspræparater |
| MA07BC54 | attapulgit, kombinationer |
| MA07C | elektrolytter med kulhydrater |
| MA07CA | orale rehydreringssalt-formuleringer |
| MA07D | antipropulsiva |
| MA07DA | antipropulsiva |
| MA07DA01 | diphenoxylat |
| MA07DA02 | opium |
| MA07DA03 | loperamid |
| MA07DA04 | difenoxin |
| MA07DA05 | loperamidoxid |
| MA07DA06 | eluxadolin |
| MA07DA52 | morphin, kombinationer |
| MA07DA53 | loperamid, kombinationer |
| MA07E | intestinale antiinflammatorika |
| MA07EA | corticosteroider med lokal virkning |
| MA07EA01 | prednisolon |
| MA07EA02 | hydrocortison |
| MA07EA03 | prednison |
| MA07EA04 | betamethason |
| MA07EA05 | tixocortol |
| MA07EA06 | budesonid |
| MA07EA07 | beclometason |
| MA07EB | antiallergika, excl. corticosteroider |
| MA07EB01 | cromoglicinsyre |
| MA07EC | aminosalicylsyre og analoger |
| MA07EC01 | sulfasalazin |
| MA07EC02 | mesalazin |
| MA07EC03 | olsalazin |
| MA07EC04 | balsalazid |
| MA07F | mikroorganismer med virkning mod diarré |
| MA07FA | mikroorganismer med virkning mod diarré |
| MA07FA01 | mælkesyreproducerende organismer |
| MA07FA02 | saccharomyces boulardii |
| MA07FA03 | escherichia coli |
| MA07FA51 | mælkesyreproducerende organismer, kombinationer |
| MA07X | andre midler mod diarré |
| MA07XA | andre midler mod diarré |
| MA07XA01 | albumintannat |
| MA07XA02 | ceratonia |
| MA07XA03 | calcium-forbindelser |
| MA07XA04 | racecadotril |
| MA07XA06 | crofelemer |
| MA07XA51 | albumintannat, komb. |
| MA08 | midler mod fedme, excl. diætmidler |
| MA08A | midler mod fedme, excl. diætmidler |
| MA08AA | centralt virkende anoreksika |
| MA08AA01 | phentermin |
| MA08AA02 | fenfluramin |
| MA08AA03 | amfepramon |
| MA08AA04 | dexfenfluramin |
| MA08AA05 | mazindol |
| MA08AA06 | etilamfetamin |
| MA08AA07 | cathin |
| MA08AA08 | clobenzorex |
| MA08AA09 | mefenorex |
| MA08AA10 | sibutramin |
| MA08AA11 | lorcaserin |
| MA08AA12 | setmelanotid |
| MA08AA51 | phentermin og topiramat |
| MA08AA56 | ephedrin, kombinationer |
| MA08AA62 | bupropion og naltrexon |
| MA08AB | midler mod fedme med perifer virkning |
| MA08AB01 | orlistat |
| MA08AX | andre midler mod fedme |
| MA08AX01 | rimonabant |
| MA09 | digestiva, incl. enzymer |
| MA09A | digestiva, incl. enzymer |
| MA09AA | enzympræparater |
| MA09AA01 | diastase |
| MA09AA02 | multienzymer (lipase, protease etc.) |
| MA09AA03 | pepsin |
| MA09AA04 | tilactase |
| MA09AB | syrepræparater |
| MA09AB01 | glutaminsyre |
| MA09AB02 | betainhydrochlorid |
| MA09AB03 | saltsyre |
| MA09AB04 | citronsyre |
| MA09AC | enzym- og syrepræparater, kombinationer |
| MA09AC01 | pepsin og syrepræparater |
| MA09AC02 | multienzymer og syrepræparater |
| MA10 | antidiabetika |
| MA10A | insuliner og analoger |
| MA10AB | insuliner og analoger til injektion, hurtigtvirkende |
| MA10AB01 | insulin (human) |
| MA10AB02 | insulin (okse) |
| MA10AB03 | insulin (svin) |
| MA10AB04 | insulin lispro |
| MA10AB05 | insulin aspart |
| MA10AB06 | insulin glulisin |
| MA10AB30 | kombinationer af insuliner og analoger til injektion, hurtigtvirkende |
| MA10AC | insuliner og analoger til injektion, middellang virkningstid |
| MA10AC01 | insulin (human) |
| MA10AC02 | insulin (okse) |
| MA10AC03 | insulin (svin) |
| MA10AC04 | insulin lispro |
| MA10AC30 | kombinationer af insuliner og analoger til injektion, middellang virkningstid |
| MA10AD | insuliner og analoger til injektion, middel- og langtidsvirkende i kombinationer med hurtigtvirkende |
| MA10AD01 | insulin (human) |
| MA10AD02 | insulin (okse) |
| MA10AD03 | insulin (svin) |
| MA10AD04 | insulin lispro |
| MA10AD05 | insulin aspart |
| MA10AD06 | insulin degludec og insulin aspart |
| MA10AD30 | kombinationer af insuliner og analoger til injektion, middel- og langtidsvirkende i kombinationer med hurtigtvirkende |
| MA10AE | insuliner og analoger til injektion, langtidsvirkende |
| MA10AE01 | insulin (human) |
| MA10AE02 | insulin (okse) |
| MA10AE03 | insulin (svin) |
| MA10AE04 | insulin glargin |
| MA10AE05 | insulin detemir |
| MA10AE06 | insulin degludec |
| MA10AE07 | insulin icodec |
| MA10AE30 | kombinationer af insuliner og analoger til injektion, langtidsvirkende |
| MA10AE54 | insulin glargin og lixisenatid |
| MA10AE56 | insulin degludec og liraglutid |
| MA10AF | insuliner og analoger, til inhalation |
| MA10AF01 | insulin (human) |
| MA10B | blod-glucose sænkende midler, exkl. insuliner |
| MA10BA | biguanider |
| MA10BA01 | phenformin |
| MA10BA02 | metformin |
| MA10BA03 | buformin |
| MA10BB | sulfonylcarbamid |
| MA10BB01 | glibenclamid |
| MA10BB02 | chlorpropamid |
| MA10BB03 | tolbutamid |
| MA10BB04 | glibornurid |
| MA10BB05 | tolazamid |
| MA10BB06 | carbutamid |
| MA10BB07 | glipizid |
| MA10BB08 | gliquidon |
| MA10BB09 | gliclazid |
| MA10BB10 | metahexamid |
| MA10BB11 | glisoxepid |
| MA10BB12 | glimepirid |
| MA10BB31 | acetohexamid |
| MA10BC | sulfonamider (heterocycliske) |
| MA10BC01 | glymidin |
| MA10BD | komb. af orale blod-glucose sænkende midler |
| MA10BD01 | phenformin og sulfonylcarbamider |
| MA10BD02 | metformin og sulfonylcarbamider |
| MA10BD03 | metformin og rosiglitazon |
| MA10BD04 | glimepirid og rosiglitazon |
| MA10BD05 | metformin og pioglitazon |
| MA10BD06 | glimepirid og pioglitazon |
| MA10BD07 | metformin og sitagliptin |
| MA10BD08 | metformin og vildagliptin |
| MA10BD09 | pioglitazon og alogliptin |
| MA10BD10 | metformin og saxagliptin |
| MA10BD11 | metformin og linagliptin |
| MA10BD12 | pioglitazon og sitagliptin |
| MA10BD13 | metformin og alogliptin |
| MA10BD14 | metformin og repaglinid |
| MA10BD15 | metformin og dapagliflozin |
| MA10BD16 | metformin og canagliflozin |
| MA10BD17 | metformin og acarbose |
| MA10BD18 | metformin og gemigliptin |
| MA10BD19 | linagliptin og empagliflozin |
| MA10BD20 | metformin og empagliflozin |
| MA10BD21 | saxagliptin og dapagliflozin |
| MA10BD22 | metformin og evogliptin |
| MA10BD23 | metformin og ertugliflozin |
| MA10BD24 | sitagliptin og ertugliflozin |
| MA10BD25 | metformin, saxagliptin og dapagliflozin |
| MA10BD26 | metformin og lobeglitazon |
| MA10BD27 | metformin, linagliptin og empagliflozin |
| MA10BD28 | metformin og teneligliptin |
| MA10BD29 | sitagliptin og dapagliflozin |
| MA10BD30 | gemigliptin og dapagliflozin |
| MA10BF | alfa-glucosidase hæmmere |
| MA10BF01 | acarbose |
| MA10BF02 | miglitol |
| MA10BF03 | voglibose |
| MA10BG | thiazolindioner |
| MA10BG01 | troglitazon |
| MA10BG02 | rosiglitazon |
| MA10BG03 | pioglitazon |
| MA10BG04 | lobeglitazon |
| MA10BH | dipeptidylpeptidase 4 (DPP-4) hæmmere |
| MA10BH01 | sitagliptin |
| MA10BH02 | vildagliptin |
| MA10BH03 | saxagliptin |
| MA10BH04 | alogliptin |
| MA10BH05 | linagliptin |
| MA10BH06 | gemigliptin |
| MA10BH07 | evogliptin |
| MA10BH08 | teneligliptin |
| MA10BH51 | sitagliptin og simvastatin |
| MA10BH52 | gemigliptin og rosuvastatin |
| MA10BJ | glucagon-lignende peptid-1 receptor (GLP-1) analog |
| MA10BJ01 | exenatid |
| MA10BJ02 | liraglutid |
| MA10BJ03 | lixisenatid |
| MA10BJ04 | albiglutid |
| MA10BJ05 | dulaglutid |
| MA10BJ06 | semaglutid |
| MA10BJ07 | beinaglutid |
| MA10BK | natrium-glucose co-transporter 2 (SGLT2) inhibitorer |
| MA10BK01 | dapagliflozin |
| MA10BK02 | canagliflozin |
| MA10BK03 | empagliflozin |
| MA10BK04 | ertugliflozin |
| MA10BK05 | ipragliflozin |
| MA10BK06 | sotagliflozin |
| MA10BK07 | luseogliflozin |
| MA10BK08 | bexagliflozin |
| MA10BK09 | enavogliflozin |
| MA10BX | andre blod-glucose sænkende midler, ekskl. insuliner |
| MA10BX01 | guar gummi |
| MA10BX02 | repaglinid |
| MA10BX03 | nateglinid |
| MA10BX05 | pramlintid |
| MA10BX06 | benfluorex |
| MA10BX08 | mitiglinid |
| MA10BX15 | imeglimin |
| MA10BX16 | tirzepatid |
| MA10BX17 | carfloglitazar |
| MA10BX18 | dorzagliatin |
| MA10X | andre midler til behandling af diabetes |
| MA10XA | aldose-reductase hæmmere |
| MA10XA01 | tolrestat |
| MA10XX | andre midler mod diabetes |
| MA10XX01 | teplizumab |
| MA10XX02 | donislecel |
| MA11 | vitaminer |
| MA11A | multivitaminer, kombinationer |
| MA11AA | multivitaminer med mineraler |
| MA11AA01 | multivitaminer og jern |
| MA11AA02 | multivitaminer og calcium |
| MA11AA03 | multivitaminer og andre mineraler, incl. komb. |
| MA11AA04 | multivitaminer og mineraler i spormængde |
| MA11AB | multivitaminer, andre kombinationer |
| MA11B | multivitaminer, usammensatte |
| MA11BA | multivitaminer, usammensatte |
| MA11C | vitamin a og d, incl. kombinationer af disse |
| MA11CA | vitamin a, usammensatte præparater |
| MA11CA01 | retinol (vitamin a) |
| MA11CA02 | betacaroten |
| MA11CB | vitamin A og D i kombination |
| MA11CC | vitamin D og analoger |
| MA11CC01 | ergocalciferol |
| MA11CC02 | dihydrotachysterol |
| MA11CC03 | alfacalcidol |
| MA11CC04 | calcitriol |
| MA11CC05 | colecalciferol |
| MA11CC06 | calcifediol |
| MA11CC20 | kombinationer af vitamin D og analoger |
| MA11CC55 | cholecalciferol, kombinationer |
| MA11D | vitamin B1, også i komb. med vitamin B6 and B12 |
| MA11DA | thiamin (vitamin B1), usammensatte præparater |
| MA11DA01 | thiamin (vitamin B1) |
| MA11DA02 | sulbutiamin |
| MA11DA03 | benfotiamin |
| MA11DB | vitamin B1 i komb. med vit. B6 og/eller vit. B12 |
| MA11E | vitamin B-complex, incl. kombinationer |
| MA11EA | vitamin B-complex, uden andre stoffer |
| MA11EB | vitamin B-complex med vitamin C |
| MA11EC | vitamin B-complex med mineraler |
| MA11ED | vitamin B-complex med anaboliske steroider |
| MA11EX | vitamin B-complex, andre kombinationer |
| MA11G | ascorbinsyre (vitamin C), incl. kombinationer |
| MA11GA | ascorbinsyre (vitamin C), usammensatte præp. |
| MA11GA01 | ascorbinsyre (vitamin C) |
| MA11GB | ascorbinsyre (vitamin C), kombinationer |
| MA11GB01 | ascorbinsyre (vitamin C) og calcium |
| MA11H | andre usammensatte vitaminpræparater |
| MA11HA | andre usammensatte vitaminpræparater |
| MA11HA01 | nicotinamid |
| MA11HA02 | pyridoxin (vitamin B6) |
| MA11HA03 | tocopherol (vitamin E) |
| MA11HA04 | riboflavin (vitamin B2) |
| MA11HA05 | biotin |
| MA11HA06 | pyridoxalphosphat |
| MA11HA07 | inositol |
| MA11HA08 | tocofersolan |
| MA11HA30 | dexpanthenol |
| MA11HA31 | calciumpantothenat |
| MA11HA32 | pantethin |
| MA11J | andre sammensatte vitaminpræparater |
| MA11JA | kombinationer af vitaminer |
| MA11JB | vitaminer med mineraler |
| MA11JC | vitaminer, andre kombinationer |
| MA12 | mineralpræparater |
| MA12A | calcium |
| MA12AA | calcium |
| MA12AA01 | calciumphosphat |
| MA12AA02 | calciumglubionat |
| MA12AA03 | calciumgluconat |
| MA12AA04 | calciumcarbonat |
| MA12AA05 | calciumlactat |
| MA12AA06 | calciumlactogluconat |
| MA12AA07 | calciumchlorid |
| MA12AA08 | calciumglycerylphosphat |
| MA12AA09 | calciumcitrat-lysin complex |
| MA12AA10 | calciumglucoheptonat |
| MA12AA11 | calciumpangamat |
| MA12AA13 | calciumcitrat |
| MA12AA20 | calcium (forskellige salte i kombination) |
| MA12AA30 | calciumlaevulat |
| MA12AX | calcium, kombinationer med D-vitamin og/eller andre stoffer |
| MA12B | kalium |
| MA12BA | kalium |
| MA12BA01 | kaliumchlorid |
| MA12BA02 | kaliumcitrat |
| MA12BA03 | kaliumhydrogentartrat |
| MA12BA04 | kaliumhydrogencarbonat |
| MA12BA05 | kaliumgluconat |
| MA12BA30 | kalium (forskellige salte i kombination) |
| MA12BA51 | kaliumchlorid, kombinationer |
| MA12C | andre mineralpræparater |
| MA12CA | natrium |
| MA12CA01 | natriumchlorid |
| MA12CA02 | natriumsulfat |
| MA12CB | zink |
| MA12CB01 | zinksulfat |
| MA12CB02 | zinkgluconat |
| MA12CB03 | zinkprotein-kompleks |
| MA12CC | magnesium |
| MA12CC01 | magnesiumchlorid |
| MA12CC02 | magnesiumsulfat |
| MA12CC03 | magnesiumgluconat |
| MA12CC04 | magnesiumcitrat |
| MA12CC05 | magnesiumaspartat |
| MA12CC06 | magnesiumlactat |
| MA12CC07 | magnesiumlevulinat |
| MA12CC08 | magnesiumpidolat |
| MA12CC09 | magnesiumorotat |
| MA12CC10 | magnesiumoxid |
| MA12CC30 | magnesium (forskellige salte i kombination) |
| MA12CD | fluorid |
| MA12CD01 | natriumfluorid |
| MA12CD02 | natriummonofluorophosphat |
| MA12CD51 | fluorid, kombinationer |
| MA12CE | selen |
| MA12CE01 | natriumselenat |
| MA12CE02 | natriumselenit |
| MA12CX | diverse mineralpræparater |
| MA13 | tonika |
| MA13A | tonika |
| MA14 | anaboliske midler til systemisk brug |
| MA14A | anaboliske steroider |
| MA14AA | androstan-derivater |
| MA14AA01 | androstanolon |
| MA14AA02 | stanozolol |
| MA14AA03 | metandienon |
| MA14AA04 | metenolon |
| MA14AA05 | oxymetholon |
| MA14AA06 | quinbolon |
| MA14AA07 | prasteron |
| MA14AA08 | oxandrolon |
| MA14AA09 | norethandrolon |
| MA14AB | estren-derivater |
| MA14AB01 | nandrolon |
| MA14AB02 | ethylestrenol |
| MA14AB03 | oxaboloncipionat |
| MA14B | andre anaboliske midler |
| MA15 | appetitstimulerende midler |
| MA16 | andre midler til fordøjelsesorganer og stofskifte |
| MA16A | andre midler til fordøjelsesorganer og stofskifte |
| MA16AA | aminosyrer og derivater |
| MA16AA01 | levocarnitin |
| MA16AA02 | ademetionin |
| MA16AA03 | levoglutamid |
| MA16AA04 | mercaptamin |
| MA16AA05 | cargluminsyre |
| MA16AA06 | betain |
| MA16AA07 | metreleptin |
| MA16AB | enzymer |
| MA16AB01 | alglucerase |
| MA16AB02 | imiglucerase |
| MA16AB03 | agalsidase alfa |
| MA16AB04 | agalsidase beta |
| MA16AB05 | laronidase |
| MA16AB06 | sacrosidase |
| MA16AB07 | alglucosidase alfa |
| MA16AB08 | galsulfase |
| MA16AB09 | idursulfase |
| MA16AB10 | velaglucerase alfa |
| MA16AB11 | taliglucerase alfa |
| MA16AB12 | elosulfase alfa |
| MA16AB13 | asfotase alfa |
| MA16AB14 | sebelipase alfa |
| MA16AB15 | velmanase alfa |
| MA16AB16 | idursulfase beta |
| MA16AB17 | cerliponase alfa |
| MA16AB18 | vestronidase alfa |
| MA16AB19 | pegvaliase |
| MA16AB20 | pegunigalsidase Alfa |
| MA16AB21 | atidarsagene autotemcel |
| MA16AB22 | avalglucosidase alfa |
| MA16AB23 | cipaglucosidase alfa |
| MA16AB24 | pegzilarginase |
| MA16AB25 | olipudase alfa |
| MA16AB26 | eladocagene exuparvovec |
| MA16AB27 | pabinafusp alfa |
| MA16AX | div. midler til fordøjelsesorganer og stofskifte |
| MA16AX01 | tiotinsyre |
| MA16AX02 | anetholtrithion |
| MA16AX03 | natriumphenylbutyrat |
| MA16AX04 | nitisinon |
| MA16AX05 | zinkacetat |
| MA16AX06 | miglustat |
| MA16AX07 | sapropterin |
| MA16AX08 | teduglutid |
| MA16AX09 | glycerolphenylbutyrat |
| MA16AX10 | eliglustat |
| MA16AX11 | natriumbenzoat |
| MA16AX12 | trientin |
| MA16AX13 | uridintriacetat |
| MA16AX14 | migalastat |
| MA16AX15 | telotristat |
| MA16AX16 | givosiran |
| MA16AX17 | triheptanoin |
| MA16AX18 | lumasiran |
| MA16AX19 | fosdenopterin |
| MA16AX20 | lonafarnib |
| MA16AX21 | elivaldogene autotemcel |
| MA16AX22 | tiomolibdinsyre |
| MA16AX23 | leriglitazon |
| MA16AX24 | govorestat |
| MA16AX30 | natriumbenzoat og natriumphenylacetat |
| MB | Blod og bloddannende organer |
| MB01 | antithrombosemidler |
| MB01A | antithrombosemidler |
| MB01AA | vitamin k antagonister |
| MB01AA01 | dicoumarol |
| MB01AA02 | phenindion |
| MB01AA03 | warfarin |
| MB01AA04 | phenprocoumon |
| MB01AA07 | acenocoumarol |
| MB01AA08 | ethyl biscoumacetat |
| MB01AA09 | clorindion |
| MB01AA10 | diphenadion |
| MB01AA11 | tioclomarol |
| MB01AA12 | fluindion |
| MB01AB | heparin-gruppen |
| MB01AB01 | heparin |
| MB01AB02 | antithrombin |
| MB01AB04 | dalteparin |
| MB01AB05 | enoxaparin |
| MB01AB06 | nadroparin |
| MB01AB07 | parnaparin |
| MB01AB08 | reviparin |
| MB01AB09 | danaparoid |
| MB01AB10 | tinzaparin |
| MB01AB11 | sulodexid |
| MB01AB12 | bemiparin |
| MB01AB51 | heparin, kombinationer |
| MB01AC | blodplade-aggregationshæmmere excl. heparin |
| MB01AC01 | ditazol |
| MB01AC02 | cloricromen |
| MB01AC03 | picotamid |
| MB01AC04 | clopidogrel |
| MB01AC05 | ticlopidin |
| MB01AC06 | acetylsalicylsyre |
| MB01AC07 | dipyridamol |
| MB01AC08 | carbasalat calcium |
| MB01AC09 | epoprostenol |
| MB01AC10 | indobufen |
| MB01AC11 | iloprost |
| MB01AC13 | abciximab |
| MB01AC15 | aloxiprin |
| MB01AC16 | eptifibatid |
| MB01AC17 | tirofiban |
| MB01AC18 | triflusal |
| MB01AC19 | beraprost |
| MB01AC21 | treprostinil |
| MB01AC22 | prasugrel |
| MB01AC23 | cilostazol |
| MB01AC24 | ticagrelor |
| MB01AC25 | cangrelor |
| MB01AC26 | vorapaxar |
| MB01AC27 | selexipag |
| MB01AC28 | limaprost |
| MB01AC30 | kombinationer af blodplade-aggregationshæmmere excl. heparin |
| MB01AC56 | acetylsalicylsyre, kombinationer med protonpumpeinhibitorer |
| MB01AD | enzymer |
| MB01AD01 | streptokinase |
| MB01AD02 | alteplase |
| MB01AD03 | anistreplase |
| MB01AD04 | urokinase |
| MB01AD05 | fibrinolysin |
| MB01AD06 | brinase |
| MB01AD07 | reteplase |
| MB01AD08 | saruplase |
| MB01AD09 | ancrod |
| MB01AD10 | drotrecogin alfa (aktiveret) |
| MB01AD11 | tenecteplase |
| MB01AD12 | protein C |
| MB01AD13 | apadamtase alfa og cinaxadamtase alfa |
| MB01AE | direkte virkende thrombin-inhibitorer |
| MB01AE01 | desirudin |
| MB01AE02 | lepirudin |
| MB01AE03 | argatroban |
| MB01AE04 | melagatran |
| MB01AE05 | ximelagatran |
| MB01AE06 | bivalirudin |
| MB01AE07 | dabigatranetexilat |
| MB01AF | direkte faktor Xa-hæmmere |
| MB01AF01 | rivaroxaban |
| MB01AF02 | apixaban |
| MB01AF03 | edoxaban |
| MB01AF04 | betrixaban |
| MB01AF51 | rivaroxaban og acetylsalicylsyre |
| MB01AX | andre antithrombosemidler |
| MB01AX01 | defibrotid |
| MB01AX04 | dermatansulfat |
| MB01AX05 | fondaparinux |
| MB01AX07 | caplacizumab |
| MB02 | hæmostatika |
| MB02A | antifibrinolytika |
| MB02AA | aminosyrer |
| MB02AA01 | aminocapronsyre |
| MB02AA02 | tranexamsyre |
| MB02AA03 | aminomethylbenzoesyre |
| MB02AB | proteinase hæmmere |
| MB02AB01 | aprotinin |
| MB02AB02 | alfa1 antitrypsin |
| MB02AB04 | camostat |
| MB02AB05 | ulinastatin |
| MB02B | vitamin K og andre hæmostatika |
| MB02BA | vitamin K |
| MB02BA01 | phytomenadion |
| MB02BA02 | menadion |
| MB02BB | fibrinogen |
| MB02BB01 | human fibrinogen |
| MB02BC | hæmostatika til lokal brug |
| MB02BC01 | absorberbar gelatinesvamp |
| MB02BC02 | oxideret cellulose |
| MB02BC03 | tetragalacturonsyre hydroxymethylester |
| MB02BC05 | adrenalon |
| MB02BC06 | thrombin |
| MB02BC07 | collagen |
| MB02BC08 | calciumalginat |
| MB02BC09 | adrenalin |
| MB02BC30 | kombinationer af haemostatica til lokal brug |
| MB02BD | blodkoagulationsfaktorer |
| MB02BD01 | koagulationsfaktor IX, II, VII og X i kombination |
| MB02BD02 | koagulationsfaktor VIII |
| MB02BD03 | faktor VIII-hæmmer passerende koagulationsfaktor |
| MB02BD04 | koagulationsfaktor IX |
| MB02BD05 | koagulationsfaktor VII |
| MB02BD06 | von Willebrand faktor og koag.faktor VIII i komb. |
| MB02BD07 | koagulationsfaktor XIII |
| MB02BD08 | koagulationsfaktor VIIa |
| MB02BD10 | von Willebrand faktor |
| MB02BD11 | catridecacog |
| MB02BD13 | koagulationsfaktor X |
| MB02BD14 | susoctocog alfa |
| MB02BD15 | valoctocogene roxaparvovec |
| MB02BD16 | etranacogen dezaparvovec |
| MB02BD17 | fidanacogene elaparvovec |
| MB02BD30 | thrombin |
| MB02BX | andre systemiske hæmostatika |
| MB02BX01 | etamsylat |
| MB02BX02 | carbazochrom |
| MB02BX03 | batroxobin |
| MB02BX04 | romiplostim |
| MB02BX05 | eltrombopag |
| MB02BX06 | emicizumab |
| MB02BX07 | lusutrombopag |
| MB02BX08 | avatrombopag |
| MB02BX09 | fostamatinib |
| MB02BX10 | concizumab |
| MB03 | midler mod anæmi |
| MB03A | jernpræparater |
| MB03AA | jern(II), orale midler |
| MB03AA01 | ferroglycinsulfat |
| MB03AA02 | ferrofumarat |
| MB03AA03 | ferrogluconat |
| MB03AA04 | ferrocarbonat |
| MB03AA05 | ferrochlorid |
| MB03AA06 | ferrosuccinat |
| MB03AA07 | ferrosulfat |
| MB03AA08 | ferrotartrat |
| MB03AA09 | ferroaspartat |
| MB03AA10 | ferroascorbat |
| MB03AA11 | ferroiodid |
| MB03AA12 | ferronatriumcitrat |
| MB03AB | jern(III), orale midler |
| MB03AB01 | ferrinatriumcitrat |
| MB03AB02 | ferrioxidsaccharat |
| MB03AB03 | natriumfer-edetat |
| MB03AB04 | ferrihydroxid |
| MB03AB05 | ferrioxid-polymaltosekomplekser |
| MB03AB07 | chondroitinsulfat-jern komplex |
| MB03AB08 | ferriacetyltransferrin |
| MB03AB09 | ferriproteinsuccinylat |
| MB03AB10 | ferrimaltol |
| MB03AC | jern, parenterale midler |
| MB03AD | jern i kombination med folsyre |
| MB03AD01 | ferroaminosyrekompleks og folsyre |
| MB03AD02 | ferrofumarat og folsyre |
| MB03AD03 | ferrosulfat og folsyre |
| MB03AD04 | ferrioxid-polymaltosekomplekser og folsyre |
| MB03AD05 | ferrogluconat og folsyre |
| MB03AE | jern i andre kombinationer |
| MB03AE01 | jern, vitamin B12 og folsyre |
| MB03AE02 | jern, multivitaminer og folsyre |
| MB03AE03 | jern og multivitaminer |
| MB03AE04 | jern, multivitaminer og mineraler |
| MB03AE10 | diverse kombinationer, inkluderende jern |
| MB03B | vitamin B12 og folsyre |
| MB03BA | vitamin B12 (cyanocobalamin og derivater) |
| MB03BA01 | cyanocobalamin |
| MB03BA02 | cyanocobalamin-tannin-komplex |
| MB03BA03 | hydroxocobalamin |
| MB03BA04 | cobamamid |
| MB03BA05 | mecobalamin |
| MB03BA51 | cyanocobalamin, kombinationer |
| MB03BA53 | hydroxocobalamin, komb. |
| MB03BB | folsyre og derivater |
| MB03BB01 | folsyre |
| MB03BB51 | folsyre, kombinationer |
| MB03X | andre midler mod anæmi |
| MB03XA | andre midler mod anæmi |
| MB03XA01 | erythropoietin |
| MB03XA02 | darbepoetin alfa |
| MB03XA03 | methoxypolyethylenglycol-epoetin beta |
| MB03XA04 | peginesatid |
| MB03XA05 | roxadustat |
| MB03XA06 | luspatercept |
| MB03XA07 | daprodustat |
| MB03XA08 | vadadustat |
| MB03XA09 | molidustat |
| MB03XA10 | efepoetin alfa |
| MB05 | blodsubstitutter og perfusionsvæsker |
| MB05A | blod og beslægtede produkter |
| MB05AA | blodsubstitutter og plasmaprotein-fraktioner |
| MB05AA01 | albumin |
| MB05AA02 | andre plasmaprotein-fraktioner |
| MB05AA03 | fluorocarbon blodsubstitutter |
| MB05AA05 | dextran |
| MB05AA06 | gelatineforbindelser |
| MB05AA07 | hydroxyethylstivelse |
| MB05AA08 | hæmoglobin-crosfumaril |
| MB05AA09 | hæmoglobin raffimer |
| MB05AA10 | hæmoglobin glutamer (bovin) |
| MB05AX | andre blodprodukter |
| MB05AX01 | erythrocytter |
| MB05AX02 | thrombocytter |
| MB05AX03 | blodplasma |
| MB05AX04 | stamceller fra navlesnorsblod |
| MB05B | infusionsvæsker |
| MB05BA | opløsninger til parenteral ernæring |
| MB05BA01 | aminosyrer |
| MB05BA02 | fedtemulsioner |
| MB05BA03 | kulhydrater |
| MB05BA04 | proteinhydrolysater |
| MB05BA10 | kombinationer af opløsninger til parenteral ernæring |
| MB05BB | opløsninger med virkning på elektrolytbalancen |
| MB05BB01 | elektrolytter |
| MB05BB02 | elektrolytter med kulhydrater |
| MB05BB03 | trometamol |
| MB05BB04 | elektrolytter i komb. med andre stoffer |
| MB05BC | opløsninger til osmotisk diurese |
| MB05BC01 | mannitol |
| MB05BC02 | carbamid |
| MB05C | skyllevæsker |
| MB05CA | antiinfektiva |
| MB05CA01 | cetylpyridin |
| MB05CA02 | chlorhexidin |
| MB05CA03 | nitrofural |
| MB05CA04 | sulfamethizol |
| MB05CA05 | taurolidin |
| MB05CA06 | mandelsyre |
| MB05CA07 | noxytiolin |
| MB05CA08 | ethacridinlactat |
| MB05CA09 | neomycin |
| MB05CA10 | kombinationer af antiinfectiva |
| MB05CB | saltopløsninger |
| MB05CB01 | natriumchlorid |
| MB05CB02 | natriumcitrat |
| MB05CB03 | magnesiumcitrat |
| MB05CB04 | natriumhydrogencarbonat |
| MB05CB10 | kombinationer af saltopløsninger |
| MB05CX | andre skyllevæsker |
| MB05CX01 | glucose |
| MB05CX02 | sorbitol |
| MB05CX03 | glycin |
| MB05CX04 | mannitol |
| MB05CX10 | kombinationer af andre skyllevæsker |
| MB05D | peritonealdialysevæsker |
| MB05DA | isotoniske opløsninger |
| MB05DB | hypertoniske opløsninger |
| MB05X | infusionskoncentrater |
| MB05XA | elektrolyt-opløsninger |
| MB05XA01 | kaliumchlorid |
| MB05XA02 | natriumhydrogencarbonat |
| MB05XA03 | natriumchlorid |
| MB05XA04 | ammoniumchlorid |
| MB05XA05 | magnesiumsulfat |
| MB05XA06 | kaliumphosphat, incl. komb. m. andre kaliumsalte |
| MB05XA07 | calciumchlorid |
| MB05XA08 | natriumacetat |
| MB05XA09 | natriumphosphat |
| MB05XA10 | magnesiumphosphat |
| MB05XA11 | magnesiumchlorid |
| MB05XA12 | zinkchlorid |
| MB05XA13 | saltsyre |
| MB05XA14 | natriumglycerophosphat |
| MB05XA15 | kaliumlactat |
| MB05XA16 | kardioplegi-opløsninger |
| MB05XA17 | kaliumacetat |
| MB05XA18 | zinksulfat |
| MB05XA19 | calciumgluconat |
| MB05XA20 | natriumselenit |
| MB05XA30 | kombinationer af elektrolytter |
| MB05XA31 | elektrolytter i komb. med andre stoffer |
| MB05XB | aminosyrer |
| MB05XB01 | argininhydrochlorid |
| MB05XB02 | alanylglutamin |
| MB05XB03 | lysin |
| MB05XC | vitaminer |
| MB05XX | andre infusionskoncentrater |
| MB05XX02 | trometamol |
| MB05Z | hæmodialysevæsker og hæmofiltrater |
| MB05ZA | hæmodialysekoncentrater |
| MB05ZB | hæmofiltrater |
| MB06 | andre hæmatologiske midler |
| MB06A | andre hæmatologiske midler |
| MB06AA | enzymer |
| MB06AA02 | fibrinolysin og desoxyribonuclease |
| MB06AA03 | hyaluronidase |
| MB06AA04 | chymotrypsin |
| MB06AA07 | trypsin |
| MB06AA10 | desoxyribonuclease |
| MB06AA55 | streptokinase, kombinationer |
| MB06AB | hæmprodukter |
| MB06AB01 | hæmin |
| MB06AC | midler til arvelig angioødem |
| MB06AC01 | C1-inhibitor, fra plasma |
| MB06AC02 | icatibant |
| MB06AC03 | ecallantid |
| MB06AC04 | conestat alfa |
| MB06AC05 | lanadelumab |
| MB06AC06 | berotralstat |
| MB06AC07 | garadacimab |
| MB06AX | andre hæmatologiske midler |
| MB06AX01 | crizanlizumab |
| MB06AX02 | betibeglogen autotemcel |
| MB06AX03 | voxelotor |
| MB06AX04 | mitapivat |
| MB06AX05 | exagamglogene autotemcel |
| MC | Kardiovaskulære system |
| MC01 | hjerteterapi |
| MC01A | hjerteglycosider |
| MC01AA | digitalis-glycosider |
| MC01AA01 | acetyldigitoxin |
| MC01AA02 | acetyldigoxin |
| MC01AA03 | digitalisblad |
| MC01AA04 | digitoxin |
| MC01AA05 | digoxin |
| MC01AA06 | lanatosid C |
| MC01AA07 | deslanosid |
| MC01AA08 | metildigoxin |
| MC01AA09 | gitoformat |
| MC01AA52 | acetyldigoxin, komb. |
| MC01AB | scilla-glycosider |
| MC01AB01 | proscillaridin |
| MC01AB51 | proscillaridin, kombinationer |
| MC01AC | strophantus-glycosider |
| MC01AC01 | g-strophanthin |
| MC01AC03 | cymarin |
| MC01AX | andre hjerteglycosider |
| MC01AX02 | peruvosid |
| MC01B | antiarytmika, klasse I og III |
| MC01BA | antiarytmika, klasse I a |
| MC01BA01 | quinidin |
| MC01BA02 | procainamid |
| MC01BA03 | disopyramid |
| MC01BA04 | spartein |
| MC01BA05 | ajmalin |
| MC01BA08 | prajmalin |
| MC01BA12 | lorajmin |
| MC01BA13 | hydroquinidin |
| MC01BA51 | quinidin, kombinationer |
| MC01BA71 | quinidin, kombination med psykoleptika |
| MC01BB | antiarytmika, klasse I b |
| MC01BB01 | lidocain |
| MC01BB02 | mexiletin |
| MC01BB03 | tocainid |
| MC01BB04 | aprindin |
| MC01BC | antiarytmika, klasse I c |
| MC01BC03 | propafenon |
| MC01BC04 | flecainid |
| MC01BC07 | lorcainid |
| MC01BC08 | encainid |
| MC01BC09 | ethacizin |
| MC01BD | antiarytmika, klasse III |
| MC01BD01 | amiodaron |
| MC01BD02 | bretyliumtosilat |
| MC01BD03 | bunaftin |
| MC01BD04 | dofetilid |
| MC01BD05 | ibutilid |
| MC01BD06 | tedisamil |
| MC01BD07 | dronedaron |
| MC01BG | andre antiarytmika, klasse I og III |
| MC01BG01 | moracizin |
| MC01BG07 | cibenzolin |
| MC01BG11 | vernakalant |
| MC01C | hjertestimulerende midler excl. hjerteglycosider |
| MC01CA | adrenerge og dopaminerge midler |
| MC01CA01 | etilefrin |
| MC01CA02 | isoprenalin |
| MC01CA03 | noradrenalin |
| MC01CA04 | dopamin |
| MC01CA05 | norfenefrin |
| MC01CA06 | phenylephrin |
| MC01CA07 | dobutamin |
| MC01CA08 | oxedrin |
| MC01CA09 | metaraminol |
| MC01CA10 | methoxamin |
| MC01CA11 | mephentermin |
| MC01CA12 | dimetofrin |
| MC01CA13 | prenalterol |
| MC01CA14 | dopexamin |
| MC01CA15 | gepefrin |
| MC01CA16 | ibopamin |
| MC01CA17 | midodrin |
| MC01CA18 | octopamin |
| MC01CA19 | fenoldopam |
| MC01CA21 | cafedrin |
| MC01CA22 | arbutamin |
| MC01CA23 | theodrenalin |
| MC01CA24 | adrenalin |
| MC01CA25 | amezinium metilsulfat |
| MC01CA26 | efedrin |
| MC01CA27 | droxidopa |
| MC01CA28 | centhaquin |
| MC01CA30 | kombinationer af adrenerge og dopaminerge midler |
| MC01CA51 | etilefrin, komb. |
| MC01CE | phosphodiesterase hæmmere |
| MC01CE01 | amrinon |
| MC01CE02 | milrinon |
| MC01CE03 | enoximon |
| MC01CE04 | bucladesin |
| MC01CX | andre hjertestimulerende midler |
| MC01CX06 | angiotensinamid |
| MC01CX07 | xamoterol |
| MC01CX08 | levosimendan |
| MC01CX09 | angiotensin II |
| MC01CX10 | omecamtiv mecarbil |
| MC01D | vasodilatorer anvendt ved hjertesygdomme |
| MC01DA | organiske nitrater |
| MC01DA02 | glyceryltrinitrat |
| MC01DA04 | methylpropylpropandioldinitrat |
| MC01DA05 | pentaerithrityltetranitrat |
| MC01DA07 | propatylnitrat |
| MC01DA08 | isosorbiddinitrat |
| MC01DA09 | trolnitrat |
| MC01DA13 | erithrityltetranitrat |
| MC01DA14 | isosorbidmononitrat |
| MC01DA20 | organiske nitrater i kombinationer |
| MC01DA38 | tenitramin |
| MC01DA52 | glyceryltrinitrat, kombinationer |
| MC01DA54 | methylpropylpropandioldinitrat, kombinationer |
| MC01DA55 | pentaerithrityltetranitrat, kombinationer |
| MC01DA57 | propatylnitrat, kombinationer |
| MC01DA58 | isosorbidedinitrat, kombinationer |
| MC01DA59 | trolnitrat, kombinationer |
| MC01DA63 | erithrityltetranitrat, kombinationer |
| MC01DA70 | kombinationer med psykoleptika |
| MC01DB | quinolon-vasodilatorer |
| MC01DB01 | flosequinan |
| MC01DX | andre vasodilatorer anvendt ved hjertesygdom |
| MC01DX01 | itramintosilat |
| MC01DX02 | prenylamin |
| MC01DX03 | oxyfedrin |
| MC01DX04 | benziodaron |
| MC01DX05 | carbocromen |
| MC01DX06 | hexobendin |
| MC01DX07 | etafenon |
| MC01DX08 | heptaminol |
| MC01DX09 | imolamin |
| MC01DX10 | dilazep |
| MC01DX11 | trapidil |
| MC01DX12 | molsidomin |
| MC01DX13 | efloxat |
| MC01DX14 | cinepazet |
| MC01DX15 | cloridarol |
| MC01DX16 | nicorandil |
| MC01DX18 | linsidomin |
| MC01DX19 | nesiritid |
| MC01DX21 | serelaxin |
| MC01DX22 | vericiguat |
| MC01DX51 | itramintosilat, kombinationspræparater |
| MC01DX52 | prenylamin, kombinationspræparater |
| MC01DX53 | oxyfedrin, kombinationspræparater |
| MC01DX54 | benziodaron, kombinationpræparater |
| MC01E | andre midler til hjerteterapi |
| MC01EA | prostaglandiner |
| MC01EA01 | alprostadil |
| MC01EB | andre hjertemidler |
| MC01EB02 | campher |
| MC01EB03 | indometacin |
| MC01EB04 | crataegus-glycosider |
| MC01EB05 | creatinolphosphat |
| MC01EB06 | fosfocreatin |
| MC01EB07 | fructose 1,6-diphosphat |
| MC01EB09 | ubidecarenon |
| MC01EB10 | adenosin |
| MC01EB11 | tiracizin |
| MC01EB13 | acadesin |
| MC01EB15 | trimetazidin |
| MC01EB16 | ibuprofen |
| MC01EB17 | ivabradin |
| MC01EB18 | ranolazin |
| MC01EB21 | regadenoson |
| MC01EB22 | meldonium |
| MC01EB23 | tiazotinsyre |
| MC01EB24 | mavacamten |
| MC01EB25 | acoramidis |
| MC01EX | andre hjertemidler, kombinationer |
| MC02 | antihypertensiva |
| MC02A | antiadrenerge midler, centralt virkende |
| MC02AA | rauwolfia-alkaloider |
| MC02AA01 | rescinnamin |
| MC02AA02 | reserpin |
| MC02AA03 | rauwolfia alkaloider i blanding |
| MC02AA04 | rauwolfia alkaloider, hele roden |
| MC02AA05 | deserpidin |
| MC02AA06 | methoserpidin |
| MC02AA07 | bietaserpin |
| MC02AA52 | reserpin, kombinationspræparater |
| MC02AA53 | rauwolfia alkaloider i blanding, kombinationspræp. |
| MC02AA57 | bietaserpin, kombinationspræparater |
| MC02AB | methyldopa |
| MC02AB01 | methyldopa (L-form) |
| MC02AB02 | methyldopa (racemisk) |
| MC02AC | imidazolin-receptor agonister |
| MC02AC01 | clonidin |
| MC02AC02 | guanfacin |
| MC02AC04 | tolonidin |
| MC02AC05 | moxonidin |
| MC02AC06 | rilmenidin |
| MC02B | antiadrenerge midler, ganglie-blokerende |
| MC02BA | sulfonium-derivater |
| MC02BA01 | trimetaphan |
| MC02BB | sekundære og tertiære aminer |
| MC02BB01 | mecamylamin |
| MC02BC | bis-kvaternære ammonium-forbindelser |
| MC02C | antiadrenerge midler, perifert virkende |
| MC02CA | alfa-adrenoceptor blokerende midler |
| MC02CA01 | prazosin |
| MC02CA02 | indoramin |
| MC02CA03 | trimazosin |
| MC02CA04 | doxazosin |
| MC02CA06 | urapidil |
| MC02CC | guanidin-derivater |
| MC02CC01 | betanidin |
| MC02CC02 | guanethidin |
| MC02CC03 | guanoxan |
| MC02CC04 | debrisoquin |
| MC02CC05 | guanoclor |
| MC02CC06 | guanazodin |
| MC02CC07 | guanoxabenz |
| MC02D | arteriolær glat muskulatur, midler m. virkn. på |
| MC02DA | thiazid-derivater |
| MC02DA01 | diazoxid |
| MC02DB | hydrazinophthalazin-derivater |
| MC02DB01 | dihydralazin |
| MC02DB02 | hydralazin |
| MC02DB03 | endralazin |
| MC02DB04 | cadralazin |
| MC02DC | pyrimidin-derivater |
| MC02DC01 | minoxidil |
| MC02DD | nitroferricyanid-derivater |
| MC02DD01 | nitroprussid |
| MC02DG | guanidin-derivater |
| MC02DG01 | pinacidil |
| MC02K | andre antihypertensiva |
| MC02KA | alkaloider, excl. rauwolfia |
| MC02KA01 | veratrum |
| MC02KB | tyrosin-hydroxylase hæmmere |
| MC02KB01 | metirosin |
| MC02KC | mao-hæmmere |
| MC02KC01 | pargylin |
| MC02KD | serotonin-antagonister |
| MC02KD01 | ketanserin |
| MC02KN | andre antihypertensiva |
| MC02KN01 | aprocitentan |
| MC02KX | antihypertensiva til pulmonal arteriel hypertension |
| MC02KX01 | bosentan |
| MC02KX02 | ambrisentan |
| MC02KX03 | sitaxentan |
| MC02KX04 | macitentan |
| MC02KX05 | riociguat |
| MC02KX06 | sotatercept |
| MC02KX52 | ambrisentan og tadalafil |
| MC02KX54 | macitentan og tadalafil |
| MC02L | antihypertensiva og diuretika i kombination |
| MC02LA | rauwolfia alkaloider og diuretika i kombination |
| MC02LA01 | reserpin og diuretika |
| MC02LA02 | rescinnamin og diuretika |
| MC02LA03 | deserpidin og diuretika |
| MC02LA04 | methoserpidin og diuretika |
| MC02LA07 | bietaserpin og diuretika |
| MC02LA08 | rauwolfia alkaloider (hele roden) og diuretika |
| MC02LA09 | syrosingopin og diuretika |
| MC02LA50 | komb. af rauwolfia alkaloider og diuretika incl andre kombinationer |
| MC02LA51 | reserpin og diuretika incl andre kombinationer |
| MC02LA52 | rescinnamin og diuretika incl andre kombinationer |
| MC02LA71 | reserpin og diuretika incl. kombinationer med psykoleptika |
| MC02LB | methyldopa og diuretika i kombination |
| MC02LB01 | methyldopa (venstredrejende) og diuretika |
| MC02LC | imidazolinreceptor-agonister i kombination med diuretika |
| MC02LC01 | clonidin og diuretika |
| MC02LC05 | moxonidin og diuretika |
| MC02LC51 | clonidin og diuretika incl andre kombinationer |
| MC02LE | alfa-adrenoceptor blokerende midler og diuretika |
| MC02LE01 | prazosin og diuretika |
| MC02LF | guanidin-derivater og diuretika |
| MC02LF01 | guanethidin og diuretika |
| MC02LG | hydrazinophthalazin derivater og diuretika |
| MC02LG01 | dihydralazin og diuretika |
| MC02LG02 | hydralazin og diuretika |
| MC02LG03 | picodralazin og diuretika |
| MC02LG51 | dihydralazin og diuretika, kombinationer med andre lægemidler |
| MC02LG73 | picodralazin og diuretika, kombinationer med psykoleptika |
| MC02LK | alkaloider, excl rauwolfia, i kombination med diuretika |
| MC02LK01 | veratrum og diuretika |
| MC02LL | mao-hæmmere og diuretika |
| MC02LL01 | pargylin og diuretika |
| MC02LN | serotonin-antagonister og diuretika |
| MC02LX | andre antihypertensiva og diuretika |
| MC02LX01 | pinacidil og diuretika |
| MC02N | kombinationer af antihypertensiva i atc-gr. C02 |
| MC03 | diuretika |
| MC03A | low-ceiling diuretika, thiazider |
| MC03AA | thiazider, usammensatte præparater |
| MC03AA01 | bendroflumethiazid |
| MC03AA02 | hydroflumethiazid |
| MC03AA03 | hydrochlorthiazid |
| MC03AA04 | chlorthiazid |
| MC03AA05 | polythiazid |
| MC03AA06 | trichlormethiazid |
| MC03AA07 | cyclopenthiazid |
| MC03AA08 | methyclothiazid |
| MC03AA09 | cyclothiazid |
| MC03AA13 | mebutizid |
| MC03AB | thiazider og kalium i kombination |
| MC03AB01 | bendroflumethiazid og kalium |
| MC03AB02 | hydroflumethiazid og kalium |
| MC03AB03 | hydrochlorthiazid og kalium |
| MC03AB04 | chlorthiazid og kalium |
| MC03AB05 | polythiazid og kalium |
| MC03AB06 | trichlormethiazid og kalium |
| MC03AB07 | cyclopenthiazid og kalium |
| MC03AB08 | methyclothiazid og kalium |
| MC03AB09 | cyclothiazid og kalium |
| MC03AH | thiazider, kombinationer med psykoleptika og/eller analgetika |
| MC03AH01 | chlorthiazid, kombinationspræparater |
| MC03AH02 | hydroflumethiazid, kombinationer |
| MC03AX | thiazider, komb. med andre stoffer |
| MC03AX01 | hydrochlorthiazid, kombinationer |
| MC03B | low-ceiling diuretika, excl. thiazider |
| MC03BA | sulfonamider, usammensatte |
| MC03BA02 | quinethazon |
| MC03BA03 | clopamid |
| MC03BA04 | chlortalidon |
| MC03BA05 | mefrusid |
| MC03BA07 | clofenamid |
| MC03BA08 | metolazon |
| MC03BA09 | meticran |
| MC03BA10 | xipamid |
| MC03BA11 | indapamid |
| MC03BA12 | clorexolon |
| MC03BA13 | fenquizon |
| MC03BA82 | clorexolon, kombinationer med psykoleptika |
| MC03BB | sulfonamider og kalium i kombination |
| MC03BB02 | quinethazon og kalium |
| MC03BB03 | clopamid og kalium |
| MC03BB04 | chlortalidon og kalium |
| MC03BB05 | mefrusid og kalium |
| MC03BB07 | clofenamid og kalium |
| MC03BC | kviksølvholdige diuretika |
| MC03BC01 | mersalyl |
| MC03BD | xanthin-derivater |
| MC03BD01 | theobromin |
| MC03BK | sulfonamider, komb. med andre stoffer |
| MC03BX | andre low-ceiling diuretika |
| MC03BX03 | cicletanin |
| MC03C | high-ceiling diuretika |
| MC03CA | sulfonamider, usammensatte |
| MC03CA01 | furosemid |
| MC03CA02 | bumetanid |
| MC03CA03 | piretanid |
| MC03CA04 | torasemid |
| MC03CB | sulfonamider og kalium i kombination |
| MC03CB01 | furosemid og kalium |
| MC03CB02 | bumetanid og kalium |
| MC03CC | aryloxyeddikesyre-derivater |
| MC03CC01 | etacrynsyre |
| MC03CC02 | tienilinsyre |
| MC03CD | pyrazolon-derivater |
| MC03CD01 | muzolimin |
| MC03CX | andre high-ceiling diuretika |
| MC03CX01 | etozolin |
| MC03D | aldosteronantagonister og andre kaliumbesparende midler |
| MC03DA | aldosteron-antagonister |
| MC03DA01 | spironolacton |
| MC03DA02 | kaliumcanrenoat |
| MC03DA03 | canrenon |
| MC03DA04 | eplerenon |
| MC03DA05 | finerenon |
| MC03DB | andre kaliumbesparende midler |
| MC03DB01 | amilorid |
| MC03DB02 | triamteren |
| MC03E | diuretika og kaliumbesparende midler i kombination |
| MC03EA | low-ceiling diuretika og kaliumbesparende midler |
| MC03EA01 | hydrochlorthiazid og kaliumbesparende midler |
| MC03EA02 | trichlormethiazid og kaliumbesparende midler |
| MC03EA03 | epitizid og kaliumbesparende midler |
| MC03EA04 | altizid og kaliumbesparende midler |
| MC03EA05 | mebutizid og kaliumbesparende midler |
| MC03EA06 | chlortalidon og kaliumbesparende midler |
| MC03EA07 | cyclopenthiazid og kaliumbesparende midler |
| MC03EA12 | metolazon og kaliumbesparende midler |
| MC03EA13 | bendroflumethiazid og kaliumbesparende midler |
| MC03EA14 | butizid og kaliumbesparende midler |
| MC03EB | high-ceiling diuretika og kaliumbesparende midler |
| MC03EB01 | furosemid og kaliumbesparende midler |
| MC03EB02 | bumetanid og kaliumbesparende midler |
| MC03X | andre diuretika |
| MC03XA | vasopressin antagonister |
| MC03XA01 | tolvaptan |
| MC03XA02 | conivaptan |
| MC04 | perifere vasodilatorer |
| MC04A | perifere vasodilatorer |
| MC04AA | 2-amino-1-phenylethanol derivater |
| MC04AA01 | isoxsuprin |
| MC04AA02 | buphenin |
| MC04AA31 | bamethan |
| MC04AB | imidazolin-derivater |
| MC04AB01 | phentolamin |
| MC04AB02 | tolazolin |
| MC04AC | nicotinsyre og derivater |
| MC04AC01 | nicotinsyre |
| MC04AC02 | nicotinylalkohol (pyridylcarbinol) |
| MC04AC03 | inositolnicotinat |
| MC04AC07 | ciclonicat |
| MC04AD | purin-derivater |
| MC04AD01 | pentifyllin |
| MC04AD02 | xantinolnicotinat |
| MC04AD03 | pentoxifyllin |
| MC04AD04 | etofyllinnicotinat |
| MC04AE | sekale-alkaloider |
| MC04AE01 | ergoloid-mesylater |
| MC04AE02 | nicergolin |
| MC04AE04 | dihydroergocristin |
| MC04AE51 | ergoloid-mesylater, kombinationer |
| MC04AE54 | dihydroergocristin, kombinationer |
| MC04AF | enzymer |
| MC04AF01 | kallidinogenase |
| MC04AX | andre perifere vasodilatorer |
| MC04AX01 | cyclandelat |
| MC04AX02 | phenoxybenzamin |
| MC04AX06 | betahistin |
| MC04AX07 | vincamin |
| MC04AX09 | cinnarizin |
| MC04AX10 | moxisylyt |
| MC04AX11 | bencyclan |
| MC04AX17 | vinburmin |
| MC04AX19 | sulcotidil |
| MC04AX20 | buflomedil |
| MC04AX21 | naftidrofuryl |
| MC04AX22 | flunarizin |
| MC04AX23 | butalamin |
| MC04AX24 | visnadin |
| MC04AX26 | cetiedil |
| MC04AX27 | cinepazid |
| MC04AX28 | ifenprodil |
| MC04AX30 | azapetin |
| MC04AX32 | fasudil |
| MC04AX33 | clazosentan |
| MC05 | vasoprotectiva |
| MC05A | midler til behandling af hæmorider og analfissurer til lokalt brug |
| MC05AA | corticosteroider |
| MC05AA01 | hydrocortison |
| MC05AA04 | prednisolon |
| MC05AA05 | betamethason |
| MC05AA06 | fluorometholon |
| MC05AA08 | fluocortolon |
| MC05AA09 | dexamethason |
| MC05AA10 | fluocinolonacetonid |
| MC05AA11 | fluocinonid |
| MC05AA12 | triamcinolon |
| MC05AB | antibiotika |
| MC05AD | lokalanæstetika |
| MC05AD01 | lidocain |
| MC05AD02 | tetracain |
| MC05AD03 | benzocain |
| MC05AD04 | cinchocain |
| MC05AD05 | procain |
| MC05AD06 | oxetacain |
| MC05AD07 | pramocain |
| MC05AE | muskelafslappende midler |
| MC05AE01 | glyceryltrinitrat |
| MC05AE02 | isosorbiddinitrat |
| MC05AE03 | diltiazem |
| MC05AX | andre midler til behandling af hæmorider og analfissurer til lokalt brug |
| MC05AX01 | aluminiumpræparater |
| MC05AX02 | bismuthpræparater, kombinationer |
| MC05AX03 | andre præparater, kombinationer |
| MC05AX04 | zinkpræparater |
| MC05AX05 | tribenosid |
| MC05AX06 | phenylephrin |
| MC05B | antivarice terapi |
| MC05BA | hepariner eller heparinoider til lokalt brug |
| MC05BA01 | organo-heparinoid |
| MC05BA02 | natriumapolat |
| MC05BA03 | heparin |
| MC05BA04 | pentosanpolysulfatnatrium |
| MC05BA51 | heparinoid, komb. |
| MC05BA53 | heparin, kombinationer |
| MC05BB | scleroserende midler til lokal injektion |
| MC05BB01 | monoethanolaminoleat |
| MC05BB02 | polidocanol |
| MC05BB03 | invertose |
| MC05BB04 | natriumtetradecylsulfat |
| MC05BB05 | phenol |
| MC05BB56 | glucose, komb. |
| MC05BX | andre scleroserende midler |
| MC05BX01 | calciumdobesilat |
| MC05BX51 | calciumdobesilat, kombinationer |
| MC05C | kapillærstabiliserende midler |
| MC05CA | bioflavonoider |
| MC05CA01 | rutosid |
| MC05CA02 | monoxerutin |
| MC05CA03 | diosmin |
| MC05CA04 | troxerutin |
| MC05CA05 | hidrosmin |
| MC05CA51 | rutosid, kombinationer |
| MC05CA53 | diosmin, kombinationer |
| MC05CA54 | troxerutin, kombinationer |
| MC05CX | andre kapillærstabiliserende midler |
| MC05CX01 | tribenosid |
| MC05CX02 | naftazon |
| MC05CX03 | hestekastanjefrø |
| MC05X | andre vasoprotectiva |
| MC05XX | andre vasoprotectiva |
| MC05XX01 | beperminogene perplasmid |
| MC07 | beta-blokerende midler |
| MC07A | beta-blokerende midler, usammensatte |
| MC07AA | beta-blokerende midler, usammensatte, non-selekt. |
| MC07AA01 | alprenolol |
| MC07AA02 | oxprenolol |
| MC07AA03 | pindolol |
| MC07AA05 | propranolol |
| MC07AA06 | timolol |
| MC07AA07 | sotalol |
| MC07AA12 | nadolol |
| MC07AA14 | mepindolol |
| MC07AA15 | carteolol |
| MC07AA16 | tertatolol |
| MC07AA17 | bopindolol |
| MC07AA19 | bupranolol |
| MC07AA23 | penbutolol |
| MC07AA27 | cloranolol |
| MC07AB | beta-blokerende midler, usammensatte, selektive |
| MC07AB01 | practolol |
| MC07AB02 | metoprolol |
| MC07AB03 | atenolol |
| MC07AB04 | acebutolol |
| MC07AB05 | betaxolol |
| MC07AB06 | bevantolol |
| MC07AB07 | bisoprolol |
| MC07AB08 | celiprolol |
| MC07AB09 | esmolol |
| MC07AB10 | epanolol |
| MC07AB11 | s-atenolol |
| MC07AB12 | nebivolol |
| MC07AB13 | talinolol |
| MC07AB14 | landiolol |
| MC07AG | alfa- og beta-blokerende midler |
| MC07AG01 | labetalol |
| MC07AG02 | carvedilol |
| MC07B | beta-blokerende midler og thiazider |
| MC07BA | beta-blokkere, non-selektive og thiazider |
| MC07BA02 | oxprenolol og thiazider |
| MC07BA05 | propranolol og thiazider |
| MC07BA06 | timolol og thiazider |
| MC07BA07 | sotalol og thiazider |
| MC07BA12 | nadolol og thiazider |
| MC07BA68 | metipranolol og thiazider, komb. |
| MC07BB | beta-blokkere, selektive, og thiazider |
| MC07BB02 | metoprolol og thiazider |
| MC07BB03 | atenolol og thiazider |
| MC07BB04 | acebutolol og thiazider |
| MC07BB06 | bevantolol og thiazider |
| MC07BB07 | bisoprolol og thiazider |
| MC07BB12 | nebivolol og thiazider |
| MC07BB52 | metoprolol og thiazider, komb. |
| MC07BG | alfa- og beta-blokkere og thiazider |
| MC07BG01 | labetalol og thiazider |
| MC07C | beta-blokkere og andre diuretika |
| MC07CA | beta-blokkere, non-selektive, og andre diuretika |
| MC07CA02 | oxprenolol og andre diuretika |
| MC07CA03 | pindolol og andre diuretika |
| MC07CA17 | bopindolol og andre diuretika |
| MC07CA23 | penbutolol og andre diuretika |
| MC07CB | beta-blokkere, selektive, og andre diuretika |
| MC07CB02 | metoprolol og andre diuretika |
| MC07CB03 | atenolol og andre diuretika |
| MC07CB53 | atenolol og andre diuretika, kombinationer |
| MC07CG | alfa- og beta-blokkere og andre diuretika |
| MC07CG01 | labetalol og andre diuretika |
| MC07D | beta-blokkere, thiazider og andre diuretika |
| MC07DA | beta-blok. non-selektive, thiazider+andre diuret. |
| MC07DA06 | timolol, thiazider og andre diuretika |
| MC07DB | beta-blokkere,selektive, thiazider og andre diuretika |
| MC07DB01 | atenolol, thiazider og andre diuretika |
| MC07E | beta-blokkere og vasodilatorer |
| MC07EA | beta-blokkere, non-selektive, og vasodilatorer |
| MC07EB | beta-blokkere, selektive, og vasodilatorer |
| MC07F | beta-blokkere, andre kombinationer |
| MC07FB | beta-blokerende midler og calciumantagonister |
| MC07FB02 | metoprolol og felodipin |
| MC07FB03 | atenolol og nifedipin |
| MC07FB07 | bisoprolol og amlodipin |
| MC07FB12 | nevibolol og amlodipin |
| MC07FB13 | metoprolol og amlodipin |
| MC07FX | beta-blokerende midler, andre kombinationer |
| MC07FX01 | propranolol og andre kombinationer |
| MC07FX02 | sotalol og acetylsalicylsyre |
| MC07FX03 | metoprolol og acetylsalicylsyre |
| MC07FX04 | bisoprolol og acetylsalicylsyre |
| MC07FX05 | metoprolol og ivabradin |
| MC07FX06 | carvedilol og ivabradin |
| MC08 | calciumantagonister |
| MC08C | selektive calciumantagonister m. overv. vaskulær effekt |
| MC08CA | dihydropyridin-derivater |
| MC08CA01 | amlodipin |
| MC08CA02 | felodipin |
| MC08CA03 | isradipin |
| MC08CA04 | nicardipin |
| MC08CA05 | nifedipin |
| MC08CA06 | nimodipin |
| MC08CA07 | nisoldipin |
| MC08CA08 | nitrendipin |
| MC08CA09 | lacidipin |
| MC08CA10 | nilvadipin |
| MC08CA11 | manidipin |
| MC08CA12 | barnidipin |
| MC08CA13 | lercanidipin |
| MC08CA14 | cilnidipin |
| MC08CA15 | benidipin |
| MC08CA16 | clevidipin |
| MC08CA17 | levamlodipin |
| MC08CA51 | amlodipin og celecoxib |
| MC08CA55 | nifedipin, kombinationer |
| MC08CX | andre selekt. calciumantagonister m. primært vasculær effekt |
| MC08CX01 | mibefradil |
| MC08D | selektive calciumantagonister m. direkte cardiel effekt |
| MC08DA | phenylalkylamin-derivater |
| MC08DA01 | verapamil |
| MC08DA02 | gallopamil |
| MC08DA03 | etripamil |
| MC08DA51 | verapamil, kombinationer |
| MC08DB | benzothiazepin-derivater |
| MC08DB01 | diltiazem |
| MC08E | ikke-selektive calciumantagonister |
| MC08EA | phenylalkylamin-derivater |
| MC08EA01 | fendilin |
| MC08EA02 | bepridil |
| MC08EX | andre ikke-selektive calciumantagonister |
| MC08EX01 | lidoflazin |
| MC08EX02 | perhexilin |
| MC08G | calciumantagonister og diuretika |
| MC08GA | calciumantagonister og diuretika |
| MC08GA01 | nifedipin og diuretika |
| MC08GA02 | amlodipin og diuretika |
| MC09 | midler med virkning på renin-angiotensin systemet |
| MC09A | ACE-hæmmere, usammensatte |
| MC09AA | ACE-hæmmere, usammensatte |
| MC09AA01 | captopril |
| MC09AA02 | enalapril |
| MC09AA03 | lisinopril |
| MC09AA04 | perindopril |
| MC09AA05 | ramipril |
| MC09AA06 | quinapril |
| MC09AA07 | benazepril |
| MC09AA08 | cilazapril |
| MC09AA09 | fosinopril |
| MC09AA10 | trandolapril |
| MC09AA11 | spirapril |
| MC09AA12 | delapril |
| MC09AA13 | moexipril |
| MC09AA14 | temocapril |
| MC09AA15 | zofenopril |
| MC09AA16 | imidapril |
| MC09B | ACE-hæmmere, kombinationer |
| MC09BA | ACE-hæmmere og diuretika |
| MC09BA01 | captopril og diuretika |
| MC09BA02 | enalapril og diuretika |
| MC09BA03 | lisinopril og diuretika |
| MC09BA04 | perindopril og diuretika |
| MC09BA05 | ramipril og diuretika |
| MC09BA06 | quinapril og diuretika |
| MC09BA07 | benazepril og diuretika |
| MC09BA08 | cilazapril og diuretika |
| MC09BA09 | fosinopril og diuretika |
| MC09BA12 | delapril og diuretika |
| MC09BA13 | moexepril og diuretika |
| MC09BA15 | zofenopril og diuretika |
| MC09BB | ACE-hæmmere og calciumantagonister |
| MC09BB02 | enalapril og lercanidipin |
| MC09BB03 | lisinopril og amlodipin |
| MC09BB04 | perindopril og amlodipin |
| MC09BB05 | ramipril og felodipin |
| MC09BB06 | enalapril og nitrendipin |
| MC09BB07 | ramipril og amlodipin |
| MC09BB10 | trandolapril og verapamil |
| MC09BB12 | delapril og manidipin |
| MC09BB13 | benazepril og amlodipin |
| MC09BX | ace inhibitorer, andre kombinationer |
| MC09BX01 | perindopril, amlodipin og indapamid |
| MC09BX02 | perindopril og bisoprolol |
| MC09BX03 | ramipril, amlodipin og hydrochlorothiazid |
| MC09BX04 | perindopril, bisoprolol og amlodipin |
| MC09BX05 | ramipril og bisoprolol |
| MC09BX06 | perindopril, bisoprolol, amlodipin og indapamid |
| MC09BX07 | zofenopril og nebivolol |
| MC09C | angiotensin II receptor blokkere (ARBS), usammensatte |
| MC09CA | angiotensin II receptor blokkere (ARBS), usammensatte |
| MC09CA01 | losartan |
| MC09CA02 | eprosartan |
| MC09CA03 | valsartan |
| MC09CA04 | irbesartan |
| MC09CA05 | tasosartan |
| MC09CA06 | candesartan |
| MC09CA07 | telmisartan |
| MC09CA08 | olmesartanmedoxomil |
| MC09CA09 | azilsartan medoxomil |
| MC09CA10 | fimasartan |
| MC09D | angiotensin II receptor blokkere (ARBS), kombinationer |
| MC09DA | angiotensin II receptor blokkere (ARBS) og diuretika |
| MC09DA01 | losartan og diuretika |
| MC09DA02 | eprosartan og diuretika |
| MC09DA03 | valsartan og diuretika |
| MC09DA04 | irbesartan og diuretika |
| MC09DA06 | candesartan og diuretika |
| MC09DA07 | telmisartan og diuretika |
| MC09DA08 | olmesartanmedoxomil og diuretika |
| MC09DA09 | azilsartan medoxomil og diuretika |
| MC09DA10 | fimasartan og diuretika |
| MC09DB | angiotensin II receptor blokkere (ARBS) og calciumantagonister (CCB) |
| MC09DB01 | valsartan og amlodipin |
| MC09DB02 | olmesartanmedoxomil og amlodipin |
| MC09DB04 | telmisartan og amlodipin |
| MC09DB05 | irbesartan og amlodipin |
| MC09DB06 | losartan og amlodipin |
| MC09DB07 | candesartan og amlodipin |
| MC09DB08 | valsartan og lercanidipin |
| MC09DB09 | fimasartan og amlodipin |
| MC09DX | angiotensin II receptor blokkere (arbs), andre kombinationer |
| MC09DX01 | valsartan, amlodipin og hydrochlorthiazid |
| MC09DX02 | valsartan og aliskiren |
| MC09DX03 | olmesartan medoxomil, amlodipin og hydrochlorthiazid |
| MC09DX04 | valsartan og sacubitril |
| MC09DX05 | valsartan og nebivolol |
| MC09DX06 | candesartan, amlodipin og hydrochlorothiazid |
| MC09DX07 | irbesartan, amlodipin og hydrochlorothiazid |
| MC09DX08 | telmisartan, amlodipin og hydrochlorthiazid |
| MC09X | andre midler med virkn. på renin-angiotensin systemet |
| MC09XA | renin-inhibitorer |
| MC09XA01 | remikeren |
| MC09XA02 | aliskiren |
| MC09XA52 | aliskiren og hydrochlorthiazid |
| MC09XA53 | aliskiren og amlodipin |
| MC09XA54 | aliskiren, amlodipin og hydrochlorthiazid |
| MC09XX | andre midler med virkning på renin-angiotensin systemet |
| MC09XX01 | sparsentan |
| MC10 | lipid-modificerende midler |
| MC10A | lipid-modificerende midler, usammensatte |
| MC10AA | HMG COA reduktase-inhibitorer |
| MC10AA01 | simvastatin |
| MC10AA02 | lovastatin |
| MC10AA03 | pravastatin |
| MC10AA04 | fluvastatin |
| MC10AA05 | atorvastatin |
| MC10AA06 | cerivastatin |
| MC10AA07 | rosuvastatin |
| MC10AA08 | pitavastatin |
| MC10AB | fibrater |
| MC10AB01 | clofibrat |
| MC10AB02 | bezafibrat |
| MC10AB03 | aluminiumclofibrat |
| MC10AB04 | gemfibrozil |
| MC10AB05 | fenofibrat |
| MC10AB06 | simfibrat |
| MC10AB07 | ronifibrat |
| MC10AB08 | ciprofibrat |
| MC10AB09 | etofibrat |
| MC10AB10 | clofibrid |
| MC10AB11 | cholin fenofibrat |
| MC10AB12 | pemafibrat |
| MC10AC | galdesyrebindende midler |
| MC10AC01 | colestyramin |
| MC10AC02 | colestipol |
| MC10AC03 | colextran |
| MC10AC04 | colesevelam |
| MC10AD | nicotinsyre og derivater |
| MC10AD01 | niceritrol |
| MC10AD02 | nicotinsyre |
| MC10AD03 | nicofuranose |
| MC10AD04 | aluminiumnicotinat |
| MC10AD05 | nicotinylalcohol (pyridylcarbinol) |
| MC10AD06 | acipimox |
| MC10AD52 | nicotinsyre, kombinationer |
| MC10AX | andre lipid-modificerende midler |
| MC10AX01 | dextrothyroxin |
| MC10AX02 | probucol |
| MC10AX03 | tiadenol |
| MC10AX05 | meglutol |
| MC10AX06 | omega-3-triglycerider inkl. andre estre og syrer |
| MC10AX07 | magnesiumpyridoxal 5-phosphatglutamat |
| MC10AX08 | policosanol |
| MC10AX09 | ezetimib |
| MC10AX10 | alipogen tiparvovec |
| MC10AX11 | mipomersen |
| MC10AX12 | lomitapid |
| MC10AX13 | evolocumab |
| MC10AX14 | alirocumab |
| MC10AX15 | bempedoinsyre |
| MC10AX16 | inclisiran |
| MC10AX17 | evinacumab |
| MC10AX18 | volanesorsen |
| MC10B | lipid-modificerende midler, komb. |
| MC10BA | lipid-modificerende midler, kombinationer |
| MC10BA01 | lovastatin og nicotinsyre |
| MC10BA02 | simvastatin og ezetimib |
| MC10BA03 | pravastatin og fenofibrat |
| MC10BA04 | simvastatin og fenofibrat |
| MC10BA05 | atorvastatin og ezetimibe |
| MC10BA06 | rosuvastatin og ezetimib |
| MC10BA07 | rosuvastatin og omega-3-fedtsyrer |
| MC10BA08 | atorvastatin og omega-3-fedtsyrer |
| MC10BA09 | rosuvastatin og fenofibrat |
| MC10BA10 | bempedoinsyre og ezetimib |
| MC10BA11 | pravastatin og ezetimib |
| MC10BA12 | pravastatin, ezetimib og fenofibrat |
| MC10BA13 | pitavastatin og ezetimib |
| MC10BX | lipid-modificerende midler i kombination med andre lægemidler |
| MC10BX01 | simvastatin og acetylsalicylsyre |
| MC10BX02 | pravastatin og acetylsalicylsyre |
| MC10BX03 | atorvastatin og amlodipin |
| MC10BX04 | simvastatin, acetylsalicylsyre og ramipril |
| MC10BX05 | rosuvastatin og acetylsalicylsyre |
| MC10BX06 | atorvastatin, acetylsalicylsyre og ramipril |
| MC10BX07 | rosuvastatin, amlodipin og lisinopril |
| MC10BX08 | atorvastatin og acetylsalicylicsyre |
| MC10BX09 | rosuvastatin og amlodipin |
| MC10BX10 | rosuvastatin og valsartan |
| MC10BX11 | atorvastatin, amlodipin og perindopril |
| MC10BX12 | atorvastatin, acetylsalicylsyre og perindopril |
| MC10BX13 | rosuvastatin, perindopril og indapamid |
| MC10BX14 | rosuvastatin, amlodipin og perindopril |
| MC10BX15 | atorvastatin og perindopril |
| MC10BX16 | rosuvastatin og fimasartan |
| MC10BX17 | rosuvastatin og ramipril |
| MC10BX18 | atorvastatin, amlodipin og ramipril |
| MC10BX19 | atorvastatin, amlodipin og candesartan |
| MC10BX20 | rosuvastatin og telmisartan |
| MC10BX21 | rosuvastatin og perindopril |
| MC10BX22 | rosuvastatin og nebivolol |
| MD | Dermatologiske midler |
| MD01 | fungicider til dermatologisk brug |
| MD01A | fungicider til udvortes brug |
| MD01AA | antibiotika |
| MD01AA01 | nystatin |
| MD01AA02 | natamycin |
| MD01AA03 | hachimycin |
| MD01AA04 | pecilocin |
| MD01AA06 | mepartricin |
| MD01AA07 | pyrrolnitrin |
| MD01AA08 | griseofulvin |
| MD01AA20 | kombinationer af antibiotika |
| MD01AC | imidazol- og triazol-derivater |
| MD01AC01 | clotrimazol |
| MD01AC02 | miconazol |
| MD01AC03 | econazol |
| MD01AC04 | clomidazol |
| MD01AC05 | isoconazol |
| MD01AC06 | tiabendazol |
| MD01AC07 | tioconazol |
| MD01AC08 | ketoconazol |
| MD01AC09 | sulconazol |
| MD01AC10 | bifonazol |
| MD01AC11 | oxiconazol |
| MD01AC12 | fenticonazol |
| MD01AC13 | omoconazol |
| MD01AC14 | sertaconazol |
| MD01AC15 | fluconazol |
| MD01AC16 | flutrimazol |
| MD01AC17 | eberconazol |
| MD01AC18 | luliconazol |
| MD01AC19 | efinaconazol |
| MD01AC20 | imidazoler/triazoler i kombination med corticosteroider |
| MD01AC21 | neticonazol |
| MD01AC22 | lanoconazol |
| MD01AC52 | miconazol, kombinationer |
| MD01AC60 | bifonazol kombinationer |
| MD01AE | andre fungicider til udvortes brug |
| MD01AE01 | bromchlorsalicylanilid |
| MD01AE02 | methylrosanilin |
| MD01AE03 | tribromometacresol |
| MD01AE04 | undecylensyre |
| MD01AE05 | polynoxylin |
| MD01AE06 | 2-(4-chlorphenoxy)-ethanol |
| MD01AE07 | chlorphenesin |
| MD01AE08 | ticlaton |
| MD01AE09 | sulbentin |
| MD01AE10 | ethylhydroxybenzoat |
| MD01AE11 | haloprogin |
| MD01AE12 | salicylsyre |
| MD01AE13 | selensulfid |
| MD01AE14 | ciclopirox |
| MD01AE15 | terbinafin |
| MD01AE16 | amorolfin |
| MD01AE17 | dimazol |
| MD01AE18 | tolnaftat |
| MD01AE19 | tolciclat |
| MD01AE20 | kombinationer af andre fungicider til udvortes brug |
| MD01AE21 | flucytosin |
| MD01AE22 | naftifin |
| MD01AE23 | butenafin |
| MD01AE24 | tavaborol |
| MD01AE25 | liranaftat |
| MD01AE54 | undecylensyre, komb. |
| MD01B | fungicider til systemisk brug |
| MD01BA | fungicider til systemisk brug |
| MD01BA01 | griseofulvin |
| MD01BA02 | terbinafin |
| MD01BA03 | fosravuconazol |
| MD02 | blødgørende og hudbeskyttende midler |
| MD02A | blødgørende og hudbeskyttende midler |
| MD02AA | siliconepræparater |
| MD02AB | zinkoxidpræparater |
| MD02AC | vaselin og fedtstoffer |
| MD02AD | flydende plaster |
| MD02AE | carbamidpræparater |
| MD02AE01 | carbamid |
| MD02AE51 | carbamid, komb. |
| MD02AF | salicylsyrepræparater |
| MD02AX | andre blødgørende og hudbeskyttende midler |
| MD02B | midler beskyttende mod UV-stråling |
| MD02BA | midler beskyttende mod UV-stråling, udvortes brug |
| MD02BA01 | aminobenzoesyre |
| MD02BA02 | octinoxat |
| MD02BB | midler beskyttende mod UV-stråling, systemisk brug |
| MD02BB01 | betacaroten |
| MD02BB02 | afamelanotid |
| MD03 | midler til sårbehandling |
| MD03A | sårhelende midler |
| MD03AA | levertransalver |
| MD03AX | andre sårhelende midler |
| MD03AX01 | cadexomer iod |
| MD03AX02 | dextranomer |
| MD03AX03 | dexpanthenol |
| MD03AX04 | calciumpantothenat |
| MD03AX05 | hyaluronsyre |
| MD03AX06 | becaplermin |
| MD03AX09 | crilanomer |
| MD03AX10 | enoxolon |
| MD03AX11 | natriumchlorit |
| MD03AX12 | trolamin |
| MD03AX13 | birkebark |
| MD03AX14 | asiatisk centellaurt, inkl. kombinationer |
| MD03AX15 | trafermin |
| MD03AX16 | beremagen geperpavec |
| MD03B | enzymer |
| MD03BA | proteolytiske enzymer |
| MD03BA01 | trypsin |
| MD03BA02 | collagenase |
| MD03BA03 | bromelainer |
| MD03BA52 | collagenase, kombinationer |
| MD04 | kløestillende midler, incl. antihistaminer, anæstetika, etc. |
| MD04A | kløestillende midler, incl. antihistaminer, anæstetika, etc. |
| MD04AA | antihistaminer til dermatologisk brug |
| MD04AA01 | thonzylamin |
| MD04AA02 | mepyramin |
| MD04AA03 | thenalidin |
| MD04AA04 | tripelennamin |
| MD04AA09 | chloropyramin |
| MD04AA10 | promethazin |
| MD04AA12 | tolpropamin |
| MD04AA13 | dimetinden |
| MD04AA14 | clemastin |
| MD04AA15 | bamipin |
| MD04AA16 | pheniramin |
| MD04AA22 | isothipendyl |
| MD04AA32 | diphenhydramin |
| MD04AA33 | diphenhydraminmethylbromid |
| MD04AA34 | chlorphenoxamin |
| MD04AB | lokalanæstetika til dermatologisk brug |
| MD04AB01 | lidocain |
| MD04AB02 | cinchocain |
| MD04AB03 | oxybuprocain |
| MD04AB04 | benzocain |
| MD04AB05 | quinisocain |
| MD04AB06 | tetracain |
| MD04AB07 | pramocain |
| MD04AX | andre kløestillende midler |
| MD04AX01 | doxepin |
| MD05 | midler mod psoriasis |
| MD05A | midler mod psoriasis til udvortes brug |
| MD05AA | tjæreholdige præparater |
| MD05AC | antracen-derivater |
| MD05AC01 | dithranol |
| MD05AC51 | dithranol, kombinationer |
| MD05AD | psoralener til udvortes brug |
| MD05AD01 | trioxysalen, udvortes |
| MD05AD02 | methoxalen, udvortes |
| MD05AX | andre midler mod psoriasis til udvortes brug |
| MD05AX01 | fumarsyre |
| MD05AX02 | calcipotriol |
| MD05AX03 | calcitriol |
| MD05AX04 | tacalcitol |
| MD05AX05 | tazaroten |
| MD05AX06 | roflumilast |
| MD05AX07 | tapinarof |
| MD05AX52 | calcipotriol, kombinationer |
| MD05AX55 | tazaroten og ulobetasol |
| MD05B | midler mod psoriasis til systemisk brug |
| MD05BA | psoralener til systemisk brug |
| MD05BA01 | trioxysalen, systemisk |
| MD05BA02 | methoxalen, systemisk |
| MD05BA03 | bergapten |
| MD05BB | retinoider til psoriasisbehandling |
| MD05BB01 | etretinat |
| MD05BB02 | acitretin |
| MD05BX | andre midler mod psoriasis til systemisk brug |
| MD05BX01 | fumarsyre |
| MD05BX51 | fumarsyre-derivater, komb. |
| MD06 | antibiotika og kemoterapeutika til dermatologisk brug |
| MD06A | antibiotika til udvortes brug |
| MD06AA | tetracyclin og derivater |
| MD06AA01 | demeclocyclin |
| MD06AA02 | chlortetracyclin |
| MD06AA03 | oxytetracyclin |
| MD06AA04 | tetracyclin |
| MD06AX | andre antibiotika til udvortes brug |
| MD06AX01 | fusidinsyre |
| MD06AX02 | chloramphenicol |
| MD06AX04 | neomycin |
| MD06AX05 | bacitracin |
| MD06AX07 | gentamicin |
| MD06AX08 | tyrothricin |
| MD06AX09 | mupirocin |
| MD06AX10 | virginiamycin |
| MD06AX11 | rifaximin |
| MD06AX12 | amikacin |
| MD06AX13 | retapamulin |
| MD06AX14 | ozenoxacin |
| MD06AX15 | rifamycin |
| MD06B | kemoterapeutika til udvortes brug |
| MD06BA | sulfonamider |
| MD06BA01 | sølvsulfadiazin |
| MD06BA02 | sulfathiazol |
| MD06BA03 | mafenid |
| MD06BA04 | sulfamethizol |
| MD06BA05 | sulfanilamid |
| MD06BA06 | sulfamerazin |
| MD06BA51 | sølvsulfadiazin, kombinationer |
| MD06BB | antivirale midler |
| MD06BB01 | idoxuridin |
| MD06BB02 | tromantadin |
| MD06BB03 | aciclovir |
| MD06BB04 | podophyllotoxin |
| MD06BB05 | inosin |
| MD06BB06 | penciclovir |
| MD06BB07 | lysozym |
| MD06BB08 | ibacitabin |
| MD06BB09 | edoxudin |
| MD06BB10 | imiquimod |
| MD06BB11 | docosanol |
| MD06BB12 | sinecatechins |
| MD06BB53 | aciclovir, kombinationer |
| MD06BX | andre kemoterapeutika |
| MD06BX01 | metronidazol |
| MD06BX02 | ingenolmebutat |
| MD06BX03 | tirbanibulin |
| MD06C | antibiotika og kemoterapeutika i kombination |
| MD07 | corticosteroider til dermatologisk brug |
| MD07A | corticosteroider til udvortes brug, usammensatte |
| MD07AA | corticosteroider, svagt virk. (gruppe I) |
| MD07AA01 | methylprednisolon |
| MD07AA02 | hydrocortison |
| MD07AA03 | prednisolon |
| MD07AB | corticosteroider, middelstærkt virk. (gruppe II) |
| MD07AB01 | clobetason |
| MD07AB02 | hydrocortisonbutyrat |
| MD07AB03 | flumetason |
| MD07AB04 | fluocortin |
| MD07AB05 | fluperolon |
| MD07AB06 | fluorometholon |
| MD07AB07 | flupredniden |
| MD07AB08 | desonid |
| MD07AB09 | triamcinolon |
| MD07AB10 | alclometason |
| MD07AB11 | hydrocortisonbuteprat |
| MD07AB19 | dexamethason |
| MD07AB21 | clocortolon |
| MD07AB30 | kombinationer af corticosteroider |
| MD07AC | corticosteroider, stærkt virk. (gruppe III) |
| MD07AC01 | betamethason |
| MD07AC02 | fluclorolon |
| MD07AC03 | desoximetason |
| MD07AC04 | fluocinolon |
| MD07AC05 | fluocortolon |
| MD07AC06 | diflucortolon |
| MD07AC07 | fludroxycortid |
| MD07AC08 | fluocinonid |
| MD07AC09 | budesonid |
| MD07AC10 | diflorason |
| MD07AC11 | amcinonid |
| MD07AC12 | halometason |
| MD07AC13 | mometason |
| MD07AC14 | methylprednisolonaceponat |
| MD07AC15 | beclometason |
| MD07AC16 | hydrocortisonaceponat |
| MD07AC17 | fluticason |
| MD07AC18 | prednicarbat |
| MD07AC19 | difluprednat |
| MD07AC21 | ulobetasol |
| MD07AD | corticosteroider, ekstra stærkt virk. (gruppe Iv) |
| MD07AD01 | clobetasol |
| MD07AD02 | halcinonid |
| MD07B | corticosteroider i kombination med antiseptika |
| MD07BA | corticosteroider (gruppe I) og antiseptika |
| MD07BA01 | prednisolon og antiseptika |
| MD07BA04 | hydrocortison og antiseptika |
| MD07BB | corticosteroider (gruppe II) og antiseptika |
| MD07BB01 | flumetason og antiseptika |
| MD07BB02 | desonid og antiseptika |
| MD07BB03 | triamcinolon og antiseptika |
| MD07BB04 | hydrocortisonbutyrat og antiseptika |
| MD07BC | corticosteroider (gruppe III) og antiseptika |
| MD07BC01 | betamethason og antiseptika |
| MD07BC02 | fluocinolon og antiseptika |
| MD07BC03 | fluocortolon og antiseptika |
| MD07BC04 | diflucortolon og antiseptika |
| MD07BD | corticosteroider (gruppe IV) og antiseptika |
| MD07C | corticosteroider i kombination med antibiotika |
| MD07CA | corticosteroider (gruppe I) og antibiotika |
| MD07CA01 | hydrocortison og antibiotika |
| MD07CA02 | methylprednisolon og antibiotika |
| MD07CA03 | prednisolon og antibiotika |
| MD07CB | corticosteroider (gruppe II) og antibiotika |
| MD07CB01 | triamcinolon og antibiotika |
| MD07CB02 | flupredniden og antibiotika |
| MD07CB03 | fluorometholon og antibiotika |
| MD07CB04 | dexamethason og antibiotika |
| MD07CB05 | flumetason og antibiotika |
| MD07CC | corticosteroider (gruppe III) og antibiotika |
| MD07CC01 | betamethason og antibiotika |
| MD07CC02 | fluocinolon og antibiotika |
| MD07CC03 | fludroxycortid og antibiotika |
| MD07CC04 | beclometason og antibiotika |
| MD07CC05 | fluocinonid og antibiotika |
| MD07CC06 | fluocortolon og antibiotika |
| MD07CD | corticosteroider (gruppe IV) og antibiotika |
| MD07CD01 | clobetasol og antibiotika |
| MD07X | corticosteroider, andre kombinationer |
| MD07XA | corticosteroider (gruppe I), andre kombinationer |
| MD07XA01 | hydrocortison |
| MD07XA02 | prednisolon |
| MD07XB | corticosteroider (gruppe II), andre kombinationer |
| MD07XB01 | flumetason |
| MD07XB02 | triamcinolon |
| MD07XB03 | flupredniden |
| MD07XB04 | fluorometholon |
| MD07XB05 | dexamethason |
| MD07XB30 | kombinationer af corticosteroider |
| MD07XC | corticosteroider (gruppe III), andre kombinationer |
| MD07XC01 | betamethason |
| MD07XC02 | desoximetason |
| MD07XC03 | mometason |
| MD07XC04 | biphenylol |
| MD07XC05 | fluocortolon |
| MD07XD | corticosteroider (gruppe IV), andre kombinationer |
| MD08 | antiseptika og desinficerende midler |
| MD08A | antiseptika og desinficerende midler |
| MD08AA | acridin-derivater |
| MD08AA01 | ethacridinlactat |
| MD08AA02 | aminoacridin |
| MD08AA03 | euflavin |
| MD08AB | aluminiumforbindelser |
| MD08AC | biguanider og amidiner |
| MD08AC01 | dibrompropamidin |
| MD08AC02 | chlorhexidin |
| MD08AC03 | propamidin |
| MD08AC04 | hexamidin |
| MD08AC05 | polihexanid |
| MD08AC52 | chlorhexidin, kombinationer |
| MD08AD | borsyrepræparater |
| MD08AE | phenol og derivater |
| MD08AE01 | hexachlorophen |
| MD08AE02 | metacresolsulfonsyre-formaldehyd |
| MD08AE03 | phenol |
| MD08AE04 | triclosan |
| MD08AE05 | chloroxylenol |
| MD08AE06 | biphenylol |
| MD08AF | furan-derivater |
| MD08AF01 | nitrofural |
| MD08AG | iodpræparater |
| MD08AG01 | iod/octylphenoxypolyglycolether |
| MD08AG02 | iod/polyvidon |
| MD08AG03 | iod |
| MD08AG04 | diiodhydroxypropan |
| MD08AH | quinolin-derivater |
| MD08AH01 | dequalinium |
| MD08AH02 | chlorquinaldol |
| MD08AH03 | oxyquinolin |
| MD08AH30 | clioquinol |
| MD08AJ | kvartære ammoniumforbindelser |
| MD08AJ01 | benzalkon |
| MD08AJ02 | cetrimon |
| MD08AJ03 | cetylpyridin |
| MD08AJ04 | cetrimid |
| MD08AJ05 | benzoxoniumchlorid |
| MD08AJ06 | didecyldimethylammoniumchlorid |
| MD08AJ08 | benzethoniumchlorid |
| MD08AJ10 | decamethoxin |
| MD08AJ57 | octenidin, komb. |
| MD08AJ58 | benzetoniumchlorid, komb. |
| MD08AJ59 | dodecloniumbromid, komb. |
| MD08AK | kviksølvforbindelser |
| MD08AK01 | mercuriamidochlorid |
| MD08AK02 | phenylmercuriborat |
| MD08AK03 | mercurichlorid |
| MD08AK04 | merbromin |
| MD08AK05 | kviksølv, metallisk |
| MD08AK06 | thiomersal |
| MD08AK30 | mercuriiodid |
| MD08AL | sølvforbindelser |
| MD08AL01 | sølvnitrat |
| MD08AL30 | sølv |
| MD08AX | andre antiseptika og desinficerende midler |
| MD08AX01 | hydrogenperoxid |
| MD08AX02 | eosin |
| MD08AX03 | propanol |
| MD08AX04 | tosylchloramidnatrium |
| MD08AX05 | isopropanol |
| MD08AX06 | kaliumpermanganat |
| MD08AX07 | natriumhypochlorit |
| MD08AX08 | ethanol |
| MD08AX53 | propanol, komb. |
| MD09 | medicinske forbindsstoffer |
| MD09A | medicinske forbindsstoffer |
| MD09AA | salvekompresser med antiinfektiva |
| MD09AA01 | framycetin |
| MD09AA02 | fusidinsyre |
| MD09AA03 | nitrofural |
| MD09AA04 | phenylmercurinitrat |
| MD09AA05 | benzododecin |
| MD09AA06 | triclosan |
| MD09AA07 | cetylpyridin |
| MD09AA08 | aluminiumchlorhydrat |
| MD09AA09 | povidone-iod |
| MD09AA10 | clioquinol |
| MD09AA11 | benzalkon |
| MD09AA12 | chlorhexidin |
| MD09AA13 | iodoform |
| MD09AB | zinkbandager |
| MD09AB01 | zinkbandage uden tilsætninger |
| MD09AB02 | zinkbandage med tilsætninger |
| MD09AX | vaselinkompresser |
| MD10 | midler mod acne |
| MD10A | midler mod acne til udvortes brug |
| MD10AA | corticosteroider, komb. til acnebehandling |
| MD10AA01 | fluormetholon |
| MD10AA02 | methylprednisolon |
| MD10AA03 | dexamethason |
| MD10AB | svovlholdige acne-midler |
| MD10AB01 | bithionol |
| MD10AB02 | svovl |
| MD10AB03 | tioxolon |
| MD10AB05 | mesulfen |
| MD10AD | retinoider til udvortes brug mod acne |
| MD10AD01 | tretinoin |
| MD10AD02 | retinol |
| MD10AD03 | adapalen |
| MD10AD04 | isotretinoin |
| MD10AD05 | motretinid |
| MD10AD06 | trifaroten |
| MD10AD51 | tretinoin, komb. |
| MD10AD53 | adapalen, kombinationer |
| MD10AD54 | isotretinoin, komb. |
| MD10AE | peroxider |
| MD10AE01 | benzoylperoxid |
| MD10AE51 | benzoylperoxid, komb. |
| MD10AF | antiinfektiva til acne-behandling |
| MD10AF01 | clindamycin |
| MD10AF02 | erythromycin |
| MD10AF03 | chloramphenicol |
| MD10AF04 | meclocyclin |
| MD10AF05 | nadifloxacin |
| MD10AF06 | sulfacetamid |
| MD10AF07 | minocyclin |
| MD10AF51 | clindamycin, komb. |
| MD10AF52 | erythromycin, kombinationer |
| MD10AX | andre midler mod acne til udvortes brug |
| MD10AX01 | aluminiumchlorid |
| MD10AX02 | resorcinol |
| MD10AX03 | azelainsyre |
| MD10AX04 | aluminiumoxid |
| MD10AX05 | dapson |
| MD10AX06 | clascoteron |
| MD10AX30 | diverse kombinationer inkluderende andre midler mod acne til udvortes brug |
| MD10B | midler mod acne til systemisk brug |
| MD10BA | retinoider til behandling af acne |
| MD10BA01 | isotretinoin |
| MD10BX | andre midler mod acne til systemisk brug |
| MD10BX01 | ichtammol |
| MD11 | andre dermatologiske midler |
| MD11A | andre dermatologiske midler |
| MD11AA | antihidrotica |
| MD11AA01 | glycopyrronium |
| MD11AC | medicinsk shampoo |
| MD11AC01 | cetrimid |
| MD11AC02 | cadmiumforbindelser |
| MD11AC03 | selenforbindelser |
| MD11AC06 | iod/polyvidon |
| MD11AC08 | svovlforbindelser |
| MD11AC09 | xenysalat |
| MD11AC30 | medicinsk shampoo, andre |
| MD11AE | androgener til udvortes brug |
| MD11AE01 | metandienon |
| MD11AF | midler mod vorter og ligtorne |
| MD11AH | midler til dermatitis, ekskl. corticosteroider |
| MD11AH01 | tacrolimus |
| MD11AH02 | pimecrolimus |
| MD11AH03 | cromoglicinsyre |
| MD11AH04 | alitretinoin |
| MD11AH05 | dupilumab |
| MD11AH06 | crisaborol |
| MD11AH07 | tralokinumab |
| MD11AH08 | abrocitinib |
| MD11AH09 | ruxolitinib |
| MD11AH10 | lebrikizumab |
| MD11AH11 | delgocitinib |
| MD11AH12 | nemolizumab |
| MD11AX | andre dermatologiske midler |
| MD11AX01 | minoxidil, udvortes |
| MD11AX02 | gamolensyre |
| MD11AX03 | calciumgluconat |
| MD11AX04 | lithiumsuccinat |
| MD11AX05 | magnesiumsulfat |
| MD11AX06 | mequinol |
| MD11AX08 | tiratricol |
| MD11AX09 | oxaceprol |
| MD11AX10 | finasterid |
| MD11AX11 | hydroquinon |
| MD11AX12 | zinkpyrithion |
| MD11AX13 | monobenzon |
| MD11AX16 | eflornithin |
| MD11AX18 | diclofenac |
| MD11AX21 | brimonidin |
| MD11AX22 | ivermectin |
| MD11AX23 | aminobenzoatkalium |
| MD11AX24 | deoxycholsyre |
| MD11AX25 | hydrogenperoxid |
| MD11AX26 | caffein |
| MD11AX27 | oxymetazolin |
| MD11AX52 | gamolensyre, kombinationer |
| MD11AX57 | collagen, kombinationer |
| MG | Urogenitalsystem og kønshormoner |
| MG01 | gynækologiske antiinfektiva og antiseptika |
| MG01A | antiinfektiva/antiseptika, excl. kombinationer med corticosteroida |
| MG01AA | antibiotika |
| MG01AA01 | nystatin |
| MG01AA02 | natamycin |
| MG01AA03 | amphotericin |
| MG01AA04 | candicidin |
| MG01AA05 | chloramphenicol |
| MG01AA06 | trichomycin |
| MG01AA07 | oxytetracyclin |
| MG01AA08 | carfecillin |
| MG01AA09 | mepartricin |
| MG01AA10 | clindamycin |
| MG01AA11 | pentamycin |
| MG01AA51 | nystatin, komb. |
| MG01AB | arsen-forbindelser |
| MG01AB01 | acetarsol |
| MG01AC | quinolin-derivater |
| MG01AC01 | diiodohydroxyquinolin |
| MG01AC02 | clioquinol |
| MG01AC03 | chlorquinaldol |
| MG01AC05 | dequalon |
| MG01AC06 | broxyquinolin |
| MG01AC30 | oxyquinolin |
| MG01AD | organiske syrer |
| MG01AD01 | mælkesyre |
| MG01AD02 | eddikesyre |
| MG01AD03 | ascorbinsyre |
| MG01AE | sulfonamider |
| MG01AE01 | sulfatolamid |
| MG01AE10 | kombinationer af sulfonamider |
| MG01AF | imidazol-derivater |
| MG01AF01 | metronidazol |
| MG01AF02 | clotrimazol |
| MG01AF04 | miconazol |
| MG01AF05 | econazol |
| MG01AF06 | ornidazol |
| MG01AF07 | isoconazol |
| MG01AF08 | tioconazol |
| MG01AF11 | ketoconazol |
| MG01AF12 | fenticonazol |
| MG01AF13 | azanidazol |
| MG01AF14 | propenidazol |
| MG01AF15 | butoconazol |
| MG01AF16 | omoconazol |
| MG01AF17 | oxiconazol |
| MG01AF18 | flutrimazol |
| MG01AF19 | sertaconazol |
| MG01AF20 | kombinationer af imidazol-derivater |
| MG01AF21 | tinidazol |
| MG01AF55 | econazol, kombinationer |
| MG01AG | triazol-derivater |
| MG01AG02 | terconazol |
| MG01AX | andre antiinfektiva og antiseptika |
| MG01AX01 | clodantoin |
| MG01AX02 | inosin |
| MG01AX03 | metacresolsulfonsyre-formaldehyd |
| MG01AX05 | nifuratel |
| MG01AX06 | furazolidon |
| MG01AX09 | methylrosanilin |
| MG01AX11 | iod/polyvidon |
| MG01AX12 | ciclopirox |
| MG01AX13 | protiofat |
| MG01AX14 | lactobacillus |
| MG01AX15 | kobberusnat |
| MG01AX16 | hexetidin |
| MG01AX17 | dapivirin |
| MG01AX66 | octenidin, kombinationer |
| MG01B | antiinfektiva/antiseptika i kombination med corticosteroida |
| MG01BA | antibiotika og corticosteroider |
| MG01BC | quinolin-derivater og corticosteroider |
| MG01BD | antiseptika og corticosteroida |
| MG01BE | sulfonamider og corticosteroider |
| MG01BF | imidazol-derivater og corticosteroider |
| MG02 | andre gynækologiske midler |
| MG02A | uterotonika |
| MG02AB | secale-alkaloider |
| MG02AB01 | methylergometrin |
| MG02AB02 | secale-alkaloider |
| MG02AB03 | ergometrin |
| MG02AC | secale-alkaloider og oxytocin incl. derivater i kombination |
| MG02AC01 | methylergometrin og oxytocin |
| MG02AD | prostaglandiner |
| MG02AD01 | dinoprost |
| MG02AD02 | dinoproston |
| MG02AD03 | gemeprost |
| MG02AD04 | carboprost |
| MG02AD05 | sulproston |
| MG02AD06 | misoprostol |
| MG02AX | andre uterotonika |
| MG02B | antikonceptionelle midler til lokal applikation |
| MG02BA | intrauterine antikonceptionelle midler |
| MG02BA01 | plast intrauterint indlæg |
| MG02BA02 | plast intrauterint indlæg med kobber |
| MG02BA03 | plast intrauterint indlæg med gestagen |
| MG02BB | intravaginale antikonceptionelle midler |
| MG02BB01 | vaginal ring med gestagen og østrogen |
| MG02BB02 | vaginalring med gestagen |
| MG02C | andre gynækologiske midler |
| MG02CA | sympatomimetika, vehæmmende |
| MG02CA01 | ritodrin |
| MG02CA02 | buphenin |
| MG02CA03 | fenoterol |
| MG02CB | prolactin inhibitorer |
| MG02CB01 | bromocriptin |
| MG02CB02 | lisurid |
| MG02CB03 | cabergolin |
| MG02CB04 | quinagolid |
| MG02CB05 | metergolin |
| MG02CB06 | tergurid |
| MG02CC | antiinflammatoriske midler til vaginal administration |
| MG02CC01 | ibuprofen |
| MG02CC02 | naproxen |
| MG02CC03 | benzydamin |
| MG02CC04 | flunoxaprofen |
| MG02CX | andre gynækologiske midler |
| MG02CX01 | atosiban |
| MG02CX02 | flibanserin |
| MG02CX03 | kyskhedstræsfrugt |
| MG02CX04 | sølvlys jordstængel |
| MG02CX05 | bremelanotid |
| MG02CX06 | fezolinetant |
| MG03 | kønshormoner og modulatorer af genitalsystemet |
| MG03A | hormonale antikonceptiva til systemisk brug |
| MG03AA | gestagener og østrogener, faste kombinationer |
| MG03AA01 | etynodiol og estradiol |
| MG03AA02 | quingestanol og ethinylestradiol |
| MG03AA03 | lynestrenol og ethinylestradiol |
| MG03AA04 | megestrol og ethinylestradiol |
| MG03AA05 | norethisteron og ethinylestradiol |
| MG03AA06 | norgestrel og ethinylestradiol |
| MG03AA07 | levonorgestrel og ethinylestradiol |
| MG03AA08 | medroxyprogesteron og ethinylestradiol |
| MG03AA09 | desogestrel og ethinylestradiol |
| MG03AA10 | gestoden og ethinylestradiol |
| MG03AA11 | norgestimat og ethinylestradiol |
| MG03AA12 | drospirenon og ethinylestradiol |
| MG03AA13 | norelgestromin og ethinylestradiol |
| MG03AA14 | nomegestrol og estradiol |
| MG03AA15 | chlormadinon og ethinylestradiol |
| MG03AA16 | dienogest og ethinylestradiol |
| MG03AA17 | medroxyprogesteron og estradiol |
| MG03AA18 | drospirenon og estetrol |
| MG03AB | gestagener og østrogener, sekvenspræparater |
| MG03AB01 | megestrol og ethinylestradiol |
| MG03AB02 | lynestrenol og ethinylestradiol |
| MG03AB03 | levonorgestrel og ethinylestradiol |
| MG03AB04 | norethisteron og ethinylestradiol |
| MG03AB05 | desogestrel og ethinylestradiol |
| MG03AB06 | gestoden og ethinylestradiol |
| MG03AB07 | chlormadinon og ethinylestradiol |
| MG03AB08 | dienogest og estradiol |
| MG03AB09 | norgestimat og ethinylestradiol |
| MG03AC | gestagener |
| MG03AC01 | norethisteron |
| MG03AC02 | lynestrenol |
| MG03AC03 | levonorgestrel |
| MG03AC04 | quingestanol |
| MG03AC05 | megestrol |
| MG03AC06 | medroxyprogesteron |
| MG03AC07 | norgestrienon |
| MG03AC08 | etonogestrel |
| MG03AC09 | desogestrel |
| MG03AC10 | drospirenon |
| MG03AD | nødprævention |
| MG03AD01 | levonorgestrel |
| MG03AD02 | ulipristal |
| MG03B | androgener |
| MG03BA | 3-oxoandrosten(4)-derivater |
| MG03BA01 | fluoxymesteron |
| MG03BA02 | methyltestosteron |
| MG03BA03 | testosteron |
| MG03BB | 5-androstanon(3)-derivater |
| MG03BB01 | mesterolon |
| MG03BB02 | androstanolon |
| MG03C | østrogener |
| MG03CA | naturlige og semisyntetiske østrogener, usammensatte |
| MG03CA01 | ethinylestradiol |
| MG03CA03 | estradiol |
| MG03CA04 | estriol |
| MG03CA06 | chlortrianisen |
| MG03CA07 | estron |
| MG03CA09 | promestrien |
| MG03CA53 | estradiol, kombinationer |
| MG03CA57 | konjugerede østrogener |
| MG03CB | syntetiske østrogener, usammensatte |
| MG03CB01 | dienestrol |
| MG03CB02 | diethylstilbestrol |
| MG03CB03 | methallenestril |
| MG03CB04 | moxestrol |
| MG03CC | østrogener, kombinationer med andre stoffer |
| MG03CC02 | dienestrol |
| MG03CC03 | methallenestril |
| MG03CC04 | estron |
| MG03CC05 | diethylstilbestrol |
| MG03CC06 | estriol |
| MG03CC07 | konjugerede østrogener og bazedoxifen |
| MG03CX | andre østrogener |
| MG03CX01 | tibolon |
| MG03D | gestagener |
| MG03DA | pregnen(4)-derivater |
| MG03DA01 | gestonoron |
| MG03DA02 | medroxyprogesteron |
| MG03DA03 | hydroxyprogesteron |
| MG03DA04 | progesteron |
| MG03DB | pregnadien-derivater |
| MG03DB01 | dydrogesteron |
| MG03DB02 | megestrol |
| MG03DB03 | medrogeston |
| MG03DB04 | nomegestrol |
| MG03DB05 | demegeston |
| MG03DB06 | chlormadinon |
| MG03DB07 | promegeston |
| MG03DB08 | dienogest |
| MG03DC | estren-derivater |
| MG03DC01 | allylestrenol |
| MG03DC02 | norethisteron |
| MG03DC03 | lynestrenol |
| MG03DC04 | ethisteron |
| MG03DC06 | etynodiol |
| MG03DC31 | methylestrenolon |
| MG03E | androgener og kvindelige kønshormoner i komb. |
| MG03EA | androgener og østrogener |
| MG03EA01 | methyltestosteron og østrogen |
| MG03EA02 | testosteron og østrogen |
| MG03EA03 | prasteron og østrogen |
| MG03EB | androgen, gestagen og østrogen i kombination |
| MG03EK | androgener og kvindel. kønshormon i komb. m. andre stoffer |
| MG03EK01 | methyltestosteron |
| MG03F | gestagener og østrogener i kombination |
| MG03FA | gestagener og østrogener, kombinationer |
| MG03FA01 | norethisteron og østrogen |
| MG03FA02 | hydroxyprogesteron og østrogen |
| MG03FA03 | ethisteron og østrogen |
| MG03FA04 | progesteron og østrogen |
| MG03FA05 | methylnortestosteron og østrogen |
| MG03FA06 | etynodiol og østrogen |
| MG03FA07 | lynestrenol og østrogen |
| MG03FA08 | megestrol og østrogen |
| MG03FA09 | noretynodrel og østrogen |
| MG03FA10 | norgestrel og østrogen |
| MG03FA11 | levonorgestrel og østrogen |
| MG03FA12 | medroxyprogesteron og østrogen |
| MG03FA13 | norgestimat og østrogen |
| MG03FA14 | dydrogesteron og østrogen |
| MG03FA15 | dienogest og østrogen |
| MG03FA16 | trimegeston og østrogen |
| MG03FA17 | drospirenon og østrogen |
| MG03FB | gestagener og østrogener, sekvenspræparater |
| MG03FB01 | norgestrel og østrogen |
| MG03FB02 | lynestrenol og østrogen |
| MG03FB03 | chlormadinon og østrogen |
| MG03FB04 | megestrol og østrogen |
| MG03FB05 | norethisteron og østrogen |
| MG03FB06 | medroxyprogesteron og østrogen |
| MG03FB07 | medrogeston og østrogen |
| MG03FB08 | dydrogesteron og østrogen |
| MG03FB09 | levonorgestrel og østrogen |
| MG03FB10 | desogestrel og østrogen |
| MG03FB11 | trimegeston og østrogen |
| MG03FB12 | nomegestrol og østrogen |
| MG03G | gonadotropin og andre ovulationsstimul. midler |
| MG03GA | gonadotropiner |
| MG03GA01 | choriongonadotropin |
| MG03GA02 | gonadotropin, human menopausal |
| MG03GA03 | serumgonadotropin |
| MG03GA04 | urofollitropin |
| MG03GA05 | follitropin alfa |
| MG03GA06 | follitropin beta |
| MG03GA07 | lutropin alfa |
| MG03GA08 | choriongonadotropin alfa |
| MG03GA09 | corifollitropin alfa |
| MG03GA10 | follitropin delta |
| MG03GA30 | kombinationer af gonadotropiner |
| MG03GB | ovulationsstimulerende midler, syntetiske |
| MG03GB01 | cyclofenil |
| MG03GB02 | clomifen |
| MG03GB03 | epimestrol |
| MG03H | antiandrogener |
| MG03HA | antiandrogener, usammensatte |
| MG03HA01 | cyproteron |
| MG03HB | antiandrogener og østrogener |
| MG03HB01 | cyproteron og østrogen |
| MG03X | andre kønshormoner og modulatorer af genitalsyst. |
| MG03XA | antigonadotropiner og lignende stoffer |
| MG03XA01 | danazol |
| MG03XA02 | gestrinon |
| MG03XB | progesteron-receptormodulatorer |
| MG03XB01 | mifepriston |
| MG03XB02 | ulipristal |
| MG03XB51 | mifepriston, kombinationer |
| MG03XC | selektive østrogenreceptor-modulatorer |
| MG03XC01 | raloxifen |
| MG03XC02 | bazedoxifen |
| MG03XC03 | lasofoxifen |
| MG03XC04 | ormeloxifen |
| MG03XC05 | ospemifen |
| MG03XX | andre kønshormoner og modulatorer af genitalsystemet |
| MG03XX01 | prasteron |
| MG04 | urologika |
| MG04B | urologiske midler |
| MG04BA | acidoserende midler |
| MG04BA01 | ammoniumchlorid |
| MG04BA03 | calciumchlorid |
| MG04BC | midler til opløsning af urinsyrekonkrementer |
| MG04BD | midler mod hyppig urinering og inkontinens |
| MG04BD01 | emepron |
| MG04BD02 | flavoxat |
| MG04BD03 | meladrazin |
| MG04BD04 | oxybutynin |
| MG04BD05 | terodilin |
| MG04BD06 | propiverin |
| MG04BD07 | tolterodin |
| MG04BD08 | solifenacin |
| MG04BD09 | trospium |
| MG04BD10 | darifenacin |
| MG04BD11 | fesoterodin |
| MG04BD12 | mirabegron |
| MG04BD13 | desfesoterodin |
| MG04BD14 | imidafenacin |
| MG04BD15 | vibegron |
| MG04BE | midler anvendt ved erektionsforstyrrelser |
| MG04BE01 | alprostadil |
| MG04BE02 | papaverin |
| MG04BE03 | sildenafil |
| MG04BE04 | yohimbin |
| MG04BE06 | moxisylyt |
| MG04BE07 | apomorphin |
| MG04BE08 | tadalafil |
| MG04BE09 | vardenafil |
| MG04BE10 | avanafil |
| MG04BE11 | udenafil |
| MG04BE30 | kombinationer af midler anvendt ved erektionsforstyrrelser |
| MG04BE52 | papaverin, kombinationer |
| MG04BX | andre urologika |
| MG04BX01 | magnesiumhydroxid |
| MG04BX03 | acetohydroxamsyre |
| MG04BX06 | phenazopyridin |
| MG04BX10 | succinimid |
| MG04BX11 | collagen |
| MG04BX12 | phenylsalicylat |
| MG04BX13 | dimethylsulfoxid |
| MG04BX14 | dapoxetin |
| MG04BX15 | pentosanpolysulfatnatrium |
| MG04BX16 | tiopronin |
| MG04BX17 | natriumsalicylat og methenamin |
| MG04C | midler anvendt ved benign prostatahypertrofi |
| MG04CA | alfa-adrenoreceptor antagonister |
| MG04CA01 | alfuzosin |
| MG04CA02 | tamsulosin |
| MG04CA03 | terazosin |
| MG04CA04 | silodosin |
| MG04CA51 | alfuzosin og finasterid |
| MG04CA52 | tamsulosin og dutasterid |
| MG04CA53 | tamsulosin og solifenacin |
| MG04CA54 | tamsulosin og tadalafil |
| MG04CA55 | doxazosin og finasterid |
| MG04CB | testosteron-5-alfa-reduktase inhibitorer |
| MG04CB01 | finasterid |
| MG04CB02 | dutasterid |
| MG04CB51 | finasterid og tadalafil |
| MG04CX | andre midler anv. v. benign prostatahypertrofi |
| MG04CX01 | afrikansk blommebark |
| MG04CX02 | savpalmefrugt |
| MG04CX03 | mepartricin |
| MG04CX04 | fexapotid |
| MH | Systemiske hormonpræparater, excl. kønshormoner |
| MH01 | hypofyse- og hypothalamus-hormoner og analoger |
| MH01A | hypofyseforlap-hormoner og analoger |
| MH01AA | acth |
| MH01AA01 | corticotropin |
| MH01AA02 | tetracosactid |
| MH01AB | thyrotropin |
| MH01AB01 | thyrotropin alfa |
| MH01AC | somatropin og somatropin agonister |
| MH01AC01 | somatropin |
| MH01AC02 | somatrem |
| MH01AC03 | mecasermin |
| MH01AC04 | sermorelin |
| MH01AC05 | mecaserminrinfabat |
| MH01AC06 | tesamorelin |
| MH01AC07 | somapacitan |
| MH01AC08 | somatrogon |
| MH01AC09 | lonapegsomatropin |
| MH01AX | andre hypofyseforlap-hormoner og analoger |
| MH01AX01 | pegvisomant |
| MH01B | hypofysebaglap-hormoner |
| MH01BA | vasopressin og analoger |
| MH01BA01 | vasopressin (argipressin) |
| MH01BA02 | desmopressin |
| MH01BA03 | lypressin |
| MH01BA04 | terlipressin |
| MH01BA05 | ornipressin |
| MH01BB | oxytocin og analoger |
| MH01BB01 | demoxytocin |
| MH01BB02 | oxytocin |
| MH01BB03 | carbetocin |
| MH01C | hypothalamus-hormoner |
| MH01CA | gonadotropin-releasing hormoner |
| MH01CA01 | gonadorelin |
| MH01CA02 | nafarelin |
| MH01CB | somatostatin og analoger |
| MH01CB01 | somatostatin |
| MH01CB02 | octreotid |
| MH01CB03 | lanreotid |
| MH01CB04 | vapreotid |
| MH01CB05 | pasireotid |
| MH01CC | anti gonadotropin releasing hormoner |
| MH01CC01 | ganirelix |
| MH01CC02 | cetrorelix |
| MH01CC03 | elagolix |
| MH01CC04 | linzagolix |
| MH01CC53 | elagolix, estradiol og norethisteron |
| MH01CC54 | relugolix, estradiol og norethisteron |
| MH02 | corticosteroider til systemisk brug |
| MH02A | corticosteroider til systemisk brug, usammensatte |
| MH02AA | mineralocorticoider |
| MH02AA01 | aldosteron |
| MH02AA02 | fludrocortison |
| MH02AA03 | desoxycorton |
| MH02AB | glucocorticoider |
| MH02AB01 | betamethason |
| MH02AB02 | dexamethason |
| MH02AB03 | fluocortolon |
| MH02AB04 | methylprednisolon |
| MH02AB05 | paramethason |
| MH02AB06 | prednisolon |
| MH02AB07 | prednison |
| MH02AB08 | triamcinolon |
| MH02AB09 | hydrocortison |
| MH02AB10 | cortison |
| MH02AB11 | prednyliden |
| MH02AB12 | rimexolon |
| MH02AB13 | deflazacort |
| MH02AB14 | cloprednol |
| MH02AB15 | meprednison |
| MH02AB17 | cortivazol |
| MH02AB18 | vamorolon |
| MH02B | corticosteroider til systemisk brug, kombinationer |
| MH02BX | corticosteroider til systemisk brug, kombinationer |
| MH02BX01 | methylprednisolon, kombinationer |
| MH02C | antiadrenale præparater |
| MH02CA | anticorticosteroider |
| MH02CA01 | trilostan |
| MH02CA02 | osilodrostat |
| MH02CA03 | ketoconazol |
| MH02CA04 | levoketoconazol |
| MH03 | thyroidea-terapi |
| MH03A | thyroideapræparater |
| MH03AA | thyroideahormoner |
| MH03AA01 | levothyroxinnatrium |
| MH03AA02 | liothyroninnatrium |
| MH03AA03 | levothyroxin og liothyronin i kombination |
| MH03AA04 | tiratricol |
| MH03AA05 | thyroideakirtel-præparater |
| MH03AA51 | levothyroxinnatrium og iodforbindelser |
| MH03B | antithyroide præparater |
| MH03BA | thiouraciler |
| MH03BA01 | methylthiouracil |
| MH03BA02 | propylthiouracil |
| MH03BA03 | benzylthiouracil |
| MH03BB | svovlholdige imidazol-derivater |
| MH03BB01 | carbimazol |
| MH03BB02 | thiamazol |
| MH03BB52 | thiamazol, kombinationer |
| MH03BC | perchlorater |
| MH03BC01 | kaliumperchlorat |
| MH03BX | andre antithyroide præparater |
| MH03BX01 | diiodtyrosin |
| MH03BX02 | dibromtyrosin |
| MH03C | iod-terapi |
| MH03CA | iod-terapi |
| MH04 | pancreas-hormoner |
| MH04A | glycogenolytiske hormoner |
| MH04AA | glycogenolytiske hormoner |
| MH04AA01 | glucagon |
| MH04AA02 | dasiglucagon |
| MH05 | calciumhomeostase |
| MH05A | parathyroidea-hormoner og analoger |
| MH05AA | parathyroidea-hormoner og analoger |
| MH05AA01 | parathyroideakirtel-ekstrakt |
| MH05AA02 | teriparatid |
| MH05AA03 | parathyroideahormon |
| MH05AA04 | abaloparatid |
| MH05AA05 | palopegteriparatid |
| MH05B | anti-parathyroide midler |
| MH05BA | calcitoninpræparater |
| MH05BA01 | calcitonin (laks, syntetisk) |
| MH05BA02 | calcitonin (svin, naturlig) |
| MH05BA03 | calcitonin (human, syntetisk) |
| MH05BA04 | elcatonin |
| MH05BX | andre anti-parathyroide midler |
| MH05BX01 | cinacalcet |
| MH05BX02 | paricalcitol |
| MH05BX03 | doxercalciferol |
| MH05BX04 | etelcalcetid |
| MH05BX05 | calcifediol |
| MH05BX06 | evocalcet |
| MJ | Midler mod infektionssygdomme til systemisk brug |
| MJ01 | antibakterielle midler til systemisk brug |
| MJ01A | tetracycliner |
| MJ01AA | tetracycliner |
| MJ01AA01 | demeclocyclin |
| MJ01AA02 | doxycyclin |
| MJ01AA03 | chlortetracyclin |
| MJ01AA04 | lymecyclin |
| MJ01AA05 | metacyclin |
| MJ01AA06 | oxytetracyclin |
| MJ01AA07 | tetracyclin |
| MJ01AA08 | minocyclin |
| MJ01AA09 | rolitetracyclin |
| MJ01AA10 | penimepicyclin |
| MJ01AA11 | clomocyclin |
| MJ01AA12 | tigecyclin |
| MJ01AA13 | eravacyclin |
| MJ01AA14 | sarecyclin |
| MJ01AA15 | omadacyclin |
| MJ01AA20 | kombinationer af tetracycliner |
| MJ01AA56 | oxytetracyclin, kombinationer |
| MJ01B | amphenicoler |
| MJ01BA | amphenicoler |
| MJ01BA01 | chloramphenicol |
| MJ01BA02 | thiamphenicol |
| MJ01BA52 | thiamphenicol, komb. |
| MJ01C | beta-lactam antibakterika, penicilliner |
| MJ01CA | penicilliner med udvidet spektrum |
| MJ01CA01 | ampicillin |
| MJ01CA02 | pivampicillin |
| MJ01CA03 | carbenicillin |
| MJ01CA04 | amoxicillin |
| MJ01CA05 | carindacillin |
| MJ01CA06 | bacampicillin |
| MJ01CA07 | epicillin |
| MJ01CA08 | pivmecillinam |
| MJ01CA09 | azlocillin |
| MJ01CA10 | mezlocillin |
| MJ01CA11 | mecillinam |
| MJ01CA12 | piperacillin |
| MJ01CA13 | ticarcillin |
| MJ01CA14 | metampicillin |
| MJ01CA15 | talampicillin |
| MJ01CA16 | sulbenicillin |
| MJ01CA17 | temocillin |
| MJ01CA18 | hetacillin |
| MJ01CA19 | aspoxicillin |
| MJ01CA20 | kombinationer af penicilliner med udvidet spektrum |
| MJ01CA51 | ampicillin, kombinationer |
| MJ01CE | beta-lactamase sensitive penicilliner |
| MJ01CE01 | benzylpenicillin |
| MJ01CE02 | phenoxymethylpenicillin |
| MJ01CE03 | propicillin |
| MJ01CE04 | azidocillin |
| MJ01CE05 | pheneticillin |
| MJ01CE06 | penamecillin |
| MJ01CE07 | clometocillin |
| MJ01CE08 | benzathin benzylpenicillin |
| MJ01CE09 | procain penicillin |
| MJ01CE10 | benzathin phenoxymethylpenicillin |
| MJ01CE30 | kombinationer af beta-lactamase sensitive penicilliner |
| MJ01CF | beta-lactamase resistente penicilliner |
| MJ01CF01 | dicloxacillin |
| MJ01CF02 | cloxacillin |
| MJ01CF03 | methicillin |
| MJ01CF04 | oxacillin |
| MJ01CF05 | flucloxacillin |
| MJ01CF06 | nafcillin |
| MJ01CG | beta-lactamase inhibitorer |
| MJ01CG01 | sulbactam |
| MJ01CG02 | tazobactam |
| MJ01CR | komb. af penicilliner, incl. beta-lactamase inhib. |
| MJ01CR01 | ampicillin og beta-lactamaseinhibitor |
| MJ01CR02 | amoxicillin og beta-lactamaseinhibitor |
| MJ01CR03 | ticarcillin og beta-lactamaseinhibitor |
| MJ01CR04 | sultamicillin og enzym-inhibitor |
| MJ01CR05 | piperacillin og beta-lactamaseinhibitor |
| MJ01CR50 | kombinationer af penicilliner |
| MJ01D | andre beta-lactam antibakterika |
| MJ01DB | cephalosporiner, 1. generation |
| MJ01DB01 | cefalexin |
| MJ01DB02 | cefaloridin |
| MJ01DB03 | cefalotin |
| MJ01DB04 | cefazolin |
| MJ01DB05 | cefadroxil |
| MJ01DB06 | cefazedon |
| MJ01DB07 | cefatrizin |
| MJ01DB08 | cefapirin |
| MJ01DB09 | cefradin |
| MJ01DB10 | cefacetril |
| MJ01DB11 | cefroxadin |
| MJ01DB12 | ceftezol |
| MJ01DC | cephalosporiner, 2. generation |
| MJ01DC01 | cefoxitin |
| MJ01DC02 | cefuroxim |
| MJ01DC03 | cefamandol |
| MJ01DC04 | cefaclor |
| MJ01DC05 | cefotetan |
| MJ01DC06 | cefonicid |
| MJ01DC07 | cefotiam |
| MJ01DC08 | loracarbef |
| MJ01DC09 | cefmetazol |
| MJ01DC10 | cefprozil |
| MJ01DC11 | ceforanid |
| MJ01DC12 | cefminox |
| MJ01DC13 | cefbuperazon |
| MJ01DC14 | flomoxef |
| MJ01DC52 | cefuroxim og beta-lactamaseinhibitor |
| MJ01DD | cephalosporiner, 3. generation |
| MJ01DD01 | cefotaxim |
| MJ01DD02 | ceftazidim |
| MJ01DD03 | cefsulodin |
| MJ01DD04 | ceftriaxon |
| MJ01DD05 | cefmenoxim |
| MJ01DD06 | latamoxef |
| MJ01DD07 | ceftizoxim |
| MJ01DD08 | cefixim |
| MJ01DD09 | cefodizim |
| MJ01DD10 | cefetamet |
| MJ01DD11 | cefpiramid |
| MJ01DD12 | cefoperazon |
| MJ01DD13 | cefpodoxim |
| MJ01DD14 | ceftibuten |
| MJ01DD15 | cefdinir |
| MJ01DD16 | cefditoren |
| MJ01DD17 | cefcapen |
| MJ01DD18 | cefteram |
| MJ01DD51 | cefotaxime and beta-lactamase inhibitor |
| MJ01DD52 | ceftazidime og beta-lactamaseinhibitor |
| MJ01DD54 | ceftriaxon, kombinationer |
| MJ01DD58 | cefixim og beta-lactamasehæmmer |
| MJ01DD62 | cefoperazone og beta-lactamaseinhibitor |
| MJ01DD63 | ceftriaxon og beta-lactamaseinhibitor |
| MJ01DD64 | cefpodoxim og beta-lactamaseinhibitor |
| MJ01DE | cephalosporiner, 4. generation |
| MJ01DE01 | cefepim |
| MJ01DE02 | cefpirom |
| MJ01DE03 | cefozopran |
| MJ01DE51 | cefepim og beta-lactamaseinhibitor |
| MJ01DF | monobactamer |
| MJ01DF01 | aztreonam |
| MJ01DF02 | carumonam |
| MJ01DF51 | aztreonam og beta-lactamase hæmmer |
| MJ01DH | carbapenemer |
| MJ01DH02 | meropenem |
| MJ01DH03 | ertapenem |
| MJ01DH04 | doripenem |
| MJ01DH05 | biapenem |
| MJ01DH06 | tebipenem pivoxil |
| MJ01DH51 | imipenem og cilastatin |
| MJ01DH52 | meropenem og vaborbactam |
| MJ01DH55 | panipenem og betamipron |
| MJ01DH56 | imipenem, cilastatin og relebactam |
| MJ01DI | andre cephalosporiner og penemer |
| MJ01DI01 | ceftobiprolmedocaril |
| MJ01DI02 | ceftarolin fosamil |
| MJ01DI03 | faropenem |
| MJ01DI04 | cefiderocol |
| MJ01DI54 | ceftolozane og beta-lactamaseinhibitor |
| MJ01E | sulfonamider og trimethoprim |
| MJ01EA | trimethoprim og derivater |
| MJ01EA01 | trimethoprim |
| MJ01EA02 | brodimoprim |
| MJ01EA03 | iclaprim |
| MJ01EB | sulfonamider med kort virkningstid |
| MJ01EB01 | sulfaisodimidin |
| MJ01EB02 | sulfamethizol |
| MJ01EB03 | sulfadimidin |
| MJ01EB04 | sulfapyridin |
| MJ01EB05 | sulfafurazol |
| MJ01EB06 | sulfanilamid |
| MJ01EB07 | sulfathiazol |
| MJ01EB08 | sulfathiourea |
| MJ01EB20 | kombinationer af sulfonamider med kort virkningstid |
| MJ01EC | sulfonamider med middellang virkningstid |
| MJ01EC01 | sulfamethoxazol |
| MJ01EC02 | sulfadiazin |
| MJ01EC03 | sulfamoxol |
| MJ01EC20 | kombinationer af sulfonamider med middellang virkningstid |
| MJ01ED | sulfonamider med lang virkningstid |
| MJ01ED01 | sulfadimethoxin |
| MJ01ED02 | sulfalen |
| MJ01ED03 | sulfamethomidin |
| MJ01ED04 | sulfamethoxydiazin |
| MJ01ED05 | sulfamethoxypyridazin |
| MJ01ED06 | sulfaperin |
| MJ01ED07 | sulfamerazin |
| MJ01ED08 | sulfaphenazol |
| MJ01ED09 | sulfamazon |
| MJ01ED20 | kombinationer af sulfonamider med lang virkningstid |
| MJ01EE | sulfonamid og trimethoprim incl. derivater i komb. |
| MJ01EE01 | sulfamethoxazol og trimethoprim |
| MJ01EE02 | sulfadiazin og trimethoprim |
| MJ01EE03 | sulfametrol og trimethoprim |
| MJ01EE04 | sulfamoxol og trimethoprim |
| MJ01EE05 | sulfadimidin og trimethoprim |
| MJ01EE06 | sulfadiazin og tetroxoprim |
| MJ01EE07 | sulfamerazin og trimethoprim |
| MJ01F | macrolider, lincosamider og streptograminer |
| MJ01FA | macrolider |
| MJ01FA01 | erythromycin |
| MJ01FA02 | spiramycin |
| MJ01FA03 | midecamycin |
| MJ01FA05 | oleandomycin |
| MJ01FA06 | roxithromycin |
| MJ01FA07 | josamycin |
| MJ01FA08 | troleandomycin |
| MJ01FA09 | clarithromycin |
| MJ01FA10 | azithromycin |
| MJ01FA11 | miocamycin |
| MJ01FA12 | rokitamycin |
| MJ01FA13 | dirithromycin |
| MJ01FA14 | flurithromycin |
| MJ01FA15 | telithromycin |
| MJ01FA16 | solithromycin |
| MJ01FF | lincosamider |
| MJ01FF01 | clindamycin |
| MJ01FF02 | lincomycin |
| MJ01FG | streptograminer |
| MJ01FG01 | pristinamycin |
| MJ01FG02 | quinupristin/dalfopristin |
| MJ01G | aminoglycosid antibakterika |
| MJ01GA | streptomyciner |
| MJ01GA01 | streptomycin |
| MJ01GA02 | streptoduocin |
| MJ01GB | andre aminoglycosider |
| MJ01GB01 | tobramycin |
| MJ01GB03 | gentamicin |
| MJ01GB04 | kanamycin |
| MJ01GB05 | neomycin |
| MJ01GB06 | amikacin |
| MJ01GB07 | netilmicin |
| MJ01GB08 | sisomicin |
| MJ01GB09 | dibekacin |
| MJ01GB10 | ribostamycin |
| MJ01GB11 | isepamicin |
| MJ01GB12 | arbekacin |
| MJ01GB13 | bekanamycin |
| MJ01GB14 | plazomicin |
| MJ01M | quinolon antibakterika |
| MJ01MA | fluorochinoloner |
| MJ01MA01 | ofloxacin |
| MJ01MA02 | ciprofloxacin |
| MJ01MA03 | pefloxacin |
| MJ01MA04 | enoxacin |
| MJ01MA05 | temafloxacin |
| MJ01MA06 | norfloxacin |
| MJ01MA07 | lomefloxacin |
| MJ01MA08 | fleroxacin |
| MJ01MA09 | sparfloxacin |
| MJ01MA10 | rufloxacin |
| MJ01MA11 | grepafloxacin |
| MJ01MA12 | levofloxacin |
| MJ01MA13 | trovafloxacin |
| MJ01MA14 | moxifloxacin |
| MJ01MA15 | gemifloxacin |
| MJ01MA16 | gatifloxacin |
| MJ01MA17 | prulifloxacin |
| MJ01MA18 | pazufloxacin |
| MJ01MA19 | garenoxacin |
| MJ01MA21 | sitafloxacin |
| MJ01MA22 | tosufloxacin |
| MJ01MA23 | delafloxacin |
| MJ01MA24 | levonadifloxacin |
| MJ01MA25 | lascufloxacin |
| MJ01MB | andre quinoloner |
| MJ01MB01 | rosoxacin |
| MJ01MB02 | nalidixinsyre |
| MJ01MB03 | piromidinsyre |
| MJ01MB04 | pipemidinsyre |
| MJ01MB05 | oxolinsyre |
| MJ01MB06 | cinoxacin |
| MJ01MB07 | flumequin |
| MJ01MB08 | nemonoxacin |
| MJ01R | kombinationer af antibakterika |
| MJ01RA | kombinationer af antibakterika |
| MJ01RA01 | penicilliner, komb. med andre antibakterika |
| MJ01RA02 | sulfonamider, kombinationer med andre antibakterika excl. trimethoprim |
| MJ01RA03 | cefuroxim og metronidazol |
| MJ01RA04 | spiramycin og metronidazol |
| MJ01RA05 | levofloxacin og ornidazol |
| MJ01RA06 | cefepim og amikacin |
| MJ01RA07 | azithromycin, fluconazol og secnidazol |
| MJ01RA08 | tetracyclin og oleandomycin |
| MJ01RA09 | ofloxacin og ornidazol |
| MJ01RA10 | ciprofloxacin og metronidazol |
| MJ01RA11 | ciprofloxacin og tinidazol |
| MJ01RA12 | ciprofloxacin og ornidazol |
| MJ01RA13 | norfloxacin og tinidazol |
| MJ01RA14 | norfloxacin og metronidazol |
| MJ01RA15 | cefixim og ornidazol |
| MJ01RA16 | cefixim og azithromycin |
| MJ01RA17 | ofloxacin og nitazoxanid |
| MJ01RA18 | ofloxacin og tinidazol |
| MJ01RA19 | tetracyclin og nystatin |
| MJ01X | andre antibakterika |
| MJ01XA | glycopeptid antibakterika |
| MJ01XA01 | vancomycin |
| MJ01XA02 | teicoplanin |
| MJ01XA03 | telavancin |
| MJ01XA04 | dalbavancin |
| MJ01XA05 | oritavancin |
| MJ01XB | polymyxiner |
| MJ01XB01 | colistin |
| MJ01XB02 | polymyxin B |
| MJ01XC | steroid antibakterika |
| MJ01XC01 | fusidinsyre |
| MJ01XD | imidazol-derivater |
| MJ01XD01 | metronidazol |
| MJ01XD02 | tinidazol |
| MJ01XD03 | ornidazol |
| MJ01XE | nitrofuran-derivater |
| MJ01XE01 | nitrofurantoin |
| MJ01XE02 | nifurtoinol |
| MJ01XE03 | furazidin |
| MJ01XE51 | nitrofurantoin, kombinationer |
| MJ01XX | andre antibakterika |
| MJ01XX01 | fosfomycin |
| MJ01XX02 | xibornol |
| MJ01XX03 | clofoctol |
| MJ01XX04 | spectinomycin |
| MJ01XX05 | methenamin |
| MJ01XX06 | mandelsyre |
| MJ01XX07 | nitroxolin |
| MJ01XX08 | linezolid |
| MJ01XX09 | daptomycin |
| MJ01XX10 | bacitracin |
| MJ01XX11 | tedizolid |
| MJ01XX12 | lefamulin |
| MJ01XX13 | gepotidacin |
| MJ02 | antimykotika til systemisk brug |
| MJ02A | antimykotika til systemisk brug |
| MJ02AA | antibiotika |
| MJ02AA01 | amphotericin |
| MJ02AA02 | hachimycin |
| MJ02AB | imidazol-derivater |
| MJ02AB01 | miconazol |
| MJ02AB02 | ketoconazol |
| MJ02AC | triazol- og tetrazolderivater |
| MJ02AC01 | fluconazol |
| MJ02AC02 | itraconazol |
| MJ02AC03 | voriconazol |
| MJ02AC04 | posaconazol |
| MJ02AC05 | isavuconazol |
| MJ02AC06 | oteseconazol |
| MJ02AX | andre antimykotika til systemisk brug |
| MJ02AX01 | flucytosin |
| MJ02AX04 | caspofungin |
| MJ02AX05 | micafungin |
| MJ02AX06 | anidulafungin |
| MJ02AX07 | ibrexafungerp |
| MJ02AX08 | rezafunginacetat |
| MJ04 | antimycobacterica |
| MJ04A | stoffer til behandling af tuberculose |
| MJ04AA | aminosalicylsyre og derivater |
| MJ04AA01 | aminosalicylsyre |
| MJ04AA02 | natriumaminosalicylat |
| MJ04AA03 | calciumaminosalicylat |
| MJ04AB | antibiotika |
| MJ04AB01 | cycloserin |
| MJ04AB02 | rifampicin |
| MJ04AB03 | rifamycin |
| MJ04AB04 | rifabutin |
| MJ04AB05 | rifapentin |
| MJ04AB06 | enviomycin |
| MJ04AB30 | capreomycin |
| MJ04AC | hydrazider |
| MJ04AC01 | isoniazid |
| MJ04AC02 | ftivazid |
| MJ04AC51 | isoniazid, kombinationer |
| MJ04AD | thiocarbamid-derivater |
| MJ04AD01 | protionamid |
| MJ04AD02 | tiocarlid |
| MJ04AD03 | ethionamid |
| MJ04AK | andre stoffer til behandling af tuberculose |
| MJ04AK01 | pyrazinamid |
| MJ04AK02 | ethambutol |
| MJ04AK03 | terizidon |
| MJ04AK04 | morinamid |
| MJ04AK05 | bedaquilin |
| MJ04AK06 | delamanid |
| MJ04AK07 | thioacetazon |
| MJ04AK08 | pretomanid |
| MJ04AM | komb. af stoffer til behandling af tuberculose |
| MJ04AM01 | streptomycin og isoniazid |
| MJ04AM02 | rifampicin og isoniazid |
| MJ04AM03 | ethambutol og isoniazid |
| MJ04AM04 | thioacetazon og isoniazid |
| MJ04AM05 | rifampicin, pyrazinamid og isoniazid |
| MJ04AM06 | rifampicin, pyrazinamid, ethambutol og isoniazid |
| MJ04AM07 | rifampicin, ethambutol og isoniazid |
| MJ04AM08 | isoniazid, sulfamethoxazol, trimethoprim og pyridoxin |
| MJ04AM09 | pyrazinamid, ethambutol, isoniazid og lomefloxacin |
| MJ04AM10 | pyrazinamid, ethambutol, protionamid og lomefloxacin |
| MJ04AM11 | rifabutin, pyrazinamid og protionamid |
| MJ04AM12 | rifampicin, pyrazinamid, isoniazid og levofloxacin |
| MJ04B | midler til behandling af lepra |
| MJ04BA | midler til behandling af lepra |
| MJ04BA01 | clofazimin |
| MJ04BA02 | dapson |
| MJ04BA03 | aldesulfonnatrium |
| MJ04BA50 | dapson og rifampicin |
| MJ04BA51 | dapson, rifampicin og clofazimin |
| MJ05 | antivirale midler til systemisk brug |
| MJ05A | direkte virkende antivirale midler |
| MJ05AA | thiosemicarbazoner |
| MJ05AA01 | metisazon |
| MJ05AB | nucleosider og nucleotider excl. revers transcriptase-hæmmere |
| MJ05AB01 | aciclovir |
| MJ05AB02 | idoxuridin |
| MJ05AB03 | vidarabin |
| MJ05AB06 | ganciclovir |
| MJ05AB09 | famciclovir |
| MJ05AB11 | valaciclovir |
| MJ05AB12 | cidofovir |
| MJ05AB13 | penciclovir |
| MJ05AB14 | valganciclovir |
| MJ05AB15 | brivudin |
| MJ05AB16 | remdesivir |
| MJ05AB17 | brincidofovir |
| MJ05AB18 | molnupiravir |
| MJ05AC | cykliske aminer |
| MJ05AC02 | rimantadin |
| MJ05AC03 | tromantadin |
| MJ05AD | phosphonsyre-derivater |
| MJ05AD01 | foscarnet |
| MJ05AD02 | fosfonet |
| MJ05AE | protease inhibitorer |
| MJ05AE01 | saquinavir |
| MJ05AE02 | indinavir |
| MJ05AE03 | ritonavir |
| MJ05AE04 | nelfinavir |
| MJ05AE05 | amprenavir |
| MJ05AE07 | fosamprenavir |
| MJ05AE08 | atazanavir |
| MJ05AE09 | tipranavir |
| MJ05AE10 | darunavir |
| MJ05AE16 | ensitrelvir |
| MJ05AE30 | nirmatrelvir og ritonavir |
| MJ05AF | nucleosid og nucleotid revers transcriptase-hæmmere |
| MJ05AF01 | zidovudin |
| MJ05AF02 | didanosin |
| MJ05AF03 | zalcitabin |
| MJ05AF04 | stavudin |
| MJ05AF05 | lamivudin |
| MJ05AF06 | abacavir |
| MJ05AF07 | tenofovir disoproxil |
| MJ05AF08 | adefovir dipivoxil |
| MJ05AF09 | emtricitabin |
| MJ05AF10 | entecavir |
| MJ05AF11 | telbivudin |
| MJ05AF12 | clevudin |
| MJ05AF13 | tenofovir alafenamid |
| MJ05AG | non-nucleosid revers transcriptase-hæmmere |
| MJ05AG01 | nevirapin |
| MJ05AG02 | delavirdin |
| MJ05AG03 | efavirenz |
| MJ05AG04 | etravirin |
| MJ05AG05 | rilpivirin |
| MJ05AG06 | doravirin |
| MJ05AG07 | elsulfavirin |
| MJ05AH | neuraminidase-inhibitorer |
| MJ05AH01 | zanamivir |
| MJ05AH02 | oseltamivir |
| MJ05AH03 | peramivir |
| MJ05AH04 | laninamivir |
| MJ05AJ | integrasehæmmere |
| MJ05AJ01 | raltegravir |
| MJ05AJ02 | elvitegravir |
| MJ05AJ03 | dolutegravir |
| MJ05AJ04 | cabotegravir |
| MJ05AP | antivirale midler til behandling af HCV-infektioner |
| MJ05AP01 | ribavirin |
| MJ05AP02 | telaprevir |
| MJ05AP03 | boceprevir |
| MJ05AP04 | faldaprevir |
| MJ05AP05 | simeprevir |
| MJ05AP06 | asunaprevir |
| MJ05AP07 | daclatasvir |
| MJ05AP08 | sofosbuvir |
| MJ05AP09 | dasabuvir |
| MJ05AP10 | elbasvir |
| MJ05AP11 | grazoprevir |
| MJ05AP12 | coblopasvir |
| MJ05AP13 | ravidasvir |
| MJ05AP14 | narlaprevir |
| MJ05AP51 | sofosbuvir og ledipasvir |
| MJ05AP52 | dasabuvir, ombitasvir, paritaprevir og ritonavir |
| MJ05AP53 | ombitasvir, paritaprevir og ritonavir |
| MJ05AP54 | elbasvir og grazoprevir |
| MJ05AP55 | sofosbuvir og velpatasvir |
| MJ05AP56 | sofosbuvir, velpatasvir og voxilaprevir |
| MJ05AP57 | glecaprevir og pibrentasvir |
| MJ05AP58 | daclatasvir, asunaprevir og beclabuvir |
| MJ05AR | antivirale midler til behandling af HIV-infektioner, komb. |
| MJ05AR01 | zidovudin og lamivudin |
| MJ05AR02 | lamivudin og abacavir |
| MJ05AR03 | tenofovirdisoproxil og emtricitabin |
| MJ05AR04 | zidovudin, lamivudin og abacavir |
| MJ05AR05 | zidovudin, lamivudin og nevirapin |
| MJ05AR06 | emtricitabin,tenofovirdisoproxil og efavirenz |
| MJ05AR07 | stavudin, lamivudin og nevirapin |
| MJ05AR08 | emtricitabin, tenofovirdisoproxil og rilpivirin |
| MJ05AR09 | emtricitabin, tenofovirdisoproxil, elvitegravir og cobicistat |
| MJ05AR10 | lopinavir og ritonavir |
| MJ05AR11 | lamivudin, tenofovir disoproxil og efavirenz |
| MJ05AR12 | lamivudin og tenofovirdisoproxil |
| MJ05AR13 | lamivudin, abacavir og dolutegravir |
| MJ05AR14 | darunavir og cobicistat |
| MJ05AR15 | atazanavir og cobicistat |
| MJ05AR16 | lamivudin og raltegravir |
| MJ05AR17 | emtricitabin og tenofovir alafenamid |
| MJ05AR18 | emtricitabin, tenofovir alafenamid, elvitegravir, cobicistat |
| MJ05AR19 | emtricitabin, tenofovir alafenamid og rilpivirin |
| MJ05AR20 | emtricitabin, tenofovir alafenamid og bictegravir |
| MJ05AR21 | dolutegravir og rilpivirin |
| MJ05AR22 | emtricitabin, tenofovir alafenamid, darunavir og cobicistat |
| MJ05AR23 | atazanavir og ritonavir |
| MJ05AR24 | lamivudin, tenofovirdisoproxil og doravirin |
| MJ05AR25 | lamivudin og dolutegravir |
| MJ05AR26 | darunavir og ritonavir |
| MJ05AR27 | lamivudin, tenofovirdisoproxil og dolutegravir |
| MJ05AR28 | stavudin og lamivudin |
| MJ05AR29 | emtricitabin, tenofovir alafenamid og dolutegravir |
| MJ05AX | andre antivirale midler |
| MJ05AX01 | moroxydin |
| MJ05AX02 | lysozym |
| MJ05AX05 | inosin pranobex |
| MJ05AX06 | pleconaril |
| MJ05AX07 | enfuvirtid |
| MJ05AX09 | maraviroc |
| MJ05AX10 | maribavir |
| MJ05AX13 | umifenovir |
| MJ05AX17 | enisamiumiodid |
| MJ05AX18 | letermovir |
| MJ05AX19 | tiloron |
| MJ05AX21 | pentandisyreimidazolylethanamid |
| MJ05AX23 | ibalizumab |
| MJ05AX24 | tecovirimat |
| MJ05AX25 | baloxavirmarboxil |
| MJ05AX26 | amenamevir |
| MJ05AX27 | favipiravir |
| MJ05AX28 | bulevirtid |
| MJ05AX29 | fostemsavir |
| MJ05AX31 | lenacapavir |
| MJ05AX32 | riamilovir |
| MJ06 | immunsera og immunoglobuliner |
| MJ06A | immunsera |
| MJ06AA | immunsera |
| MJ06AA01 | difteri antitoxin |
| MJ06AA02 | tetanus antitoxin |
| MJ06AA03 | slangegift antiserum |
| MJ06AA04 | botulinum antitoxin |
| MJ06AA05 | gas-gangræn sera |
| MJ06AA06 | rabies serum |
| MJ06B | immunoglobuliner |
| MJ06BA | immunoglobuliner, normal human |
| MJ06BA01 | immunoglobuliner, normal human til extravasc. brug |
| MJ06BA02 | immunoglobuliner, normal human til intravasc. brug |
| MJ06BB | specifikke immunoglobuliner |
| MJ06BB01 | anti-D (Rh) immunoglobulin |
| MJ06BB02 | tetanus immunoglobulin |
| MJ06BB03 | varicella/zoster immunoglobulin |
| MJ06BB04 | hepatitis B immunoglobulin |
| MJ06BB05 | rabies immunoglobulin |
| MJ06BB06 | rubella immunoglobulin |
| MJ06BB07 | vaccinia immunoglobulin |
| MJ06BB08 | staphylococcus immunoglobulin |
| MJ06BB09 | cytomegalovirus immunoglobulin |
| MJ06BB10 | difteri immunoglobulin |
| MJ06BB11 | hepatitis A immunoglobulin |
| MJ06BB12 | encephalitis, tick borne immunoglobulin |
| MJ06BB13 | pertussis immunoglobulin |
| MJ06BB14 | morbilli immunoglobulin |
| MJ06BB15 | parotitis immunoglobulin |
| MJ06BB19 | anthrax immunoglobulin |
| MJ06BB30 | kombinationer af specifikke immunoglobuliner |
| MJ06BC | antibakterielle monoklonale antistoffer |
| MJ06BC01 | nebacumab |
| MJ06BC02 | raxibacumab |
| MJ06BC03 | bezlotoxumab |
| MJ06BC04 | obiltoxaximab |
| MJ06BD | antivirale monoklonale antistoffer |
| MJ06BD01 | palivizumab |
| MJ06BD02 | motavizumab |
| MJ06BD03 | tixagevimab og cilgavimab |
| MJ06BD04 | ansuvimab |
| MJ06BD05 | sotrovimab |
| MJ06BD06 | regdanvimab |
| MJ06BD07 | casirivimab og imdevimab |
| MJ06BD08 | nirsevimab |
| MJ06BD09 | sipavibart |
| MJ07 | vacciner |
| MJ07A | bacterielle vacciner |
| MJ07AC | anthrax vacciner |
| MJ07AC01 | anthrax antigen |
| MJ07AD | brucellose vacciner |
| MJ07AD01 | brucella antigen |
| MJ07AE | cholera vacciner |
| MJ07AE01 | cholera, inaktiveret, hele celler |
| MJ07AE02 | cholera, levende attenueret |
| MJ07AE51 | cholera,komb. med typhoid vac., inakt.,hele celler |
| MJ07AF | difteri vacciner |
| MJ07AF01 | difteri toxoid |
| MJ07AG | haemophilus influenzae B vacciner |
| MJ07AG01 | haemophilus influenzae B, purified antigen konjugeret |
| MJ07AG51 | haemophilus influenzae B, kombinationer med toxoider |
| MJ07AG52 | haemophilus influenzae B, kombinationer med pertussis og toxoider |
| MJ07AG53 | haemophilus influenzae B, kombinationer med meningococcus C, konjugeret |
| MJ07AG54 | haemophilus influenzae B, kombinationer med meningococcus C,Y, konjugeret |
| MJ07AH | meningokok vacciner |
| MJ07AH01 | miningococcus A, purified polysaccharides antigen |
| MJ07AH02 | andre meningococcal monovalent purified polysaccharides antigen |
| MJ07AH03 | meningococcus A,C, bivalent purified polysaccharides antigen |
| MJ07AH04 | meningococcus A,C,Y,W135, tetravalent purified polysaccharides antigen |
| MJ07AH05 | andre meningococcal polyvalent purified polysaccharides antigen |
| MJ07AH06 | meningococcus B, outer membrane vesicle vaccine |
| MJ07AH07 | meningococcus C, purified polysaccharides antigen konjugat |
| MJ07AH08 | meningococcus A,C,Y,W135, tetravalent purified polysaccharides antigen konjugat |
| MJ07AH09 | meningococcus B, multikomponent vaccine |
| MJ07AH10 | meningococcus A, renset polysaccharid antigen konjugat |
| MJ07AH11 | meningococcus A,B,C,Y,W-135, pentavalent renset polysaccarid antigen konjugeret og faktor H-binding protein |
| MJ07AJ | pertussis vacciner |
| MJ07AJ01 | pertussis, inaktiveret, hele celler |
| MJ07AJ02 | pertussis, renset antigen |
| MJ07AJ51 | pertussis, inakt., hele celler, kombinationer med toxoider |
| MJ07AJ52 | pertusiss, renset antigen, kombinationer med toxoider |
| MJ07AK | pest vacciner |
| MJ07AK01 | pest, inaktiveret, hele celler |
| MJ07AL | pneumokok vacciner |
| MJ07AL01 | pneumococcus, purified polysaccharides antigen |
| MJ07AL02 | pneumococcus, purified polysacc. antigen conj. |
| MJ07AL52 | pneumococcus, renset polysaccharid antigen og haemophillus influenzae, konjugat |
| MJ07AM | tetanus vacciner |
| MJ07AM01 | tetanus toxoid |
| MJ07AM51 | tetanus toxoid, komb. med difteri toxoid |
| MJ07AM52 | tetanus toxoid, komb. med tetanus immunoglobulin |
| MJ07AN | tuberculose vacciner |
| MJ07AN01 | tuberculose, levende attenueret |
| MJ07AP | tyfus vacciner |
| MJ07AP01 | tyfus, oral, levende attenueret |
| MJ07AP02 | tyfus, inaktiveret, hele celler |
| MJ07AP03 | tyfus, renset polysaccharid antigen |
| MJ07AP10 | tyfus, kombinationer med paratyfus typer |
| MJ07AR | typhus exanthematicus vacciner |
| MJ07AR01 | typhus exanthematicus, inaktiveret, hele celler |
| MJ07AX | andre bacterielle vacciner |
| MJ07AX01 | leptospira vacciner |
| MJ07B | virale vacciner |
| MJ07BA | encephalitis vacciner |
| MJ07BA01 | encephalitis, tick borne, inaktiveret, hele virus |
| MJ07BA02 | encephalitis, japansk, inaktiveret, hele virus |
| MJ07BA03 | encephalitis, japansk, levende svækket |
| MJ07BB | influenza vacciner |
| MJ07BB01 | influenza, inaktiveret, hele virus |
| MJ07BB02 | influenza, renset antigen |
| MJ07BB03 | influenza, levende svækket |
| MJ07BB04 | influenza, viruslignende partikler |
| MJ07BB05 | influenza, RNA-baseret vaccine |
| MJ07BC | hepatitis vacciner |
| MJ07BC01 | hepatitis B, renset antigen |
| MJ07BC02 | hepatitis A, inaktiveret, hel virus |
| MJ07BC20 | kombinationer af hepatitis vacciner |
| MJ07BD | mæslingevacciner |
| MJ07BD01 | mæslinger, levende attenueret |
| MJ07BD51 | mæslinger, komb. m. fåresyge, levende attenueret |
| MJ07BD52 | mæslinger, komb. m. fåresyge og rubella, levende attenueret |
| MJ07BD53 | mæslinger, komb. m. rubella, levende attenueret |
| MJ07BD54 | mæslinger, komb. med fåresyge, rubella og varicella, levende attenueret |
| MJ07BE | fåresygevacciner |
| MJ07BE01 | fåresyge, levende attenueret |
| MJ07BF | poliomyelitis vacciner |
| MJ07BF01 | poliomyelitis oral, monovalent, levende attenueret |
| MJ07BF02 | poliomyelitis oral, trivalent, levende attenueret |
| MJ07BF03 | poliomyelitis, trivalent, inaktiveret, hele virus |
| MJ07BF04 | poliomyelitis oral, bivalent, levende attenueret |
| MJ07BG | rabies vacciner |
| MJ07BG01 | rabies, inaktiveret, hele virus |
| MJ07BH | rota virus diarrhea vacciner |
| MJ07BH01 | rota virus, levende attenueret |
| MJ07BH02 | rota virus, pentavalent, levende, reassorted |
| MJ07BJ | rubella vacciner |
| MJ07BJ01 | rubella, levende attenueret |
| MJ07BJ51 | rubella, komb. m. fåresyge, levende attenueret |
| MJ07BK | varicella zoster vacciner |
| MJ07BK01 | varicella, levende attenueret |
| MJ07BK02 | zoster virus, levende attenueret |
| MJ07BK03 | zoster, renset antigen |
| MJ07BL | gul feber vacciner |
| MJ07BL01 | gul feber, levende attenueret |
| MJ07BM | papillomavirus-vacciner |
| MJ07BM01 | papillomavirus (human type 6, 11, 16, 18) |
| MJ07BM02 | papillomavirus (human type 16, 18) |
| MJ07BM03 | papillomavirus (human type 6, 11, 16, 18, 31, 33, 45, 52,58) |
| MJ07BN | COVID-19 vacciner |
| MJ07BN01 | COVID-19, RNA-baseret vaccine |
| MJ07BN02 | COVID-19, virusvektor, non-replikerende |
| MJ07BN03 | COVID-19, inaktiveret virus |
| MJ07BN04 | COVID-19, protein subunit |
| MJ07BN05 | COVID-19, viruslignende partikler |
| MJ07BX | andre virale vacciner |
| MJ07BX01 | koppevaccine og abekoppevaccine |
| MJ07BX02 | ebolavirus |
| MJ07BX04 | denguefeber vacciner |
| MJ07BX05 | respiratorisk syncytialvirus-vacciner |
| MJ07BX06 | enterovirus 71 vacciner |
| MJ07C | bacterielle og virale vacciner, kombinerede |
| MJ07CA | bacterielle og virale vacciner, kombinerede |
| MJ07CA01 | difteri-poliomyelitis-tetanus |
| MJ07CA02 | difteri-pertussis-poliomyelitis-tetanus |
| MJ07CA03 | difteri-rubella-tetanus |
| MJ07CA04 | haemophilus influenzae B og poliomyelitis |
| MJ07CA05 | difteri-hepatitis B-pertussis-tetanus |
| MJ07CA06 | difteri-haemophilus influenzae B-pertussis-polio-tetanus |
| MJ07CA07 | difteri-hepatitis B-tetanus |
| MJ07CA08 | haemophilus influenzae og hepatitis B |
| MJ07CA09 | difteri-haemophilus influenzae B-pertussis-polio-tetanus-hepatitis B |
| MJ07CA10 | tyfus - hepatitis A |
| MJ07CA11 | difteri-haemophilus influenzae B-pertussis-tetanus-hepatitis B |
| MJ07CA12 | difteri-pertussis-polio-tetanus-hepatitis B |
| MJ07CA13 | difteri-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A+C |
| MJ07X | andre vacciner |
| MJ07XA | parasitære vacciner |
| MJ07XA01 | malariavacciner |
| ML | Antineoplastiske og immunomodulerende midler |
| ML01 | antineoplastiske stoffer |
| ML01A | alkyleringsmidler |
| ML01AA | kvælstofsennepsgas-analoger |
| ML01AA01 | cyclophosphamid |
| ML01AA02 | chlorambucil |
| ML01AA03 | melphalan |
| ML01AA05 | chlormethin |
| ML01AA06 | ifosfamid |
| ML01AA07 | trofosfamid |
| ML01AA08 | prednimustin |
| ML01AA09 | bendamustin |
| ML01AA10 | melphalanflufenamid |
| ML01AB | alkylsulfonater |
| ML01AB01 | busulfan |
| ML01AB02 | treosulfan |
| ML01AB03 | mannosulfan |
| ML01AC | ethyleniminer |
| ML01AC01 | thiotepa |
| ML01AC02 | triaziquon |
| ML01AC03 | carboquon |
| ML01AD | nitrosoureastoffer |
| ML01AD01 | carmustin |
| ML01AD02 | lomustin |
| ML01AD03 | semustin |
| ML01AD04 | streptozocin |
| ML01AD05 | fotemustin |
| ML01AD06 | nimustin |
| ML01AD07 | ranimustin |
| ML01AD08 | uramustin |
| ML01AG | epoxider |
| ML01AG01 | etoglucid |
| ML01AX | andre alkyleringsmidler |
| ML01AX01 | mitobronitol |
| ML01AX02 | pipobroman |
| ML01AX03 | temozolomid |
| ML01AX04 | dacarbazin |
| ML01B | antimetabolitter |
| ML01BA | folsyre-analoger |
| ML01BA01 | methotrexat |
| ML01BA03 | raltitrexed |
| ML01BA04 | pemetrexed |
| ML01BA05 | pralatrexat |
| ML01BB | purin-analoger |
| ML01BB02 | mercaptopurin |
| ML01BB03 | tioguanin |
| ML01BB04 | cladribin |
| ML01BB05 | fludarabin |
| ML01BB06 | clofarabin |
| ML01BB07 | nelarabin |
| ML01BC | pyrimidin-analoger |
| ML01BC01 | cytarabin |
| ML01BC02 | fluoruracil |
| ML01BC03 | tegafur |
| ML01BC04 | carmofur |
| ML01BC05 | gemcitabin |
| ML01BC06 | capecitabin |
| ML01BC07 | azacitidin |
| ML01BC08 | decitabin |
| ML01BC09 | floxuridin |
| ML01BC52 | fluoruracil, kombinationer |
| ML01BC53 | tegafur, komb. |
| ML01BC58 | decitabin, kombinationer |
| ML01BC59 | trifluridin, kombinationer |
| ML01C | plantealkaloider og andre naturprodukter |
| ML01CA | vinca-alkaloider og analoger |
| ML01CA01 | vinblastin |
| ML01CA02 | vincristin |
| ML01CA03 | vindesin |
| ML01CA04 | vinorelbin |
| ML01CA05 | vinflunin |
| ML01CA06 | vintafolid |
| ML01CB | podophyllotoxin-derivater |
| ML01CB01 | etoposid |
| ML01CB02 | teniposid |
| ML01CC | colchicin-derivater |
| ML01CC01 | demecolcin |
| ML01CD | taxaner |
| ML01CD01 | paclitaxel |
| ML01CD02 | docetaxel |
| ML01CD03 | paclitaxel poliglumex |
| ML01CD04 | cabazitaxel |
| ML01CD51 | paclitaxel og encequidar |
| ML01CE | topoisomerase 1 hæmmere |
| ML01CE01 | topotecan |
| ML01CE02 | irinotecan |
| ML01CE03 | etirinotecan pegol |
| ML01CE04 | belotecan |
| ML01CX | andre plantealkaloider og naturprodukter |
| ML01CX01 | trabectedin |
| ML01D | cytotoksiske antibiotika og beslægtede stoffer |
| ML01DA | actinomyciner |
| ML01DA01 | dactinomycin |
| ML01DB | anthracycliner og beslægtede stoffer |
| ML01DB01 | doxorubicin |
| ML01DB02 | daunorubicin |
| ML01DB03 | epirubicin |
| ML01DB04 | aclarubicin |
| ML01DB05 | zorubicin |
| ML01DB06 | idarubicin |
| ML01DB07 | mitoxantron |
| ML01DB08 | pirarubicin |
| ML01DB09 | valrubicin |
| ML01DB10 | amrubicin |
| ML01DB11 | pixantron |
| ML01DC | andre cytotoxiske antibiotika |
| ML01DC01 | bleomycin |
| ML01DC02 | plicamycin |
| ML01DC03 | mitomycin |
| ML01DC04 | ixabepilon |
| ML01DC05 | utidelon |
| ML01E | proteinkinasehæmmere |
| ML01EA | BCR-ABL tyrosinkinasehæmmere |
| ML01EA01 | imatinib |
| ML01EA02 | dasatinib |
| ML01EA03 | nilotinib |
| ML01EA04 | bosutinib |
| ML01EA05 | ponatinib |
| ML01EA06 | asciminib |
| ML01EB | epidermal vækstfaktor receptor (EGFR)-tyrosinkinasehæmmere |
| ML01EB01 | gefitinib |
| ML01EB02 | erlotinib |
| ML01EB03 | afatinib |
| ML01EB04 | osimertinib |
| ML01EB05 | rociletinib |
| ML01EB06 | olmutinib |
| ML01EB07 | dacomitinib |
| ML01EB08 | icotinib |
| ML01EB09 | lazertinib |
| ML01EB10 | mobocertinib |
| ML01EB11 | aumolertinib |
| ML01EC | B-Raf serin-threoninkinase (BRAF) hæmmere |
| ML01EC01 | vemurafenib |
| ML01EC02 | dabrafenib |
| ML01EC03 | encorafenib |
| ML01ED | anaplastisk lymfom kinase (ALK) hæmmere |
| ML01ED01 | crizotinib |
| ML01ED02 | ceritinib |
| ML01ED03 | alectinib |
| ML01ED04 | brigatinib |
| ML01ED05 | lorlatinib |
| ML01EE | mitogen-aktiverede proteinkinase (MEK) hæmmere |
| ML01EE01 | trametinib |
| ML01EE02 | cobimetinib |
| ML01EE03 | binimetinib |
| ML01EE04 | selumetinib |
| ML01EF | cyclin-afhængig kinase (CDK) hæmmere |
| ML01EF01 | palbociclib |
| ML01EF02 | ribociclib |
| ML01EF03 | abemaciclib |
| ML01EG | mammalian target of rapamycin (mTOR) kinase hæmmere |
| ML01EG01 | temsirolimus |
| ML01EG02 | everolimus |
| ML01EG03 | ridaforolimus |
| ML01EG04 | sirolimus |
| ML01EH | human epidermal vækstfaktor receptor 2 (HER2) tyrosinkinase hæmmere |
| ML01EH01 | lapatinib |
| ML01EH02 | neratinib |
| ML01EH03 | tucatinib |
| ML01EJ | janus associerede kinase (JAK) hæmmere |
| ML01EJ01 | ruxolitinib |
| ML01EJ02 | fedratinib |
| ML01EJ03 | pacritinib |
| ML01EJ04 | momelotinib |
| ML01EK | vaskulær endotelial vækstfaktor receptor (VEGFR)-tyrosinkinase hæmmere |
| ML01EK01 | axitinib |
| ML01EK02 | cediranib |
| ML01EK03 | tivozanib |
| ML01EK04 | fruquintinib |
| ML01EL | Bruton's tyrosinkinase (BTK) hæmmere |
| ML01EL01 | ibrutinib |
| ML01EL02 | acalabrutinib |
| ML01EL03 | zanubrutinib |
| ML01EL04 | orelabrutinib |
| ML01EL05 | pirtobrutinib |
| ML01EL06 | tirabrutinib |
| ML01EM | phosphatidylinositol-3-kinase (Pi3K) hæmmere |
| ML01EM01 | idelalisib |
| ML01EM02 | copanlisib |
| ML01EM03 | alpelisib |
| ML01EM04 | duvelisib |
| ML01EM05 | parsaclisib |
| ML01EN | fibroblast vækstfaktor receptor (FGFR) tyrosinkinasehæmmere |
| ML01EN01 | erdafitinib |
| ML01EN02 | pemigatinib |
| ML01EN03 | infigratinib |
| ML01EN04 | futibatinib |
| ML01EX | andre proteinkinasehæmmere |
| ML01EX01 | sunitinib |
| ML01EX02 | sorafenib |
| ML01EX03 | pazopanib |
| ML01EX04 | vandetanib |
| ML01EX05 | regorafenib |
| ML01EX06 | masitinib |
| ML01EX07 | cabozantinib |
| ML01EX08 | lenvatinib |
| ML01EX09 | nintedanib |
| ML01EX10 | midostaurin |
| ML01EX11 | quizartinib |
| ML01EX12 | larotrectinib |
| ML01EX13 | gilteritinib |
| ML01EX14 | entrectinib |
| ML01EX15 | pexidartinib |
| ML01EX17 | capmatinib |
| ML01EX18 | avapritinib |
| ML01EX19 | ripretinib |
| ML01EX21 | tepotinib |
| ML01EX22 | selpercatinib |
| ML01EX23 | pralsetinib |
| ML01EX24 | surufatinib |
| ML01EX25 | umbralisib |
| ML01EX26 | sitravatinib |
| ML01EX27 | capivasertib |
| ML01EX28 | repotrectinib |
| ML01F | monoklonale antistoffer og antistof-lægemiddel-konjugater |
| ML01FA | anti-CD20 monoklonale antistoffer |
| ML01FA01 | rituximab |
| ML01FA02 | ofatumumab |
| ML01FA03 | obinutuzumab |
| ML01FB | anti-CD22 monoklonale antistoffer |
| ML01FB01 | inotuzumab ozogamicin |
| ML01FB02 | moxetumomab pasudotox |
| ML01FC | anti-CD38 monoklonale antistoffer |
| ML01FC01 | daratumumab |
| ML01FC02 | isatuximab |
| ML01FD | human epidermal vækstfaktor receptor 2 (HER2) hæmmere |
| ML01FD01 | trastuzumab |
| ML01FD02 | pertuzumab |
| ML01FD03 | trastuzumab emtansin |
| ML01FD04 | trastuzumab deruxtecan |
| ML01FD05 | trastuzumab duocarmazin |
| ML01FD06 | margetuximab |
| ML01FD07 | zanidatamab |
| ML01FE | epidermal vækstfaktor receptor (EGFR) hæmmere |
| ML01FE01 | cetuximab |
| ML01FE02 | panitumumab |
| ML01FE03 | necitumumab |
| ML01FF | PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hæmmere |
| ML01FF01 | nivolumab |
| ML01FF02 | pembrolizumab |
| ML01FF03 | durvalumab |
| ML01FF04 | avelumab |
| ML01FF05 | atezolizumab |
| ML01FF06 | cemiplimab |
| ML01FF07 | dostarlimab |
| ML01FF08 | prolgolimab |
| ML01FF09 | tislelizumab |
| ML01FF10 | retifanlimab |
| ML01FF11 | sugemalimab |
| ML01FF12 | serplulimab |
| ML01FF13 | toripalimab |
| ML01FG | vaskulær endotelial vækstfaktor (VEGF/VEGFR) hæmmere |
| ML01FG01 | bevacizumab |
| ML01FG02 | ramucirumab |
| ML01FX | andre monoklonale antistoffer og antistof-lægemiddel-konjugater |
| ML01FX01 | edrecolomab |
| ML01FX02 | gemtuzumab ozogamicin |
| ML01FX03 | catumaxomab |
| ML01FX04 | ipilimumab |
| ML01FX05 | brentuximab vedotin |
| ML01FX06 | dinutuximab beta |
| ML01FX07 | blinatumomab |
| ML01FX08 | elotuzumab |
| ML01FX09 | mogamulizumab |
| ML01FX10 | olaratumab |
| ML01FX11 | bermekimab |
| ML01FX12 | tafasitamab |
| ML01FX13 | enfortumab vedotin |
| ML01FX14 | polatuzumab vedotin |
| ML01FX15 | belantamab mafodotin |
| ML01FX16 | oportuzumab monatox |
| ML01FX17 | sacituzumab govitecan |
| ML01FX18 | amivantamab |
| ML01FX19 | sabatolimab |
| ML01FX20 | tremelimumab |
| ML01FX21 | naxitamab |
| ML01FX22 | loncastuximab tesirin |
| ML01FX23 | tisotumab vedotin |
| ML01FX24 | teclistamab |
| ML01FX25 | mosunetuzumab |
| ML01FX26 | mirvetuximab soravtansin |
| ML01FX27 | epcoritamab |
| ML01FX28 | glofitamab |
| ML01FX29 | talquetamab |
| ML01FX31 | zolbetuximab |
| ML01FX32 | elranatamab |
| ML01FX33 | tarlatamab |
| ML01FX34 | odronextamab |
| ML01FY | kombinationer af monoklonale antistoffer og antistof-lægemiddel-konjugater |
| ML01FY01 | pertuzumab og trastuzumab |
| ML01FY02 | nivolumab og relatlimab |
| ML01FY03 | prolgolimab og nurulimab |
| ML01X | andre antineoplastiske stoffer |
| ML01XA | platin-forbindelser |
| ML01XA01 | cisplatin |
| ML01XA02 | carboplatin |
| ML01XA03 | oxaliplatin |
| ML01XA04 | satraplatin |
| ML01XA05 | polyplatillen |
| ML01XB | methylhydraziner |
| ML01XB01 | procarbazin |
| ML01XD | sensibilatorer til fotodynamisk/stråle-terapi |
| ML01XD01 | porfimernatrium |
| ML01XD03 | methylaminolevulinat |
| ML01XD04 | aminolevulinsyre |
| ML01XD05 | temoporfin |
| ML01XD06 | efaproxiral |
| ML01XD07 | padeliporfin |
| ML01XF | retinoider til cancerbehandling |
| ML01XF01 | tretinoin |
| ML01XF02 | alitretinoin |
| ML01XF03 | bexaroten |
| ML01XG | proteasomhæmmere |
| ML01XG01 | bortezomib |
| ML01XG02 | carfilzomib |
| ML01XG03 | ixazomib |
| ML01XH | histondeacetylase (HDAC) hæmmere |
| ML01XH01 | vorinostat |
| ML01XH02 | romidepsin |
| ML01XH03 | panobinostat |
| ML01XH04 | belinostat |
| ML01XH05 | entinostat |
| ML01XH06 | tucidinostat |
| ML01XH07 | resminostat |
| ML01XJ | hedgehog pathway hæmmere |
| ML01XJ01 | vismodegib |
| ML01XJ02 | sonidegib |
| ML01XJ03 | glasdegib |
| ML01XK | poly (ADP-ribose) polymerase (PARP) hæmmere |
| ML01XK01 | olaparib |
| ML01XK02 | niraparib |
| ML01XK03 | rucaparib |
| ML01XK04 | talazoparib |
| ML01XK05 | veliparib |
| ML01XK06 | pamiparib |
| ML01XK52 | niraparib og abirateron |
| ML01XL | antineoplastisk celle- og genterapi |
| ML01XL01 | sitimagen ceradenovec |
| ML01XL02 | talimogen laherparepvec |
| ML01XL03 | axicabtagen ciloleucel |
| ML01XL04 | tisagenlecleucel |
| ML01XL05 | ciltacabtagen autoleucel |
| ML01XL06 | brexucabtagen autoleucel |
| ML01XL07 | idecabtagen vicleucel |
| ML01XL08 | lisocabtagene maraleucel |
| ML01XL09 | tabelecleucel |
| ML01XL10 | nadofaragen firadenovec |
| ML01XL11 | lifileucel |
| ML01XM | isocitrat dehydrogenase (IDH) hæmmere |
| ML01XM03 | olutasidenib |
| ML01XM04 | vorasidenib |
| ML01XX | andre neoplastiske stoffer |
| ML01XX01 | amsacrin |
| ML01XX02 | asparaginase |
| ML01XX03 | altretamin |
| ML01XX05 | hydroxycarbamid |
| ML01XX07 | lonidamin |
| ML01XX08 | pentostatin |
| ML01XX10 | masoprocol |
| ML01XX11 | estramustin |
| ML01XX16 | mitoguazon |
| ML01XX18 | tiazofurin |
| ML01XX23 | mitotan |
| ML01XX24 | pegaspargase |
| ML01XX27 | arsentrioxid |
| ML01XX29 | denileukin diftitox |
| ML01XX33 | celecoxib |
| ML01XX35 | anagrelid |
| ML01XX36 | oblimersen |
| ML01XX40 | omacetaxine mepesuccinat |
| ML01XX41 | eribulin |
| ML01XX44 | aflibercept |
| ML01XX52 | venetoclax |
| ML01XX53 | vosaroxin |
| ML01XX57 | plitidepsin |
| ML01XX58 | epacadostat |
| ML01XX59 | enasidenib |
| ML01XX62 | ivosidenib |
| ML01XX66 | selinexor |
| ML01XX67 | tagraxofusp |
| ML01XX69 | lurbinectedin |
| ML01XX72 | tazemetostat |
| ML01XX73 | sotorasib |
| ML01XX74 | belzutifan |
| ML01XX75 | tebentafusp |
| ML01XX77 | adagrasib |
| ML01XX78 | navitoclax |
| ML01XX79 | eflornithin |
| ML01XX80 | imetelstat |
| ML01XX81 | nirogacestat |
| ML01XY | kombinationer af antineoplastiske stoffer |
| ML01XY01 | cytarabin og daunorubicin |
| ML02 | endocrin terapi |
| ML02A | hormoner og beslægtede stoffer |
| ML02AA | østrogener |
| ML02AA01 | diethylstilbestrol |
| ML02AA02 | polyestradiolphosphat |
| ML02AA03 | ethinylestradiol |
| ML02AA04 | fosfestrol |
| ML02AB | gestagener |
| ML02AB01 | megestrol |
| ML02AB02 | medroxyprogesteron |
| ML02AB03 | gestonoron |
| ML02AE | gonadotropin-releasing hormon analoger |
| ML02AE01 | buserelin |
| ML02AE02 | leuprorelin |
| ML02AE03 | goserelin |
| ML02AE04 | triptorelin |
| ML02AE05 | histrelin |
| ML02AE51 | leuprorelin og bicalutamid |
| ML02AX | andre hormoner |
| ML02B | hormon-antagonister og lign. stoffer |
| ML02BA | anti-østrogener |
| ML02BA01 | tamoxifen |
| ML02BA02 | toremifen |
| ML02BA03 | fulvestrant |
| ML02BA04 | elacestrant |
| ML02BB | anti-androgener |
| ML02BB01 | flutamid |
| ML02BB02 | nilutamid |
| ML02BB03 | bicalutamid |
| ML02BB04 | enzalutamid |
| ML02BB05 | apalutamid |
| ML02BB06 | darolutamid |
| ML02BG | aromatase inhibitorer |
| ML02BG01 | aminogluthetimid |
| ML02BG02 | formestan |
| ML02BG03 | anastrozol |
| ML02BG04 | letrozol |
| ML02BG05 | vorozol |
| ML02BG06 | exemestan |
| ML02BX | andre hormon-antagonister og lign. stoffer |
| ML02BX01 | abarelix |
| ML02BX02 | degarelix |
| ML02BX03 | abirateron |
| ML02BX04 | relugolix |
| ML02BX53 | abirateron og prednisolon |
| ML03 | immunstimulerende midler |
| ML03A | immunstimulanter |
| ML03AA | kolonistimulerende faktorer |
| ML03AA02 | filgrastim |
| ML03AA03 | molgramostim |
| ML03AA09 | sargramostim |
| ML03AA10 | lenograstim |
| ML03AA12 | ancestim |
| ML03AA13 | pegfilgrastim |
| ML03AA14 | lipegfilgrastim |
| ML03AA15 | balugrastim |
| ML03AA16 | empegfilgrastim |
| ML03AA17 | pegteograstim |
| ML03AA18 | efbemalenograstim alfa |
| ML03AA19 | eflapegrastim |
| ML03AB | interferoner |
| ML03AB01 | interferon alfa naturligt |
| ML03AB02 | interferon beta naturligt |
| ML03AB03 | interferon gamma |
| ML03AB04 | interferon alfa-2A |
| ML03AB05 | interferon alfa-2B |
| ML03AB06 | interferon alfa-N1 |
| ML03AB07 | interferon beta-1A |
| ML03AB08 | interferon beta-1B |
| ML03AB09 | interferon alfacon-1 |
| ML03AB10 | Peginterferon alfa-2B |
| ML03AB11 | peginterferon alfa-2A |
| ML03AB12 | albinterferon alfa-2B |
| ML03AB13 | peginterferon beta-1A |
| ML03AB14 | cepeginterferon alfa-2B |
| ML03AB15 | ropeginterferon alfa-2b |
| ML03AB16 | peginterferon alfacon-2 |
| ML03AB17 | sampeginterferon beta-1a |
| ML03AB60 | peginterferon-alfa-2B, komb. |
| ML03AB61 | peginterferon alfa-2A, kombinationer |
| ML03AC | interleukiner |
| ML03AC01 | aldesleukin |
| ML03AC02 | oprelvekin |
| ML03AX | andre immunstimulanter |
| ML03AX01 | lentinan |
| ML03AX02 | roquinimex |
| ML03AX03 | bcg vaccine |
| ML03AX04 | pegademase |
| ML03AX05 | pidotimod |
| ML03AX07 | poly I:C |
| ML03AX08 | poly ICLC |
| ML03AX09 | thymopentin |
| ML03AX10 | immunocyanin |
| ML03AX11 | tasonermin |
| ML03AX12 | melanoma vaccine |
| ML03AX13 | glatirameracetat |
| ML03AX14 | histamindihydrochlorid |
| ML03AX15 | mifamurtid |
| ML03AX16 | plerixafor |
| ML03AX17 | sipuleucel-T |
| ML03AX18 | cridanimod |
| ML03AX19 | dasiprotimut-T |
| ML03AX21 | elapegademase |
| ML03AX22 | leniolisib |
| ML04 | immunsuppressiva |
| ML04A | immunsuppressiva |
| ML04AA | selektive immunsuppressiva |
| ML04AA03 | antilymfocyt immunoglobulin |
| ML04AA04 | antithymocyt immunoglobulin |
| ML04AA06 | mycophenolsyre |
| ML04AA15 | alefacept |
| ML04AA19 | gusperimus |
| ML04AA22 | abetimus |
| ML04AA24 | abatacept |
| ML04AA28 | belatacept |
| ML04AA32 | apremilast |
| ML04AA40 | cladribin |
| ML04AA41 | imlifidase |
| ML04AA48 | belumosudil |
| ML04AA58 | efgartigimod alfa |
| ML04AA60 | remibrutinib |
| ML04AB | tumor necrosis factor alpha (TNF-alfa) hæmmere |
| ML04AB01 | etanercept |
| ML04AB02 | infliximab |
| ML04AB03 | afelimomab |
| ML04AB04 | adalimumab |
| ML04AB05 | certolizumab pegol |
| ML04AB06 | golimumab |
| ML04AB07 | opinercept |
| ML04AC | interleukinhæmmere |
| ML04AC01 | daclizumab |
| ML04AC02 | basiliximab |
| ML04AC03 | anakinra |
| ML04AC04 | rilonacept |
| ML04AC05 | ustekinumab |
| ML04AC07 | tocilizumab |
| ML04AC08 | canakinumab |
| ML04AC09 | briakinumab |
| ML04AC10 | secukinumab |
| ML04AC11 | siltuximab |
| ML04AC12 | brodalumab |
| ML04AC13 | ixekizumab |
| ML04AC14 | sarilumab |
| ML04AC15 | sirukumab |
| ML04AC16 | guselkumab |
| ML04AC17 | tildrakizumab |
| ML04AC18 | risankizumab |
| ML04AC19 | satralizumab |
| ML04AC20 | netakimab |
| ML04AC21 | bimekizumab |
| ML04AC22 | spesolimab |
| ML04AC23 | olokizumab |
| ML04AC24 | mirikizumab |
| ML04AC25 | levilimab |
| ML04AC26 | goflikicept |
| ML04AD | calcineurinhæmmere |
| ML04AD01 | ciclosporin |
| ML04AD02 | tacrolimus |
| ML04AD03 | voclosporin |
| ML04AE | sphingosin 1-phosphat (S1P) receptormodulatorer |
| ML04AE01 | fingolimod |
| ML04AE02 | ozanimod |
| ML04AE03 | siponimod |
| ML04AE04 | ponesimod |
| ML04AE05 | etrasimod |
| ML04AF | janus associerede kinase (JAK) hæmmere |
| ML04AF01 | tofacitinib |
| ML04AF02 | baricitinib |
| ML04AF03 | upadacitinib |
| ML04AF04 | filgotinib |
| ML04AF05 | itacitinib |
| ML04AF06 | peficitinib |
| ML04AF07 | deucravacitinib |
| ML04AF08 | ritlecitinib |
| ML04AG | monoklonale antistoffer |
| ML04AG01 | muromonab-CD3 |
| ML04AG02 | efalizumab |
| ML04AG03 | natalizumab |
| ML04AG04 | belimumab |
| ML04AG05 | vedolizumab |
| ML04AG06 | alemtuzumab |
| ML04AG07 | begelomab |
| ML04AG08 | ocrelizumab |
| ML04AG09 | emapalumab |
| ML04AG10 | inebilizumab |
| ML04AG11 | anifrolumab |
| ML04AG12 | ofatumumab |
| ML04AG13 | teprotumumab |
| ML04AG14 | ublituximab |
| ML04AG15 | divozilimab |
| ML04AG16 | rozanolixizumab |
| ML04AG17 | seniprutug |
| ML04AH | mammalian target of rapamycin (mTOR) kinasehæmmere |
| ML04AH01 | sirolimus |
| ML04AH02 | everolimus |
| ML04AJ | komplementhæmmere |
| ML04AJ01 | eculizumab |
| ML04AJ02 | ravulizumab |
| ML04AJ03 | pegcetacoplan |
| ML04AJ04 | sutimlimab |
| ML04AJ05 | avacopan |
| ML04AJ06 | zilucoplan |
| ML04AJ07 | crovalimab |
| ML04AJ08 | iptacopan |
| ML04AJ09 | danicopan |
| ML04AJ10 | vilobelimab |
| ML04AK | dihydroorotat dehydrogenase (DHODH) hæmmere |
| ML04AK01 | leflunomid |
| ML04AK02 | teriflunomid |
| ML04AX | andre immunosuppressiva |
| ML04AX01 | azathioprin |
| ML04AX02 | thalidomid |
| ML04AX03 | methotrexat |
| ML04AX04 | lenalidomid |
| ML04AX05 | pirfenidon |
| ML04AX06 | pomalidomid |
| ML04AX07 | dimethylfumarat |
| ML04AX08 | darvadstrocel |
| ML04AX09 | diroximelfumarat |
| MM | Muskulo-skeletal system |
| MM01 | antiinflammatoriske og antirheumatiske midler |
| MM01A | antiinflamm./antirheum. midler, non-steroide |
| MM01AA | butylpyrazolidiner |
| MM01AA01 | phenylbutazon |
| MM01AA02 | mofebutazon |
| MM01AA03 | oxyphenbutazon |
| MM01AA05 | clofezon |
| MM01AA06 | kebuzon |
| MM01AB | eddikesyre-derivater og beslægtede stoffer |
| MM01AB01 | indometacin |
| MM01AB02 | sulindac |
| MM01AB03 | tolmetin |
| MM01AB04 | zomepirac |
| MM01AB05 | diclofenac |
| MM01AB06 | alclofenac |
| MM01AB07 | bumadizon |
| MM01AB08 | etodolac |
| MM01AB09 | lonazolac |
| MM01AB10 | fentiazac |
| MM01AB11 | acemetacin |
| MM01AB12 | difenpiramid |
| MM01AB13 | oxametacin |
| MM01AB14 | proglumetacin |
| MM01AB15 | ketorolac |
| MM01AB16 | aceclofenac |
| MM01AB17 | bufexamac |
| MM01AB51 | indometacin, kombinationer |
| MM01AB55 | diclofenac, kombinationer |
| MM01AC | oxicamer |
| MM01AC01 | piroxicam |
| MM01AC02 | tenoxicam |
| MM01AC04 | droxicam |
| MM01AC05 | lornoxicam |
| MM01AC06 | meloxicam |
| MM01AC56 | meloxicam, kombinationer |
| MM01AE | propionsyre-derivater |
| MM01AE01 | ibuprofen |
| MM01AE02 | naproxen |
| MM01AE03 | ketoprofen |
| MM01AE04 | fenoprofen |
| MM01AE05 | fenbufen |
| MM01AE06 | benoxaprofen |
| MM01AE07 | suprofen |
| MM01AE08 | pirprofen |
| MM01AE09 | flurbiprofen |
| MM01AE10 | indoprofen |
| MM01AE11 | tiaprofensyre |
| MM01AE12 | oxaprozin |
| MM01AE13 | ibuproxam |
| MM01AE14 | dexibuprofen |
| MM01AE15 | flunoxaprofen |
| MM01AE16 | alminoprofen |
| MM01AE17 | dexketoprofen |
| MM01AE18 | naproxcinod |
| MM01AE19 | loxoprofen |
| MM01AE51 | ibuprofen, kombinationer |
| MM01AE52 | naproxen og esomeprazol |
| MM01AE53 | ketoprofen, kombinationer |
| MM01AE56 | naproxen og misoprostol |
| MM01AE57 | naproxen og diphenhydramin |
| MM01AG | fenamater |
| MM01AG01 | mefenamsyre |
| MM01AG02 | tolfenamsyre |
| MM01AG03 | flufenamsyre |
| MM01AG04 | meclofenamsyre |
| MM01AH | coxibs |
| MM01AH01 | celecoxib |
| MM01AH02 | rofecoxib |
| MM01AH03 | valdecoxib |
| MM01AH04 | parecoxib |
| MM01AH05 | etoricoxib |
| MM01AH06 | lumiracoxib |
| MM01AH07 | polmacoxib |
| MM01AX | andre antiinflam./antirheum. midler, non-steroide |
| MM01AX01 | nabumeton |
| MM01AX02 | niflumsyre |
| MM01AX04 | azapropazon |
| MM01AX05 | glucosamin |
| MM01AX07 | benzydamin |
| MM01AX12 | glucosamin-polyglycansulfat |
| MM01AX13 | proquazon |
| MM01AX14 | orgotein |
| MM01AX17 | nimesulid |
| MM01AX18 | feprazon |
| MM01AX21 | diacerein |
| MM01AX22 | morniflumat |
| MM01AX23 | tenidap |
| MM01AX24 | oxaceprol |
| MM01AX25 | chondroitinsulfat |
| MM01AX26 | avocado og soyabønneolie, uforsæbelige stoffer |
| MM01AX68 | feprazon, kombinationer |
| MM01B | antiinflammatoriske/antirheumatiske midler i komb. |
| MM01BA | antiinflam./antirheum. midler i komb. m. corticosteroider |
| MM01BA01 | phenylbutazon og corticosteroider |
| MM01BA02 | dipyrocetyl og corticosteroider |
| MM01BA03 | acetylsalicylsyre og corticosteroider |
| MM01BX | andre antiinflammatoriske midler i kombination |
| MM01C | specifikke antirheumatiske midler |
| MM01CA | quinoliner |
| MM01CA03 | oxycinchophen |
| MM01CB | guld-forbindelser |
| MM01CB01 | aurothiomalat-natrium |
| MM01CB02 | aurothiosulfat-natrium |
| MM01CB03 | auranofin |
| MM01CB04 | aurothioglucose |
| MM01CB05 | aurotioprol |
| MM01CC | penicillamin og lign. stoffer |
| MM01CC01 | penicillamin |
| MM01CC02 | bucillamin |
| MM01CX | andre specifikke antirheumatiske midler |
| MM02 | midler mod led- og muskelsmerter, udvortes brug |
| MM02A | midler mod led- og muskelsmerter, udvortes brug |
| MM02AA | antiinflammatorika, non-steroide, udvortes brug |
| MM02AA01 | phenylbutazon |
| MM02AA02 | mofebutazon |
| MM02AA03 | clofezon |
| MM02AA04 | oxyphenbutazon |
| MM02AA05 | benzydamin |
| MM02AA06 | etofenamat |
| MM02AA07 | piroxicam |
| MM02AA08 | felbinac |
| MM02AA09 | bufexamac |
| MM02AA10 | ketoprofen |
| MM02AA11 | bendazac |
| MM02AA12 | naproxen |
| MM02AA13 | ibuprofen |
| MM02AA14 | fentiazac |
| MM02AA15 | diclofenac |
| MM02AA16 | feprazon |
| MM02AA17 | niflumsyre |
| MM02AA18 | meclofenamsyre |
| MM02AA19 | flurbiprofen |
| MM02AA21 | tolmetin |
| MM02AA22 | suxibuzon |
| MM02AA23 | indometacin |
| MM02AA24 | nifenazon |
| MM02AA25 | aceclofenac |
| MM02AA26 | nimesulid |
| MM02AA27 | dexketoprofen |
| MM02AA28 | piketoprofen |
| MM02AA29 | esflurbiprofen |
| MM02AA31 | loxoprofen |
| MM02AB | capsaicin og lignende midler |
| MM02AB01 | capsaicin |
| MM02AB02 | zucapsaicin |
| MM02AC | præparater med salicylsyre-derivater |
| MM02AX | andre midler mod led- og muskelsmerter, udvortes |
| MM02AX02 | tolazolin |
| MM02AX03 | dimethylsulfoxid |
| MM02AX05 | idrocilamid |
| MM02AX06 | tolperison |
| MM02AX10 | diverse andre midler mod led- og muskelsmerter, udvortes |
| MM03 | muskelrelaxantia |
| MM03A | muskelrelaxantia, perifert virkende midler |
| MM03AA | curare-alkaloider |
| MM03AA01 | alcuron |
| MM03AA02 | tubocurarin |
| MM03AA04 | dimethyltubocurarin |
| MM03AB | cholin-derivater |
| MM03AB01 | suxamethon |
| MM03AC | andre kvaternære ammoniumforbindelser |
| MM03AC01 | pancuron |
| MM03AC02 | gallamin |
| MM03AC03 | vecuron |
| MM03AC04 | atracurium |
| MM03AC05 | hexafluron |
| MM03AC06 | pipecuroniumbromid |
| MM03AC07 | doxacuriumchlorid |
| MM03AC08 | fazadiniumbromid |
| MM03AC09 | rocuroniumbromid |
| MM03AC10 | mivacuriumchlorid |
| MM03AC11 | cisatracurium |
| MM03AX | andre muskelrelaxantia, perifert virkende |
| MM03AX01 | botulinum toxin |
| MM03B | muskelrelaxantia, centralt virkende midler |
| MM03BA | carbaminsyre-estere |
| MM03BA01 | phenprobamat |
| MM03BA02 | carisoprodol |
| MM03BA03 | methocarbamol |
| MM03BA04 | styramat |
| MM03BA05 | febarbamat |
| MM03BA51 | phenprobamat, kombinationer excl. psykoleptika |
| MM03BA52 | carisoprodol, kombinationer excl. psykoleptika |
| MM03BA53 | methocarbamol, kombinationer excl. psykoleptika |
| MM03BA71 | phenprobamat, kombinationer med psykoleptika |
| MM03BA72 | carisoprodol, kombinationer med psykoleptika |
| MM03BA73 | methocarbamol, kombinationer med psykoleptika |
| MM03BB | oxazol-, thiazin-, triazin-derivater |
| MM03BB02 | chlormezanon |
| MM03BB03 | chlorzoxazon |
| MM03BB52 | chlormezanon, kombinationer excl. psykoleptika |
| MM03BB53 | chlorzoxazon, kombinationer excl. psykoleptika |
| MM03BB72 | chlormezanon, kombinationer med psykoleptika |
| MM03BB73 | chlorzoxazon, kombinationer med psykoleptika |
| MM03BC | ethere, kemisk beslægtet med antihistaminer |
| MM03BC01 | orphenadrin (citrat) |
| MM03BC51 | orphenadrin, kombinationer |
| MM03BX | andre muskelrelaxantia, centralt virkende |
| MM03BX01 | baclofen |
| MM03BX02 | tizanidin |
| MM03BX03 | pridinol |
| MM03BX04 | tolperison |
| MM03BX05 | thiocolchicosid |
| MM03BX06 | mephenesin |
| MM03BX07 | tetrazepam |
| MM03BX08 | cyclobenzaprin |
| MM03BX09 | eperison |
| MM03BX30 | phenyramidol |
| MM03BX53 | pridinol, kombinationer |
| MM03BX55 | thiocolchicosid, kombinationer |
| MM03C | muskelrelaxantia, direkte virkende midler |
| MM03CA | dantrolen og derivater |
| MM03CA01 | dantrolen |
| MM04 | midler mod arthritis urica |
| MM04A | midler mod arthritis urica |
| MM04AA | midler, der hæmmer urinsyreproduktionen |
| MM04AA01 | allopurinol |
| MM04AA02 | tisopurin |
| MM04AA03 | febuxostat |
| MM04AA51 | allopurinol, kombinationer |
| MM04AB | midler, der øger urinsyreudskillelsen |
| MM04AB01 | probenecid |
| MM04AB02 | sulfinpyrazon |
| MM04AB03 | benzbromaron |
| MM04AB04 | isobromindion |
| MM04AB05 | lesinurad |
| MM04AC | midler uden virkning på urinsyre-metabolismen |
| MM04AC01 | colchicin |
| MM04AC02 | cinchophen |
| MM04AC51 | colchicin og probenecid |
| MM04AX | andre midler mod arthritis urica |
| MM04AX01 | uratoxidase |
| MM04AX02 | pegloticase |
| MM05 | midler til behandling af knoglesygdomme |
| MM05B | midler med virkning på knoglestruktur og mineralisering |
| MM05BA | bisphosphonater |
| MM05BA01 | etidronsyre |
| MM05BA02 | clodronsyre |
| MM05BA03 | pamidronsyre |
| MM05BA04 | alendronsyre |
| MM05BA05 | tiludronsyre |
| MM05BA06 | ibandronsyre |
| MM05BA07 | risedronsyre |
| MM05BA08 | zoledronsyre |
| MM05BB | bisphosphonater, kombinationer |
| MM05BB01 | etidronsyre og calcium, sekvenspræparater |
| MM05BB02 | risedronsyre og calcium, sekvenspræparater |
| MM05BB03 | alendronsyre og colecalciferol |
| MM05BB04 | risedronsyre, calcium og colecalciferol, sekvenspræparater |
| MM05BB05 | alendronsyre, calcium og colecalciferol, sekvenspræparater |
| MM05BB06 | alendronsyre og alfacalcidol, sekvenspræparater |
| MM05BB07 | risedronsyre og colecalciferol |
| MM05BB08 | zoledronsyre, calcium og cholecalciferol, sekvenspræparater |
| MM05BB09 | ibandronsyre og colecalciferol |
| MM05BC | knoglemorphogene proteiner |
| MM05BC01 | dibotermin alfa |
| MM05BC02 | eptotermin alfa |
| MM05BX | andre midler med virkning på knoglestruktur og mineralisering |
| MM05BX01 | ipriflavon |
| MM05BX02 | aluminiumchlorhydrat |
| MM05BX03 | strontiumranelat |
| MM05BX04 | denosumab |
| MM05BX05 | burosumab |
| MM05BX06 | romosozumab |
| MM05BX07 | vosoritid |
| MM05BX08 | menatetrenon |
| MM05BX53 | strontiumranelat og colecalciferol |
| MM09 | andre midler mod forstyrrelser i det muskulo-skeletale system |
| MM09A | andre midler mod forstyrrelser i det muskulo-skeletale system |
| MM09AA | chinin og derivater |
| MM09AA01 | hydroquinin |
| MM09AA72 | chinin, kombinationer med psykoleptika |
| MM09AB | enzymer |
| MM09AB01 | chymopapain |
| MM09AB02 | collagenase clostridium histolytikum |
| MM09AB03 | bromelainer |
| MM09AB52 | trypsin, kombinationer |
| MM09AX | andre midler mod forstyrrelser i det muskulo-skeletale system |
| MM09AX01 | hyaluronsyre |
| MM09AX02 | chondrocytter, autolog |
| MM09AX03 | ataluren |
| MM09AX04 | drisapersen |
| MM09AX05 | aceneuramsyre |
| MM09AX06 | eteplirsen |
| MM09AX07 | nusinersen |
| MM09AX08 | golodirsen |
| MM09AX09 | onasemnogenabeparvovec |
| MM09AX10 | risdiplam |
| MM09AX11 | palovaroten |
| MM09AX12 | viltolarsen |
| MM09AX13 | casimersen |
| MM09AX14 | givinostat |
| MM09AX15 | delandistrogen moxeparvovec |
| MN | Nervesystemet |
| MN01 | anæstetika |
| MN01A | anæstetika, generelle |
| MN01AA | ethere |
| MN01AA01 | ether (diethylether) |
| MN01AA02 | vinylether |
| MN01AB | halogenerede kulbrinter |
| MN01AB01 | halothan |
| MN01AB02 | chloroform |
| MN01AB04 | enfluran |
| MN01AB05 | trichlorethylen |
| MN01AB06 | isofluran |
| MN01AB07 | desfluran |
| MN01AB08 | sevofluran |
| MN01AF | barbiturater, usammensatte |
| MN01AF01 | methohexital |
| MN01AF02 | hexobarbital |
| MN01AF03 | thiopental |
| MN01AG | barbiturater i kombination med andre stoffer |
| MN01AG01 | narcobarbital |
| MN01AH | opioid-anæstetika |
| MN01AH01 | fentanyl |
| MN01AH02 | alfentanil |
| MN01AH03 | sufentanil |
| MN01AH04 | phenoperidin |
| MN01AH05 | anileridin |
| MN01AH06 | remifentanil |
| MN01AH51 | fentanyl, kombinationer |
| MN01AX | andre generelle anæstetika |
| MN01AX03 | ketamin |
| MN01AX04 | propanidid |
| MN01AX05 | alfaxalon |
| MN01AX07 | etomidat |
| MN01AX10 | propofol |
| MN01AX11 | natriumoxybat |
| MN01AX13 | dinitrogenoxid |
| MN01AX14 | esketamin |
| MN01AX15 | xenon |
| MN01AX63 | dinitrogenoxid, komb. |
| MN01B | lokalanæstetika |
| MN01BA | aminobenzoesyre-estere |
| MN01BA01 | metabutethamin |
| MN01BA02 | procain |
| MN01BA03 | tetracain |
| MN01BA04 | chlorprocain |
| MN01BA05 | benzocain |
| MN01BA52 | procain, kombinationer |
| MN01BA53 | tetracain, kombinationer |
| MN01BB | amider |
| MN01BB01 | bupivacain |
| MN01BB02 | lidocain |
| MN01BB03 | mepivacain |
| MN01BB04 | prilocain |
| MN01BB05 | butanilicain |
| MN01BB06 | cinchocain |
| MN01BB07 | etidocain |
| MN01BB08 | articain |
| MN01BB09 | ropivacain |
| MN01BB10 | levobupivacain |
| MN01BB20 | kombinationer af amider |
| MN01BB51 | bupivacain, kombinationer |
| MN01BB52 | lidocain, kombinationer |
| MN01BB53 | mepivacain, kombinationer |
| MN01BB54 | prilocain, kombinationer |
| MN01BB57 | etidocain, kombinationer |
| MN01BB58 | articain, kombinationer |
| MN01BB59 | bupivacain og meloxicam |
| MN01BC | benzoesyre-estere |
| MN01BC01 | cocain |
| MN01BX | andre lokalanæstetika |
| MN01BX01 | ethylchlorid |
| MN01BX02 | dyclonin |
| MN01BX03 | phenol |
| MN01BX04 | capsaicin |
| MN02 | analgetika |
| MN02A | opioider |
| MN02AA | naturlige opiumalkaloider |
| MN02AA01 | morphin |
| MN02AA02 | opium |
| MN02AA03 | hydromorphon |
| MN02AA04 | nicomorphin |
| MN02AA05 | oxycodon |
| MN02AA08 | dihydrocodein |
| MN02AA10 | papaveretum |
| MN02AA11 | oxymorphon |
| MN02AA51 | morphin, kombinationer |
| MN02AA53 | hydromorphon og naloxon |
| MN02AA55 | oxycodon og naloxon |
| MN02AA56 | oxycodon og naltrexon |
| MN02AA58 | dihydrocodein, kombinationer |
| MN02AA59 | codein, komb. ekskl. psykoleptika |
| MN02AA79 | codein, kombinationer med psykoleptika |
| MN02AB | phenylpiperidin-derivater |
| MN02AB01 | ketobemidon |
| MN02AB02 | pethidin |
| MN02AB03 | fentanyl |
| MN02AB52 | pethidin, kombinationer excl. psykoleptika |
| MN02AB72 | pethidin, kombinationer med psykoleptika |
| MN02AC | diphenylpropylamin-derivater |
| MN02AC01 | dextromoramid |
| MN02AC03 | piritramid |
| MN02AC04 | dextropropoxyphen |
| MN02AC05 | bezitramid |
| MN02AC52 | methadon, kombinationer excl. psykoleptika |
| MN02AC54 | dextropropoxyphen, kombinationer excl. psykoleptika |
| MN02AC74 | dextropropoxyphen, kombinationer med psykoleptika |
| MN02AD | benzomorphan-derivater |
| MN02AD01 | pentazocin |
| MN02AD02 | phenazocin |
| MN02AD51 | pentazocin og naloxon |
| MN02AE | oripavine-derivater |
| MN02AE01 | buprenorphin |
| MN02AF | morphinan-derivater |
| MN02AF01 | butorphanol |
| MN02AF02 | nalbufin |
| MN02AG | opioider i kombinationer med antispasmodika |
| MN02AG01 | morphin og antispasmodika |
| MN02AG02 | ketobemidon og antispasmodika |
| MN02AG03 | pethidin og antispasmodika |
| MN02AG04 | hydromorphon og antispasmodika |
| MN02AJ | opioider i kombination med non-opioide analgetika |
| MN02AJ01 | dihydrocodein og paracetamol |
| MN02AJ02 | dihydrocodein og acetylsalicylsyre |
| MN02AJ03 | dihydrocodein og andre non-opioide analgetika |
| MN02AJ06 | codein og paracetamol |
| MN02AJ07 | codein og acetylsalicylsyre |
| MN02AJ08 | codein og ibuprofen |
| MN02AJ09 | codein og andre non-opioide analgetika |
| MN02AJ13 | tramadol og paracetamol |
| MN02AJ14 | tramadol og dexketoprofen |
| MN02AJ15 | tramadol og andre non-opioide analgetika |
| MN02AJ16 | tramadol og celecoxib |
| MN02AJ17 | oxycodon og paracetamol |
| MN02AJ18 | oxycodon og acetylsalicylsyre |
| MN02AJ19 | oxycodon og ibuprofen |
| MN02AJ22 | hydrocodon og paracetamol |
| MN02AJ23 | hydrocodon og ibuprofen |
| MN02AX | andre opioider |
| MN02AX01 | tilidin |
| MN02AX02 | tramadol |
| MN02AX03 | dezocin |
| MN02AX05 | meptazinol |
| MN02AX06 | tapentadol |
| MN02AX07 | oliceridin |
| MN02AX51 | tilidin og naloxon |
| MN02B | andre analgetika og antipyretika |
| MN02BA | salicylsyre-derivater |
| MN02BA01 | acetylsalicylsyre |
| MN02BA02 | aloxiprin |
| MN02BA03 | cholinsalicylat |
| MN02BA04 | natriumsalicylat |
| MN02BA05 | salicylamid |
| MN02BA06 | salicyloylsalcylsyre |
| MN02BA07 | ethenzamid |
| MN02BA08 | morpholinsalicylat |
| MN02BA09 | dipyrocetyl |
| MN02BA10 | benorilat |
| MN02BA11 | diflunisal |
| MN02BA12 | kaliumsalicylat |
| MN02BA14 | guacetisal |
| MN02BA15 | carbasalatcalcium |
| MN02BA16 | imidazolsalicylat |
| MN02BA51 | acetylsalicylsyre, kombinationer excl. psykoleptika |
| MN02BA55 | salicylamid, kombinationer excl. psykoleptika |
| MN02BA57 | etenzamid, kombinationer excl. psykoleptika |
| MN02BA59 | dipyrocetyl, kombinationer excl. psykoleptika |
| MN02BA65 | carbasalatcalcium, kombinationer excl. psykoleptika |
| MN02BA67 | magnesiumsalicylat, kombinationer excl. psykoleptika |
| MN02BA71 | acetylsalicylsyre, kombinationer med psykoleptika |
| MN02BA75 | salicylamid, kombinationer med psykoleptika |
| MN02BA77 | etenzamid, kombinationer med psykoleptika |
| MN02BA79 | dipyrocetyl, kombinationer med psykoleptika |
| MN02BB | pyrazoloner |
| MN02BB01 | phenazon |
| MN02BB02 | metamizolnatrium |
| MN02BB03 | aminophenazon |
| MN02BB04 | propyphenazon |
| MN02BB05 | nifenazon |
| MN02BB51 | phenazon, kombinationer excl. psykoleptika |
| MN02BB52 | dipyron, kombinationer excl. psykoleptika |
| MN02BB53 | aminophenazon, kombinationer excl. psykoleptika |
| MN02BB54 | propyphenazon, kombinationer excl. psykoleptika |
| MN02BB71 | phenazon, kombinationer med psykoleptika |
| MN02BB72 | dipyron, kombinationer med psykoleptika |
| MN02BB73 | aminophenazon, kombinationer med psykoleptika |
| MN02BB74 | propyphenazon, kombinationer med psykoleptika |
| MN02BE | anilider |
| MN02BE01 | paracetamol |
| MN02BE02 | tolfenamsyre |
| MN02BE03 | phenacetin |
| MN02BE04 | bucetin |
| MN02BE05 | propacetamol |
| MN02BE51 | paracetamol, kombinationer excl. psykoleptika |
| MN02BE53 | phenacetin, kombinationer excl. psykoleptika |
| MN02BE54 | bucetin, kombinationer excl. psykoleptika |
| MN02BE71 | paracetamol, kombinationer med psykoleptika |
| MN02BE73 | phenacetin, kombinationer med psykoleptika |
| MN02BE74 | bucetin, kombinationer med psykoleptika |
| MN02BF | gabapentinoider |
| MN02BF01 | gabapentin |
| MN02BF02 | pregabalin |
| MN02BF03 | mirogabalin |
| MN02BG | andre analgetika og antipyretika |
| MN02BG02 | rimazolin |
| MN02BG03 | glafenin |
| MN02BG04 | floctafenin |
| MN02BG05 | viminol |
| MN02BG06 | nefopam |
| MN02BG07 | flupirtin |
| MN02BG08 | ziconotid |
| MN02BG09 | methoxyfluran |
| MN02BG10 | cannabinoider |
| MN02BG12 | tanezumab |
| MN02C | midler mod migræne |
| MN02CA | ergot-alkaloider |
| MN02CA01 | dihydroergotamin |
| MN02CA02 | ergotamin |
| MN02CA04 | methysergid |
| MN02CA06 | dihydroergocristin |
| MN02CA07 | lisurid |
| MN02CA51 | dihydroergotamin, kombinationspræparater |
| MN02CA52 | ergotamin, kombinationspræparater |
| MN02CA56 | dihydroergocristin, kombinationer |
| MN02CA72 | ergotamin i kombination med psykoleptika |
| MN02CB | corticosteroid-derivater |
| MN02CB01 | flumedroxon |
| MN02CC | selektive 5HT(1)-receptor-agonister |
| MN02CC01 | sumatriptan |
| MN02CC02 | naratriptan |
| MN02CC03 | zolmitriptan |
| MN02CC04 | rizatriptan |
| MN02CC05 | almotriptan |
| MN02CC06 | eletriptan |
| MN02CC07 | frovatriptan |
| MN02CC08 | lasmiditan |
| MN02CC51 | sumatriptan og naproxen |
| MN02CD | calcitoningenrelaterede peptid (CGRP) antagonister |
| MN02CD01 | erenumab |
| MN02CD02 | galcanezumab |
| MN02CD03 | fremanezumab |
| MN02CD04 | ubrogepant |
| MN02CD05 | eptinezumab |
| MN02CD06 | rimegepant |
| MN02CD07 | atogepant |
| MN02CD08 | zavegepant |
| MN02CX | andre midler mod migræne |
| MN02CX01 | pizotifen |
| MN02CX02 | clonidin |
| MN02CX03 | iprazochrom |
| MN02CX05 | dimetotiazin |
| MN02CX06 | oxetoron |
| MN03 | antiepileptika |
| MN03A | antiepileptika |
| MN03AA | barbiturater og derivater |
| MN03AA01 | methylphenobarbital |
| MN03AA02 | phenobarbital |
| MN03AA03 | primidon |
| MN03AA04 | barbexaclon |
| MN03AA30 | metharbital |
| MN03AB | hydantoin-derivater |
| MN03AB01 | ethotoin |
| MN03AB02 | phenytoin |
| MN03AB03 | amino(diphenylhydantoin)valerianesyre |
| MN03AB04 | mephenytoin |
| MN03AB05 | fosphenytoin |
| MN03AB52 | phenytoin, kombinationer |
| MN03AB54 | mephenytoin, kombinationer |
| MN03AC | oxazolidin-derivater |
| MN03AC01 | paramethadion |
| MN03AC02 | trimethadion |
| MN03AC03 | ethadion |
| MN03AD | succinimid-derivater |
| MN03AD01 | ethosuximid |
| MN03AD02 | phensuximid |
| MN03AD03 | mesuximid |
| MN03AD51 | ethosuximid, kombinationer |
| MN03AE | benzodiazepin-derivater |
| MN03AE01 | clonazepam |
| MN03AF | carboxamid-derivater |
| MN03AF01 | carbamazepin |
| MN03AF02 | oxcarbazepin |
| MN03AF03 | rufinamid |
| MN03AF04 | eslicarbazepin |
| MN03AG | fedtsyre-derivater |
| MN03AG01 | valproinsyre |
| MN03AG02 | valpromid |
| MN03AG03 | aminobutylsyre |
| MN03AG04 | vigabatrin |
| MN03AG05 | progabid |
| MN03AG06 | tiagabin |
| MN03AX | andre antiepileptika |
| MN03AX03 | sultiam |
| MN03AX07 | phenacemid |
| MN03AX09 | lamotrigin |
| MN03AX10 | felbamat |
| MN03AX11 | topiramat |
| MN03AX13 | pheneturid |
| MN03AX14 | levetiracetam |
| MN03AX15 | zonisamid |
| MN03AX17 | stiripentol |
| MN03AX18 | lacosamid |
| MN03AX19 | carisbamate |
| MN03AX21 | retigabin |
| MN03AX22 | perampanel |
| MN03AX23 | brivaracetam |
| MN03AX24 | cannabidiol |
| MN03AX25 | cenobamat |
| MN03AX26 | fenfluramin |
| MN03AX27 | ganaxolon |
| MN03AX30 | beclamid |
| MN04 | anti-parkinson midler |
| MN04A | anticholinerge stoffer |
| MN04AA | tertiære aminer med kulstofkæde |
| MN04AA01 | trihexyphenidyl |
| MN04AA02 | biperiden |
| MN04AA03 | metixen |
| MN04AA04 | procyclidin |
| MN04AA05 | profenamin |
| MN04AA08 | dexetimid |
| MN04AA09 | phenglutarimid |
| MN04AA10 | mezaticol |
| MN04AA11 | bornaprin |
| MN04AA12 | tropatepin |
| MN04AB | ethere, kemisk beslægtet med antihistaminer |
| MN04AB01 | etanautin |
| MN04AB02 | orphenadrin (chlorid) |
| MN04AC | ethere af tropin eller tropin-derivater |
| MN04AC01 | benzatropin |
| MN04AC30 | etybenzatropin |
| MN04B | dopaminerge stoffer |
| MN04BA | dopa og dopa-derivater |
| MN04BA01 | levodopa |
| MN04BA02 | levodopa og decarboxylase-hæmmer |
| MN04BA03 | levodopa, decarboxylase-hæmmer og COMT-hæmmer |
| MN04BA04 | melevodopa |
| MN04BA05 | melevodopa og decarboxylase-hæmmer |
| MN04BA06 | etilevodopa og decarboxylase-hæmmer |
| MN04BA07 | foslevodopa og decarboxylasehæmmer |
| MN04BB | adamantan-derivater |
| MN04BB01 | amantadin |
| MN04BC | dopamin-agonister |
| MN04BC01 | bromocriptin |
| MN04BC02 | pergolid |
| MN04BC03 | dihydroergocryptinmesylat |
| MN04BC04 | ropinirol |
| MN04BC05 | pramipexol |
| MN04BC06 | cabergolin |
| MN04BC07 | apomorphin |
| MN04BC08 | piribedil |
| MN04BC09 | rotigotin |
| MN04BD | monoamin-oxidase type B hæmmere |
| MN04BD01 | selegilin |
| MN04BD02 | rasagilin |
| MN04BD03 | safinamid |
| MN04BX | andre dopaminerge stoffer |
| MN04BX01 | tolcapon |
| MN04BX02 | entacapon |
| MN04BX03 | budipin |
| MN04BX04 | opicapon |
| MN04C | andre antiparkinsonmidler |
| MN04CX | andre antiparkinsonmidler |
| MN04CX01 | istradefyllin |
| MN05 | psykoleptika |
| MN05A | antipsykotika |
| MN05AA | phenothiazin med alifatisk sidekæde |
| MN05AA01 | chlorpromazin |
| MN05AA02 | levomepromazin |
| MN05AA03 | promazin |
| MN05AA04 | acepromazin |
| MN05AA05 | triflupromazin |
| MN05AA06 | cyamemazin |
| MN05AA07 | chlorproethazin |
| MN05AB | phenothiazin med piperazin-struktur |
| MN05AB01 | dixyrazin |
| MN05AB02 | fluphenazin |
| MN05AB03 | perphenazin |
| MN05AB04 | prochlorperazin |
| MN05AB05 | thiopropazat |
| MN05AB06 | trifluoperazin |
| MN05AB07 | acetophenazin |
| MN05AB08 | thioproperazin |
| MN05AB09 | butaperazin |
| MN05AB10 | perazin |
| MN05AC | phenothiazin med piperidin-struktur |
| MN05AC01 | periciazin |
| MN05AC02 | thioridazin |
| MN05AC03 | mesoridazin |
| MN05AC04 | pipotiazin |
| MN05AD | butyrophenon-derivater |
| MN05AD01 | haloperidol |
| MN05AD02 | trifluperidol |
| MN05AD03 | melperon |
| MN05AD04 | moperon |
| MN05AD05 | pipamperon |
| MN05AD06 | bromperidol |
| MN05AD07 | benperidol |
| MN05AD08 | droperidol |
| MN05AD09 | fluanison |
| MN05AD10 | lumateperon |
| MN05AE | indol-derivater |
| MN05AE01 | oxypertin |
| MN05AE02 | molindon |
| MN05AE03 | sertindol |
| MN05AE04 | ziprasidon |
| MN05AE05 | lurasidon |
| MN05AF | thioxanthen-derivater |
| MN05AF01 | flupentixol |
| MN05AF02 | clopenthixol |
| MN05AF03 | chlorprothixen |
| MN05AF04 | tiotixen |
| MN05AF05 | zuclopenthixol |
| MN05AG | diphenylbutylpiperidin-derivater |
| MN05AG01 | fluspirilen |
| MN05AG02 | pimozid |
| MN05AG03 | penfluridol |
| MN05AH | diazepiner, oxazepiner, thiazepiner og oxepiner |
| MN05AH01 | loxapin |
| MN05AH02 | clozapin |
| MN05AH03 | olanzapin |
| MN05AH04 | quetiapin |
| MN05AH05 | asenapin |
| MN05AH06 | clotiapin |
| MN05AH53 | olanzapin og samidorphan |
| MN05AK | neuroleptika, til tardive dyskinesier |
| MN05AL | benzamider |
| MN05AL01 | sulpirid |
| MN05AL02 | sultoprid |
| MN05AL03 | tiaprid |
| MN05AL04 | remoxiprid |
| MN05AL05 | amisulprid |
| MN05AL06 | veraliprid |
| MN05AL07 | levosulpirid |
| MN05AN | lithium |
| MN05AN01 | lithium |
| MN05AX | andre antipsykotika |
| MN05AX07 | prothipendyl |
| MN05AX08 | risperidon |
| MN05AX10 | mosapramin |
| MN05AX11 | zotepin |
| MN05AX12 | aripiprazol |
| MN05AX13 | paliperidon |
| MN05AX14 | iloperidon |
| MN05AX15 | cariprazin |
| MN05AX16 | brexpiprazol |
| MN05AX17 | pimavanserin |
| MN05B | anxiolytika |
| MN05BA | benzodiazepin-derivater |
| MN05BA01 | diazepam |
| MN05BA02 | chlordiazepoxid |
| MN05BA03 | medazepam |
| MN05BA04 | oxazepam |
| MN05BA05 | clorazepatkalium |
| MN05BA06 | lorazepam |
| MN05BA07 | adinazolam |
| MN05BA08 | bromazepam |
| MN05BA09 | clobazam |
| MN05BA10 | ketazolam |
| MN05BA11 | prazepam |
| MN05BA12 | alprazolam |
| MN05BA13 | halazepam |
| MN05BA14 | pinazepam |
| MN05BA15 | camazepam |
| MN05BA16 | nordazepam |
| MN05BA17 | fludiazepam |
| MN05BA18 | ethylloflazepat |
| MN05BA19 | etizolam |
| MN05BA21 | clotiazepam |
| MN05BA22 | cloxazolam |
| MN05BA23 | tofisopam |
| MN05BA24 | bentazepam |
| MN05BA25 | mexazolam |
| MN05BA56 | lorazepam, kombinationer |
| MN05BB | diphenylmethan-derivater |
| MN05BB01 | hydroxyzin |
| MN05BB02 | captodiam |
| MN05BB51 | hydroxyzin, kombinationer |
| MN05BC | carbamater |
| MN05BC01 | meprobamat |
| MN05BC03 | emylcamat |
| MN05BC04 | mebutamat |
| MN05BC51 | meprobamat, kombinationer |
| MN05BD | dibenzo-bicyclo-octadien derivater |
| MN05BD01 | benzoctamin |
| MN05BE | azaspirodecanedion-derivater |
| MN05BE01 | buspiron |
| MN05BX | andre anxiolytika |
| MN05BX01 | mefenoxalon |
| MN05BX02 | gedocarnil |
| MN05BX03 | etifoxin |
| MN05BX04 | fabomotizol |
| MN05BX05 | lavendelolie |
| MN05C | hypnotika og sedativa |
| MN05CA | barbiturater, usammensatte |
| MN05CA01 | pentobarbital |
| MN05CA02 | amobarbital |
| MN05CA03 | butobarbital |
| MN05CA04 | barbital |
| MN05CA05 | aprobarbital |
| MN05CA06 | secobarbital |
| MN05CA07 | talbutal |
| MN05CA08 | vinylbital |
| MN05CA09 | vinbarbital |
| MN05CA10 | cyclobarbital |
| MN05CA11 | heptabarbital |
| MN05CA12 | reposal |
| MN05CA15 | methohexital |
| MN05CA16 | hexobarbital |
| MN05CA19 | thiopental |
| MN05CA20 | etallobarbital |
| MN05CA21 | allobarbital |
| MN05CA22 | proxibarbal |
| MN05CB | barbiturater, kombinationr |
| MN05CB01 | kombinationer af barbiturater |
| MN05CB02 | barbiturater i kombination med andre stoffer |
| MN05CC | aldehyder og derivater |
| MN05CC01 | chloralhydrat |
| MN05CC02 | chloralodol |
| MN05CC03 | acetylglycinamidchloralhydrat |
| MN05CC04 | dichloralphenazon |
| MN05CC05 | paraldehyd |
| MN05CD | benzodiazepin-derivater |
| MN05CD01 | flurazepam |
| MN05CD02 | nitrazepam |
| MN05CD03 | flunitrazepam |
| MN05CD04 | estazolam |
| MN05CD05 | triazolam |
| MN05CD06 | lormetazepam |
| MN05CD07 | temazepam |
| MN05CD08 | midazolam |
| MN05CD09 | brotizolam |
| MN05CD10 | quazepam |
| MN05CD11 | loprazolam |
| MN05CD12 | doxefazepam |
| MN05CD13 | cinolazepam |
| MN05CD14 | remimazolam |
| MN05CD15 | nimetazepam |
| MN05CE | piperidindion-derivater |
| MN05CE01 | glutethimid |
| MN05CE02 | methyprylon |
| MN05CE03 | pyrithyldion |
| MN05CF | benzodiazepin-relaterede midler |
| MN05CF01 | zopiclon |
| MN05CF02 | zolpidem |
| MN05CF03 | zaleplon |
| MN05CF04 | eszopiclon |
| MN05CH | melatoninreceptor-agonister |
| MN05CH01 | melatonin |
| MN05CH02 | ramelteon |
| MN05CH03 | tasimelteon |
| MN05CJ | orexinreceptor antagonister |
| MN05CJ01 | suvorexant |
| MN05CJ02 | lemborexant |
| MN05CJ03 | daridorexant |
| MN05CM | andre hypnotika og sedativa |
| MN05CM01 | methaqualon |
| MN05CM02 | clomethiazol |
| MN05CM03 | bromisoval |
| MN05CM04 | carbromal |
| MN05CM05 | scopolamin |
| MN05CM06 | propiomazin |
| MN05CM07 | triclofos |
| MN05CM08 | ethchlorvynol |
| MN05CM09 | baldrianrod |
| MN05CM10 | hexapropymat |
| MN05CM11 | bromider |
| MN05CM12 | apronal |
| MN05CM13 | valnoctamid |
| MN05CM15 | methylpentynol |
| MN05CM16 | niaprazin |
| MN05CM18 | dexmedetomidin |
| MN05CX | hypnotika og sedativa, kombinationer, excl. barbiturater |
| MN05CX01 | meprobamat, kombinationer |
| MN05CX02 | methaqualon, kombinationer |
| MN05CX03 | methylpentynol, kombinationer |
| MN05CX04 | clomethiazol, kombinationer |
| MN05CX05 | emepron, kombinationer |
| MN05CX06 | dipiperonylaminoethanol, kombinationer |
| MN06 | psykoanaleptika |
| MN06A | antidepressiva |
| MN06AA | non-selektive monoamin re-optagelse inhibitorer |
| MN06AA01 | desipramin |
| MN06AA02 | imipramin |
| MN06AA03 | imipraminoxid |
| MN06AA04 | clomipramin |
| MN06AA05 | opipramol |
| MN06AA06 | trimipramin |
| MN06AA07 | lofepramin |
| MN06AA08 | dibenzepin |
| MN06AA09 | amitriptylin |
| MN06AA10 | nortriptylin |
| MN06AA11 | protriptylin |
| MN06AA12 | doxepin |
| MN06AA13 | iprindol |
| MN06AA14 | melitracen |
| MN06AA15 | butriptylin |
| MN06AA16 | dosulepin |
| MN06AA17 | amoxapin |
| MN06AA18 | dimetacrin |
| MN06AA19 | amineptin |
| MN06AA21 | maprotilin |
| MN06AA23 | quinupramin |
| MN06AB | selektive serotonin re-optagelse inhibitorer |
| MN06AB02 | zimeldin |
| MN06AB03 | fluoxetin |
| MN06AB04 | citalopram |
| MN06AB05 | paroxetin |
| MN06AB06 | sertralin |
| MN06AB07 | alaproclat |
| MN06AB08 | fluvoxamin |
| MN06AB09 | etoperidon |
| MN06AB10 | escitalopram |
| MN06AF | monoamin-oxidase hæmmere, non-selektive |
| MN06AF01 | isocarboxazid |
| MN06AF02 | nialamid |
| MN06AF03 | phenelzin |
| MN06AF04 | tranylcypromin |
| MN06AF05 | iproniazid |
| MN06AF06 | iproclozid |
| MN06AG | monoamin-oxidase type A hæmmere |
| MN06AG02 | moclobemid |
| MN06AG03 | toloxaton |
| MN06AX | andre antidepressiva |
| MN06AX01 | oxitriptan |
| MN06AX02 | tryptophan |
| MN06AX03 | mianserin |
| MN06AX04 | nomifensin |
| MN06AX05 | trazodon |
| MN06AX06 | nefazodon |
| MN06AX07 | minaprin |
| MN06AX08 | bifemelan |
| MN06AX09 | viloxazin |
| MN06AX10 | oxaflozan |
| MN06AX11 | mirtazapin |
| MN06AX12 | bupropion |
| MN06AX13 | medifoxamin |
| MN06AX14 | tianeptin |
| MN06AX15 | pivagabin |
| MN06AX16 | venlafaxin |
| MN06AX17 | milnacipran |
| MN06AX18 | reboxetin |
| MN06AX19 | gepiron |
| MN06AX21 | duloxetin |
| MN06AX22 | agomelatin |
| MN06AX23 | desvenlafaxin |
| MN06AX24 | vilazodon |
| MN06AX25 | perikon |
| MN06AX26 | vortioxetin |
| MN06AX27 | esketamin |
| MN06AX28 | levomilnacipran |
| MN06AX29 | brexanolon |
| MN06AX31 | zuranolon |
| MN06AX62 | bupropion og dextromethorphan |
| MN06B | psykostimulantia, midler for ADHD og nootropika |
| MN06BA | centralt virkende sympatomimetika |
| MN06BA01 | amfetamin |
| MN06BA02 | dexamfetamin |
| MN06BA03 | metamfetamin |
| MN06BA04 | methylphenidat |
| MN06BA05 | pemolin |
| MN06BA06 | fencamfamin |
| MN06BA07 | modafinil |
| MN06BA08 | fenozolon |
| MN06BA09 | atomoxetin |
| MN06BA10 | fenetyllin |
| MN06BA11 | dexmethylphenidat |
| MN06BA12 | lisdexamfetamin |
| MN06BA13 | armodafinil |
| MN06BA14 | solriamfetol |
| MN06BA15 | dexmethylphenidat og serdexmethylphenidat |
| MN06BC | xanthin-derivater |
| MN06BC01 | caffein |
| MN06BC02 | propentofyllin |
| MN06BX | andre psykostimulantia og nootropika |
| MN06BX01 | meclofenoxat |
| MN06BX02 | pyritinol |
| MN06BX03 | piracetam |
| MN06BX04 | deanol |
| MN06BX05 | fipexid |
| MN06BX06 | citicolin |
| MN06BX07 | oxiracetam |
| MN06BX08 | pirisudanol |
| MN06BX09 | linopirdin |
| MN06BX10 | nizofenon |
| MN06BX11 | anirazetam |
| MN06BX12 | acetylcarnitin |
| MN06BX13 | idebenon |
| MN06BX14 | prolintan |
| MN06BX15 | pipradrol |
| MN06BX16 | pramiracetam |
| MN06BX17 | adrafinil |
| MN06BX18 | vinpocetin |
| MN06BX21 | temgicoluril |
| MN06BX22 | phenibut |
| MN06C | psykoleptika og psykoanaleptika i kombination |
| MN06CA | antidepressiva i kombination med psykoleptika |
| MN06CA01 | amitriptylin og psykoleptika |
| MN06CA02 | melitracen og psykoleptika |
| MN06CA03 | fluoxetin og psykoleptika |
| MN06CB | psykostimulantia i kombination med psykoleptika |
| MN06D | midler mod demens |
| MN06DA | anticholinesteraser |
| MN06DA01 | tacrin |
| MN06DA02 | donepezil |
| MN06DA03 | rivastigmin |
| MN06DA04 | galantamin |
| MN06DA05 | ipidacrin |
| MN06DA52 | donepezil og memantin |
| MN06DA53 | donepezil, memantin og ginkgoblad |
| MN06DX | andre midler mod demens |
| MN06DX01 | memantin |
| MN06DX02 | ginkgoblad |
| MN06DX03 | aducanumab |
| MN06DX04 | lecanemab |
| MN06DX05 | donanemab |
| MN06DX30 | kombinationer af andre midler mod demens |
| MN07 | andre midler med virkn. på centralnervesystemet |
| MN07A | parasympatomimetika |
| MN07AA | anticholinesteraser |
| MN07AA01 | neostigmin |
| MN07AA02 | pyridostigmin |
| MN07AA03 | distigmin |
| MN07AA30 | ambenon |
| MN07AA51 | neostigmin, kombinationer |
| MN07AB | cholin-estere |
| MN07AB01 | carbacholin |
| MN07AB02 | bethanechol |
| MN07AX | andre parasympatomimetika |
| MN07AX01 | pilocarpin |
| MN07AX02 | cholinalfoscerat |
| MN07AX03 | cevimelin |
| MN07B | midler mod afhængighedsforstyrrelser |
| MN07BA | midler mod nicotinafhængighed |
| MN07BA01 | nicotin |
| MN07BA03 | vareniclin |
| MN07BA04 | cytisiniclin |
| MN07BB | midler mod alkoholafhængighed |
| MN07BB01 | disulfiram |
| MN07BB02 | calciumcarbimid |
| MN07BB03 | acamprosat |
| MN07BB04 | naltrexon |
| MN07BB05 | nalmefen |
| MN07BB06 | ondelopran |
| MN07BC | midler mod opioidafhængighed |
| MN07BC01 | buprenorphin |
| MN07BC02 | methadon |
| MN07BC03 | levacetylmethadol |
| MN07BC04 | lofexidin |
| MN07BC05 | levomethadon |
| MN07BC06 | diamorphin |
| MN07BC51 | buprenorphin, komb. |
| MN07C | midler mod svimmelhed |
| MN07CA | midler mod svimmelhed |
| MN07CA01 | betahistin |
| MN07CA02 | cinnarizin |
| MN07CA03 | flunarizin |
| MN07CA04 | acetylleucin |
| MN07CA52 | cinnarizin, kombinationer |
| MN07X | andre midler med virkn. på nervesystemet |
| MN07XA | gangliosider og gangliosid-derivater |
| MN07XX | andre midler med virkning på nervesystemet |
| MN07XX01 | tirilazad |
| MN07XX02 | riluzol |
| MN07XX03 | xaliproden |
| MN07XX04 | natriumoxybat |
| MN07XX05 | amifampridin |
| MN07XX06 | tetrabenazin |
| MN07XX07 | fampridin |
| MN07XX08 | tafamidis |
| MN07XX10 | laquinimod |
| MN07XX11 | pitolisant |
| MN07XX12 | patisiran |
| MN07XX13 | valbenazin |
| MN07XX14 | edaravon |
| MN07XX15 | inotersen |
| MN07XX16 | deutetrabenazin |
| MN07XX17 | arimoclomol |
| MN07XX18 | vutrisiran |
| MN07XX19 | natriumphenylbutyrat og ursodoxicoltaurin |
| MN07XX21 | eplontersen |
| MN07XX22 | tofersen |
| MN07XX23 | troriluzol |
| MN07XX24 | trofinetid |
| MN07XX59 | dextromethorphan, kombinationer |
| MP | Antiparasitære midler, insekticider og repellanter |
| MP01 | antiprotozo-midler |
| MP01A | midler mod amøbe- og andre protozo-sygdomme |
| MP01AA | hydroxyquinolin-derivater |
| MP01AA01 | broxyquinolin |
| MP01AA02 | clioquinol |
| MP01AA04 | chlorquinaldol |
| MP01AA05 | tilbroquinol |
| MP01AA30 | tilbroquinol og tiliquinol |
| MP01AA52 | clioquinol, kombinationer |
| MP01AB | nitroimidazol-derivater |
| MP01AB01 | metronidazol |
| MP01AB02 | tinidazol |
| MP01AB03 | ornidazol |
| MP01AB04 | azanidazol |
| MP01AB05 | propenidazol |
| MP01AB06 | nimorazol |
| MP01AB07 | secnidazol |
| MP01AB08 | satranidazol |
| MP01AB51 | metronidazol og furazolidon |
| MP01AB52 | metronidazol og diloxanid |
| MP01AB53 | tinidazol og diloxanid |
| MP01AC | dichloracetamid-derivater |
| MP01AC01 | diloxanid |
| MP01AC02 | clefamid |
| MP01AC03 | etofamid |
| MP01AC04 | teclozan |
| MP01AR | arsen-forbindelser |
| MP01AR01 | arsthinol |
| MP01AR02 | difetarson |
| MP01AR03 | glycobiarsol |
| MP01AR53 | glycobiarsol, kombinationer |
| MP01AX | andre midler mod amøbesygdomme |
| MP01AX01 | kiniofon |
| MP01AX02 | emetin |
| MP01AX04 | phanquinon |
| MP01AX05 | mepacrin |
| MP01AX06 | atovaquon |
| MP01AX07 | trimetrexat |
| MP01AX08 | tenonitrozol |
| MP01AX09 | dihydroemetin |
| MP01AX10 | fumagillin |
| MP01AX11 | nitazoxanid |
| MP01AX52 | emetin, kombinationer |
| MP01B | malariamidler |
| MP01BA | aminochinoliner |
| MP01BA01 | chloroquin |
| MP01BA02 | hydroxychloroquin |
| MP01BA03 | primaquin |
| MP01BA04 | mepacrin |
| MP01BA06 | amodiaquin |
| MP01BA07 | tafenoquin |
| MP01BB | biguanider |
| MP01BB01 | proguanil |
| MP01BB02 | cycloguanilembonat |
| MP01BB51 | proguanil og atovaquon |
| MP01BB52 | chloroquin og proguanil |
| MP01BC | methanolquinoliner |
| MP01BC01 | quinin |
| MP01BC02 | mefloquin |
| MP01BD | diaminopyrimidiner |
| MP01BD01 | pyrimethamin |
| MP01BD51 | pyrimethamin, kombinationer |
| MP01BE | artemisinin og derivater, usammensatte |
| MP01BE01 | artemisinin |
| MP01BE02 | artemether |
| MP01BE03 | artesunat |
| MP01BE04 | artemotil |
| MP01BE05 | artenimol |
| MP01BF | artemisinin og derivater, kombinationer |
| MP01BF01 | artemether og lumefantrin |
| MP01BF02 | artesunat og mefloquin |
| MP01BF03 | artesunat og amodiaquin |
| MP01BF04 | artesunat, sulfalen og pyrimethamin |
| MP01BF05 | artenimol og piperaquin |
| MP01BF06 | artesunat og pyronaridin |
| MP01BF07 | artemisinin og piperaquin |
| MP01BF08 | artemisinin og naphthoquin |
| MP01BF09 | artesunat, sulfadoxin og pyrimethamin |
| MP01BX | andre malariamidler |
| MP01BX01 | halofantrin |
| MP01BX02 | arterolan og piperaquin |
| MP01C | midler mod leishmaniasis og trypanosomiasis |
| MP01CA | nitroimidazol-derivater |
| MP01CA02 | benznidazol |
| MP01CA03 | fexinidazol |
| MP01CB | antimon-forbindelser |
| MP01CB01 | megluminantimonat |
| MP01CB02 | natriumstibogluconat |
| MP01CC | nitrofuran-derivater |
| MP01CC01 | nifurtimox |
| MP01CC02 | nitrofural |
| MP01CD | arsen-forbindelser |
| MP01CD01 | melarsoprol |
| MP01CD02 | acetarsol |
| MP01CX | andre midler mod leishmaniasis og trypanosomiasis |
| MP01CX01 | pentamidinisethionat |
| MP01CX02 | suraminnatrium |
| MP01CX03 | eflornithin |
| MP01CX04 | miltefosin |
| MP02 | anthelmintika |
| MP02B | antitrematode-midler |
| MP02BA | quinolin-derivater |
| MP02BA01 | praziquantel |
| MP02BA02 | oxamniquin |
| MP02BA03 | arpraziquantel |
| MP02BB | organiske phosphor-forbindelser |
| MP02BB01 | metrifonat |
| MP02BX | andre antitrematode-midler |
| MP02BX01 | bithionol |
| MP02BX02 | niridazol |
| MP02BX03 | stibophen |
| MP02BX04 | triclabendazol |
| MP02C | antinematode-midler |
| MP02CA | benzimidazol-derivater |
| MP02CA01 | mebendazol |
| MP02CA02 | tiabendazol |
| MP02CA03 | albendazol |
| MP02CA04 | ciclobendazol |
| MP02CA05 | flubendazol |
| MP02CA06 | fenbendazol |
| MP02CA51 | mebendazol, kombinationer |
| MP02CB | piperazin-derivater |
| MP02CB01 | piperazin |
| MP02CB02 | diethylcarbamazin |
| MP02CC | tetrahydropyrimidin-derivater |
| MP02CC01 | pyrantel |
| MP02CC02 | oxantel |
| MP02CE | imidazothiazol-derivater |
| MP02CE01 | levamisol |
| MP02CF | avermectiner |
| MP02CF01 | ivermectin |
| MP02CX | andre antinematode-midler |
| MP02CX01 | pyrvinium |
| MP02CX02 | bephenium |
| MP02CX03 | moxidectin |
| MP02D | anticestodale midler |
| MP02DA | salicylsyre-derivater |
| MP02DA01 | niclosamid |
| MP02DX | andre anticestodale midler |
| MP02DX01 | desaspidin |
| MP02DX02 | dichlorophen |
| MP03 | ectoparasitmidler, incl scabiesmidler, insekticider og repellanter |
| MP03A | ectoparasitmidler, incl scabiesmidler |
| MP03AA | svovlholdige midler |
| MP03AA01 | dixanthogen |
| MP03AA02 | kaliumpolysulfid |
| MP03AA03 | mesulfen |
| MP03AA04 | disulfiram |
| MP03AA05 | thiram |
| MP03AA54 | disulfiram, kombinationer |
| MP03AB | chlorholdige midler |
| MP03AB01 | clofenotan |
| MP03AB02 | lindan |
| MP03AB51 | clofenotan, kombinationer |
| MP03AC | pyrethriner, incl. syntetiske forbindelser |
| MP03AC01 | pyrethrum |
| MP03AC02 | bioallethrin |
| MP03AC03 | phenothrin |
| MP03AC04 | permethrin |
| MP03AC51 | pyrethrum, kombinationer |
| MP03AC52 | bioallethrin, kombinationer |
| MP03AC53 | phenothrin, kombinationer |
| MP03AC54 | permethrin, kombinationer |
| MP03AX | andre ectoparasitmidler, incl. scabiesmidler |
| MP03AX01 | benzylbenzoat |
| MP03AX02 | kobberoleinat |
| MP03AX03 | malathion |
| MP03AX04 | quassia |
| MP03AX05 | dimeticon |
| MP03AX06 | benzylalkohol |
| MP03AX07 | abametapir |
| MP03B | insekticider og repellanter |
| MP03BA | pyrethriner |
| MP03BA01 | cyfluthrin |
| MP03BA02 | cypermethrin |
| MP03BA03 | decamethrin |
| MP03BA04 | tetramethrin |
| MP03BX | andre insekticider og repellanter |
| MP03BX01 | diethyltoluamid |
| MP03BX02 | dimethylphthalat |
| MP03BX03 | dibutylphthalat |
| MP03BX04 | dibutylsuccinat |
| MP03BX05 | dimethylcarbat |
| MP03BX06 | etohexadiol |
| MR | Respirationssystemet |
| MR01 | midler mod sygdomme i næsehulen |
| MR01A | dekongestanter og andre midler mod sygdomme i næsehulen til lokalt brug |
| MR01AA | sympatomimetika, usammensatte |
| MR01AA02 | cyclopentamin |
| MR01AA03 | ephedrin |
| MR01AA04 | phenylephrin |
| MR01AA05 | oxymetazolin |
| MR01AA06 | tetryzolin |
| MR01AA07 | xylometazolin |
| MR01AA08 | naphazolin |
| MR01AA09 | tramazolin |
| MR01AA10 | metizolin |
| MR01AA11 | tuaminoheptan |
| MR01AA12 | fenoxazolin |
| MR01AA13 | tymazolin |
| MR01AA14 | adrenalin |
| MR01AA15 | indanazolin |
| MR01AB | sympatomimetika, kombinationer excl. corticosteroider |
| MR01AB01 | phenylephrin |
| MR01AB02 | naphazolin |
| MR01AB03 | tetryzolin |
| MR01AB05 | ephedrin |
| MR01AB06 | xylometazolin |
| MR01AB07 | oxymetazolin |
| MR01AB08 | tuaminoheptan |
| MR01AC | antiallergiske midler, excl. corticosteroider |
| MR01AC01 | cromoglicinsyre |
| MR01AC02 | levocabastin |
| MR01AC03 | azelastin |
| MR01AC04 | antazolin |
| MR01AC05 | spagluminsyre |
| MR01AC06 | thonzylamin |
| MR01AC07 | nedocromil |
| MR01AC08 | olopatadin |
| MR01AC51 | cromoglicinsyre, kombinationer |
| MR01AD | corticosteroider |
| MR01AD01 | beclomethason |
| MR01AD02 | prednisolon |
| MR01AD03 | dexamethason |
| MR01AD04 | flunisolid |
| MR01AD05 | budesonid |
| MR01AD06 | betamethason |
| MR01AD07 | tixocortol |
| MR01AD08 | fluticason |
| MR01AD09 | mometason |
| MR01AD11 | triamcinolon |
| MR01AD12 | fluticasonfuroat |
| MR01AD13 | ciclesonid |
| MR01AD52 | prednisolon, kombinationer |
| MR01AD53 | dexamethason, kombinationer |
| MR01AD57 | tixocortol, kombinationer |
| MR01AD58 | fluticason, kombinationer |
| MR01AD59 | mometason, kombinationer |
| MR01AD60 | hydrocortison, komb. |
| MR01AX | andre midler mod sygdomme i næsehulen |
| MR01AX01 | calciumhexaminthiocyanat |
| MR01AX02 | retinol |
| MR01AX03 | ipratropiumbromid |
| MR01AX05 | ritiometan |
| MR01AX06 | mupirocin |
| MR01AX07 | hexamidin |
| MR01AX08 | framycetin |
| MR01AX09 | hyaluronsyre |
| MR01AX10 | diverse andre midler mod sygdomme i næsehulen |
| MR01AX30 | kombinationer af andre midler mod sygdomme i næsehulen |
| MR01B | nasale dekongestanter til systemisk brug |
| MR01BA | sympatomimetika |
| MR01BA01 | phenylpropanolamin |
| MR01BA02 | pseudoephedrin |
| MR01BA03 | phenylephrin |
| MR01BA51 | phenylpropanolamin, kombinationer |
| MR01BA52 | pseudoephedrin, kombinationer |
| MR01BA53 | phenylephrin, komb. |
| MR02 | halsmidler |
| MR02A | halsmidler |
| MR02AA | antiseptika |
| MR02AA01 | ambazon |
| MR02AA02 | dequalon |
| MR02AA03 | dichlorbenzylalkohol |
| MR02AA05 | chlorhexidin |
| MR02AA06 | cetylpyridin |
| MR02AA09 | benzethonium |
| MR02AA10 | myristyl-benzalkon |
| MR02AA11 | chlorquinaldol |
| MR02AA12 | hexylresorcinol |
| MR02AA13 | acriflavinchlorid |
| MR02AA14 | oxyquinolin |
| MR02AA15 | povidone-iod |
| MR02AA16 | benzalkonium |
| MR02AA17 | cetrimonium |
| MR02AA18 | hexamidin |
| MR02AA19 | phenol |
| MR02AA20 | diverse antiseptika |
| MR02AA21 | octenidin |
| MR02AB | antibiotika |
| MR02AB01 | neomycin |
| MR02AB02 | tyrothricin |
| MR02AB03 | fusafungin |
| MR02AB04 | bacitracin |
| MR02AB30 | gramicidin |
| MR02AD | lokalanæstetika |
| MR02AD01 | benzocain |
| MR02AD02 | lidocain |
| MR02AD03 | cocain |
| MR02AD04 | dyclonin |
| MR02AD05 | ambroxol |
| MR02AX | andre halsmidler |
| MR02AX01 | flurbiprofen |
| MR02AX02 | ibuprofen |
| MR02AX03 | benzydamin |
| MR03 | midler mod obstruktiv lungesygdom |
| MR03A | adrenergika til inhalation |
| MR03AA | alfa- og beta-adrenoceptor agonister |
| MR03AA01 | adrenalin |
| MR03AB | non-selektive beta-adrenoceptor agonister |
| MR03AB02 | isoprenalin |
| MR03AB03 | orciprenalin |
| MR03AC | selektive beta-2-adrenoceptor agonister |
| MR03AC02 | salbutamol |
| MR03AC03 | terbutalin |
| MR03AC04 | fenoterol |
| MR03AC05 | rimiterol |
| MR03AC06 | hexoprenalin |
| MR03AC07 | isoetarin |
| MR03AC08 | pirbuterol |
| MR03AC09 | tretoquinol |
| MR03AC10 | carbuterol |
| MR03AC11 | tulobuterol |
| MR03AC12 | salmeterol |
| MR03AC13 | formoterol |
| MR03AC14 | clenbuterol |
| MR03AC15 | reproterol |
| MR03AC16 | procaterol |
| MR03AC17 | bitolterol |
| MR03AC18 | indacaterol |
| MR03AC19 | olodaterol |
| MR03AH | kombinationer af adrenergika |
| MR03AK | adrenergika kombinationer med corticosteroider/andre midler, excl. antikolinergika |
| MR03AK01 | adrenalin og andre midler mod obstruktiv lungesygdom |
| MR03AK02 | isoprenalin og andre midler mod obstruktiv lungesygdom |
| MR03AK04 | salbutamol og natriumcromoglicinsyre |
| MR03AK05 | reproterol og natriumcromoglicinsyre |
| MR03AK06 | salmeterol og fluticason |
| MR03AK07 | formoterol og budesonid |
| MR03AK08 | formoterol og beclometason |
| MR03AK09 | formoterol og mometason |
| MR03AK10 | vilanterol og fluticasonfuroat |
| MR03AK11 | formoterol og fluticason |
| MR03AK12 | salmeterol og budesonid |
| MR03AK13 | salbutamol og beclometason |
| MR03AK14 | indacaterol og mometason |
| MR03AK15 | salbutamol og budesonid |
| MR03AL | adrenergika i kombination med antikolinergika inkl. trippel-stof kombinationer med corticosteroider |
| MR03AL01 | fenoterol og ipratropiumbromid |
| MR03AL02 | salbutamol og ipratropiumbromid |
| MR03AL03 | vilanterol og umeclidiniumbromid |
| MR03AL04 | indacaterol og glycopyrroniumbromid |
| MR03AL05 | formoterol og aclidiniumbromid |
| MR03AL06 | olodaterol og tiotropiumbromid |
| MR03AL07 | formoterol og glycopyrroniumbromid |
| MR03AL08 | vilanterol, umeclidiniumbromid og fluticasonfuroat |
| MR03AL09 | formoterol, glycopyrroniumbromid og beclometason |
| MR03AL10 | formoterol og tiotropiumbromid |
| MR03AL11 | formoterol, glycopyrroniumbromid og budesonid |
| MR03AL12 | indacaterol, glycopyrroiniumbromid og mometason |
| MR03B | andre midler mod obstruktiv lungesygdom, inhalation |
| MR03BA | glucocorticoider |
| MR03BA01 | beclomethason |
| MR03BA02 | budesonid |
| MR03BA03 | flunisolid |
| MR03BA04 | betamethason |
| MR03BA05 | fluticason |
| MR03BA06 | triamcinolon |
| MR03BA07 | mometason |
| MR03BA08 | ciclesonid |
| MR03BA09 | fluticasonfuroat |
| MR03BB | antikolinergika |
| MR03BB01 | ipratropiumbromid |
| MR03BB02 | oxitropiumbromid |
| MR03BB03 | stramonium-præparater |
| MR03BB04 | tiotropiumbromid |
| MR03BB05 | aclidiniumbromid |
| MR03BB06 | glycopyrroniumbromid |
| MR03BB07 | umeclidiniumbromid |
| MR03BB08 | revefenacin |
| MR03BB54 | tiotropiumbromid, kombinationer |
| MR03BC | antiallergiske midler, excl corticosteroider |
| MR03BC01 | cromoglicinsyre |
| MR03BC03 | nedocromil |
| MR03BX | andre midler mod obstruktiv lungesygdom, inhalation |
| MR03BX01 | fenspirid |
| MR03C | adrenergika til systemisk brug |
| MR03CA | alfa- og beta-adrenoceptor agonister |
| MR03CA02 | ephedrin |
| MR03CB | non-selektive beta-adrenoceptor agonister |
| MR03CB01 | isoprenalin |
| MR03CB02 | methoxyphenamin |
| MR03CB03 | orciprenalin |
| MR03CB51 | isoprenalin, komb. |
| MR03CB53 | orciprenalin, kombinationer |
| MR03CC | selektive beta-2-adrenoceptor agonister |
| MR03CC02 | salbutamol |
| MR03CC03 | terbutalin |
| MR03CC04 | fenoterol |
| MR03CC05 | hexoprenalin |
| MR03CC06 | isoetarin |
| MR03CC07 | pirbuterol |
| MR03CC08 | procaterol |
| MR03CC09 | tretoquinol |
| MR03CC10 | carbuterol |
| MR03CC11 | tulobuterol |
| MR03CC12 | bambuterol |
| MR03CC13 | clenbuterol |
| MR03CC14 | reproterol |
| MR03CC15 | formoterol |
| MR03CC53 | terbutalin, kombinationer |
| MR03CC63 | clenbuterol og ambroxol |
| MR03CK | adrenergika og andre midler mod obstruktiv lungesygdom |
| MR03D | andre systemiske midler mod obstruktiv lungesygdom |
| MR03DA | xanthiner |
| MR03DA01 | diprophyllin |
| MR03DA02 | cholintheophyllinat |
| MR03DA03 | proxyphyllin |
| MR03DA04 | theophyllin |
| MR03DA05 | aminophyllin |
| MR03DA06 | etamiphyllin |
| MR03DA07 | theobromine |
| MR03DA08 | bamifyllin |
| MR03DA09 | acefyllinpiperazin |
| MR03DA10 | bufyllin |
| MR03DA11 | doxofyllin |
| MR03DA12 | mepyramin-theophyllinacetat |
| MR03DA20 | kombinationer af xanthiner |
| MR03DA51 | diprophyllin, kombinationer |
| MR03DA54 | theophyllin, kombinationer excl. psykoleptika |
| MR03DA55 | aminophyllin, kombinationer |
| MR03DA57 | theobromin, kombinationer |
| MR03DA74 | theophyllin, kombinationer med psykoleptika |
| MR03DB | xanthiner og adrenergika |
| MR03DB01 | diprophyllin og adrenergika |
| MR03DB02 | cholintheophyllinat og adrenergika |
| MR03DB03 | proxyphyllin og adrenergika |
| MR03DB04 | theophyllin og adrenergika |
| MR03DB05 | aminophyllin og adrenergika |
| MR03DB06 | etamiphyllin og adrenergika |
| MR03DC | leukotrien-receptor antagonister |
| MR03DC01 | zafirlukast |
| MR03DC02 | pranlukast |
| MR03DC03 | montelukast |
| MR03DC04 | ibudilast |
| MR03DC53 | montelukast, kombinationer |
| MR03DX | andre systemiske midler mod obstruktiv lungesygdom |
| MR03DX01 | amlexanox |
| MR03DX02 | eprozinol |
| MR03DX03 | fenspirid |
| MR03DX05 | omalizumab |
| MR03DX06 | seratrodast |
| MR03DX07 | roflumilast |
| MR03DX08 | reslizumab |
| MR03DX09 | mepolizumab |
| MR03DX10 | benralizumab |
| MR03DX11 | tezepelumab |
| MR05 | midler mod hoste og forkølelse |
| MR05C | expectorantia, excl. komb. med antitussiva |
| MR05CA | expectorantia |
| MR05CA01 | tyloxapol |
| MR05CA02 | kaliumiodid |
| MR05CA03 | guaifenesin |
| MR05CA04 | ipecacuanha |
| MR05CA05 | altæarod |
| MR05CA06 | senega |
| MR05CA07 | antimonpentasulfid |
| MR05CA08 | creosot |
| MR05CA09 | guaiacolsulfonat |
| MR05CA10 | kombinationer af expectorantia |
| MR05CA11 | levoverbenon |
| MR05CA12 | vedbendblad |
| MR05CA13 | cineol |
| MR05CB | mucolytika |
| MR05CB01 | acetylcystein |
| MR05CB02 | bromhexin |
| MR05CB03 | carbocistein |
| MR05CB04 | eprazinon |
| MR05CB05 | mesna |
| MR05CB06 | ambroxol |
| MR05CB07 | sobrerol |
| MR05CB08 | domiodol |
| MR05CB09 | letostein |
| MR05CB10 | kombinationer af mucolytika |
| MR05CB11 | stepronin |
| MR05CB13 | dornase alfa (desoxiribonuclease) |
| MR05CB14 | neltenexin |
| MR05CB15 | erdostein |
| MR05CB16 | mannitol |
| MR05D | antitussiva, excl. komb. m. expectorantia |
| MR05DA | opiumalkaloider og derivater |
| MR05DA01 | ethylmorphin |
| MR05DA03 | hydrocodon |
| MR05DA04 | codein |
| MR05DA05 | opiumalkaloider med morphin |
| MR05DA06 | normethadon |
| MR05DA07 | noscapin |
| MR05DA08 | pholcodin |
| MR05DA09 | dextromethorphan |
| MR05DA10 | thebacon |
| MR05DA11 | dimemorfan |
| MR05DA12 | acetyldihydrocodein |
| MR05DA20 | kombinationer af opiumalkaloider og derivater |
| MR05DB | andre antitussiva |
| MR05DB01 | benzonatat |
| MR05DB02 | benproperin |
| MR05DB03 | clobutinol |
| MR05DB04 | isoaminil |
| MR05DB05 | pentoxyverin |
| MR05DB07 | oxolamin |
| MR05DB09 | oxeladin |
| MR05DB10 | clofedanol |
| MR05DB11 | pipazetat |
| MR05DB12 | bibenzoniumbromid |
| MR05DB13 | butamirat |
| MR05DB14 | fedrilat |
| MR05DB15 | zipeprol |
| MR05DB16 | dibunat |
| MR05DB17 | droxypropin |
| MR05DB18 | prenoxdiazin |
| MR05DB19 | dropropizin |
| MR05DB20 | kombinationer af andre antitussiva |
| MR05DB21 | cloperastin |
| MR05DB22 | meprotixol |
| MR05DB23 | piperidion |
| MR05DB24 | tipepidin |
| MR05DB25 | morclofon |
| MR05DB26 | nepinalon |
| MR05DB27 | levodropropizin |
| MR05DB28 | dimethoxanat |
| MR05DB29 | gefapixant |
| MR05F | antitussiva og expectorantia i kombination |
| MR05FA | opiumderivater og expectorantia |
| MR05FA01 | opiumderivater og mucolytika |
| MR05FA02 | opiumderivater og expectorantia |
| MR05FB | andre antitussiva og expectorantia |
| MR05FB01 | antitussiva og mucolytika |
| MR05FB02 | antitussiva og expectorantia |
| MR05X | andre midler mod forkølelse |
| MR06 | antihistaminer til systemisk brug |
| MR06A | antihistaminer til systemisk brug |
| MR06AA | aminoalkyl-ethere |
| MR06AA01 | bromazin |
| MR06AA02 | diphenhydramin |
| MR06AA04 | clemastin |
| MR06AA06 | chlorphenoxamin |
| MR06AA07 | diphenylpyralin |
| MR06AA08 | carbinoxamin |
| MR06AA09 | doxylamin |
| MR06AA10 | trimethobenzamid |
| MR06AA11 | dimenhydrinat |
| MR06AA52 | diphenhydramin, kombinationer |
| MR06AA54 | clemastin, kombinationer |
| MR06AA56 | chlorphenoxamin, kombinationer |
| MR06AA57 | diphenylpyralin, kombinationer |
| MR06AA59 | doxylamin, kombinationer |
| MR06AA61 | dimenhydrinat, kombinationer |
| MR06AB | substituerede alkylaminer |
| MR06AB01 | brompheniramin |
| MR06AB02 | dexchlorpheniramin |
| MR06AB03 | dimetinden |
| MR06AB04 | chlorpheniramin |
| MR06AB05 | pheniramin |
| MR06AB06 | dexbrompheniramin |
| MR06AB07 | talastin |
| MR06AB51 | brompheniramin, kombinationer |
| MR06AB52 | dexchlorpheniramin, kombinationer |
| MR06AB54 | chlorpheniramin, kombinationer |
| MR06AB56 | dexbrompheniramin, kombinationer |
| MR06AC | substituerede ethylendiaminer |
| MR06AC01 | mepyramin |
| MR06AC02 | histapyrrodin |
| MR06AC03 | chlorpyramin |
| MR06AC04 | tripelennamin |
| MR06AC05 | methapyrilen |
| MR06AC06 | thonzylamin |
| MR06AC52 | histapyrrodin, kombinationer |
| MR06AC53 | chlorpyramin, kombinationer |
| MR06AD | phenothiazin-derivater |
| MR06AD01 | alimemazin |
| MR06AD02 | promethazin |
| MR06AD03 | thiethylperazin |
| MR06AD04 | methdilazin |
| MR06AD05 | hydroxyethylpromethazin |
| MR06AD06 | thiazinam |
| MR06AD07 | mequitazin |
| MR06AD08 | oxomemazin |
| MR06AD09 | isothipendyl |
| MR06AD52 | promethazin, kombinationer |
| MR06AD55 | hydroxyethylpromethazin, kombinationer |
| MR06AE | piperazin-derivater |
| MR06AE01 | buclizin |
| MR06AE03 | cyclizin |
| MR06AE04 | chlorcyclizin |
| MR06AE05 | meclozin |
| MR06AE06 | oxatomid |
| MR06AE07 | cetirizin |
| MR06AE09 | levocetirizin |
| MR06AE51 | buclizin, kombinationer |
| MR06AE53 | cyclizin, kombinationer |
| MR06AE55 | meclozin, kombinationer |
| MR06AK | kombinationer af antihistaminer |
| MR06AX | andre antihistaminer til systemisk brug |
| MR06AX01 | bamipin |
| MR06AX02 | cyproheptadin |
| MR06AX03 | thenalidin |
| MR06AX04 | phenindamin |
| MR06AX05 | antazolin |
| MR06AX07 | triprolidin |
| MR06AX08 | pyrrobutamin |
| MR06AX09 | azatadin |
| MR06AX11 | astemizol |
| MR06AX12 | terfenadin |
| MR06AX13 | loratadin |
| MR06AX15 | mebhydrolin |
| MR06AX16 | deptropin |
| MR06AX17 | ketotifen |
| MR06AX18 | acrivastin |
| MR06AX19 | azelastin |
| MR06AX21 | tritoqualin |
| MR06AX22 | ebastin |
| MR06AX23 | pimethixen |
| MR06AX24 | epinastin |
| MR06AX25 | mizolastin |
| MR06AX26 | fexofenadin |
| MR06AX27 | desloratadin |
| MR06AX28 | rupatadin |
| MR06AX29 | bilastin |
| MR06AX31 | quifenadin |
| MR06AX32 | sequifenadin |
| MR06AX53 | thenalidin, kombinationspræparater |
| MR06AX58 | pyrrobutamin, kombinationspræparater |
| MR07 | andre midler mod sygdomme i respirationssystemet |
| MR07A | andre midler mod sygdomme i respirationssystemet |
| MR07AA | lunge-surfactanter |
| MR07AA01 | colfoscerilpalmitat |
| MR07AA02 | naturlige phosholipider |
| MR07AA30 | kombinationer af forskellige lunge-surfactanter |
| MR07AB | respirationsstimulerende midler |
| MR07AB01 | doxapram |
| MR07AB02 | nikethamid |
| MR07AB03 | pentetrazol |
| MR07AB04 | etamivan |
| MR07AB05 | bemegrid |
| MR07AB06 | prethcamid |
| MR07AB07 | almitrin |
| MR07AB08 | dimeflin |
| MR07AB09 | mepixanox |
| MR07AB52 | nikethamid, kombinationer |
| MR07AB53 | pentetrazol, kombinationer |
| MR07AX | andre midler med virkning på respirationssystemet |
| MR07AX01 | nitrogenoxid |
| MR07AX02 | ivacaftor |
| MR07AX30 | ivacaftor og lumacaftor |
| MR07AX31 | ivacaftor og tezacaftor |
| MR07AX32 | ivacaftor, tezacaftor og elexacaftor |
| MS | Sanseorganer |
| MS01 | oftalmologika |
| MS01A | antiinfektiva |
| MS01AA | antibiotika |
| MS01AA01 | chloramphenicol |
| MS01AA02 | chlortetracyclin |
| MS01AA03 | neomycin |
| MS01AA04 | oxytetracyclin |
| MS01AA05 | tyrothricin |
| MS01AA07 | framycetin |
| MS01AA09 | tetracyclin |
| MS01AA10 | natamycin |
| MS01AA11 | gentamicin |
| MS01AA12 | tobramycin |
| MS01AA13 | fusidinsyre |
| MS01AA14 | benzylpenicillin |
| MS01AA15 | dihydrostreptomycin |
| MS01AA16 | rifamycin |
| MS01AA17 | erythromycin |
| MS01AA18 | polymyxin B |
| MS01AA19 | ampicillin |
| MS01AA20 | antibiotika i kombination med andre stoffer |
| MS01AA21 | amikacin |
| MS01AA22 | micronomicin |
| MS01AA23 | netilmicin |
| MS01AA24 | kanamycin |
| MS01AA25 | azidamfenicol |
| MS01AA26 | azithromycin |
| MS01AA27 | cefuroxim |
| MS01AA28 | vancomycin |
| MS01AA29 | dibekacin |
| MS01AA30 | kombinationer af forskellige antibiotika |
| MS01AA31 | cefmenoxim |
| MS01AA32 | bacitracin |
| MS01AB | sulfonamider |
| MS01AB01 | sulfamethizol |
| MS01AB02 | sulfafurazol |
| MS01AB03 | sulfadicramid |
| MS01AB04 | sulfacetamid |
| MS01AB05 | sulfafenazol |
| MS01AD | antivirale midler |
| MS01AD01 | idoxuridin |
| MS01AD02 | trifluridin |
| MS01AD03 | aciclovir |
| MS01AD05 | interferon |
| MS01AD06 | vidarabin |
| MS01AD07 | famciclovir |
| MS01AD08 | fomivirsen |
| MS01AD09 | ganciclovir |
| MS01AE | fluoroquinoloner |
| MS01AE01 | ofloxacin |
| MS01AE02 | norfloxacin |
| MS01AE03 | ciprofloxacin |
| MS01AE04 | lomefloxacin |
| MS01AE05 | levofloxacin |
| MS01AE06 | gatifloxacin |
| MS01AE07 | moxifloxacin |
| MS01AE08 | besifloxacin |
| MS01AE09 | tosufloxacin |
| MS01AX | andre antiinfektiva |
| MS01AX01 | kviksølvforbindelser |
| MS01AX02 | sølvforbindelser |
| MS01AX03 | zinkforbindelser |
| MS01AX04 | nitrofural |
| MS01AX05 | bibrocathol |
| MS01AX06 | resorcinol |
| MS01AX07 | natriumborat |
| MS01AX08 | hexamidin |
| MS01AX09 | chlorhexidin |
| MS01AX10 | natriumpropionat |
| MS01AX14 | dibrompropamidin |
| MS01AX15 | propamidin |
| MS01AX16 | picloxydin |
| MS01AX18 | povidon-iod |
| MS01AX24 | polihexanid |
| MS01AX25 | lotilaner |
| MS01B | antiinflammatoriske stoffer |
| MS01BA | corticosteroider, usammensatte |
| MS01BA01 | dexamethason |
| MS01BA02 | hydrocortison |
| MS01BA03 | cortison |
| MS01BA04 | prednisolon |
| MS01BA05 | triamcinolon |
| MS01BA06 | betamethason |
| MS01BA07 | fluormetholon |
| MS01BA08 | medryson |
| MS01BA09 | clobetason |
| MS01BA10 | alclometason |
| MS01BA11 | desonid |
| MS01BA12 | formocortal |
| MS01BA13 | rimexolon |
| MS01BA14 | loteprednol |
| MS01BA15 | fluocinolonacetonid |
| MS01BA16 | difluprednat |
| MS01BB | corticosteroider og mydriatika i kombination |
| MS01BB01 | hydrocortison og mydriatika |
| MS01BB02 | prednisolon og mydriatika |
| MS01BB03 | fluorometolon og mydriatika |
| MS01BB04 | betamethason og mydriatika |
| MS01BC | antiinflammatoriske midler, non-steroide |
| MS01BC01 | indometacin |
| MS01BC02 | oxyphenylbutazon |
| MS01BC03 | diclofenac |
| MS01BC04 | flurbiprofen |
| MS01BC05 | ketorolac |
| MS01BC06 | piroxicam |
| MS01BC07 | bendazac |
| MS01BC08 | salicylsyre |
| MS01BC09 | pranoprofen |
| MS01BC10 | nepafenac |
| MS01BC11 | bromfenac |
| MS01C | antiinflammatorika og antiinfektiva i kombination |
| MS01CA | corticosteroider og antiinfektiva i kombination |
| MS01CA01 | dexamethason og antiinfektiva |
| MS01CA02 | prednisolon og antiinfektiva |
| MS01CA03 | hydrocortison og antiinfektiva |
| MS01CA04 | fluocortolon og antiinfektiva |
| MS01CA05 | betamethason og antiinfektiva |
| MS01CA06 | fludrocortison og antiinfektiva |
| MS01CA07 | fluormetholon og antiinfektiva |
| MS01CA08 | methylprednisolon og antiinfektiva |
| MS01CA09 | chlorprednison og antiinfektiva |
| MS01CA10 | fluocinolonacetonid og antiinfektiva |
| MS01CA11 | clobetason og antiinfektiva |
| MS01CA12 | loteprednol og antiinfektiva |
| MS01CB | corticosteroider, antiinfektiva, sympatomimetika i kombination |
| MS01CB01 | dexamethason |
| MS01CB02 | prednisolon |
| MS01CB03 | hydrocortison |
| MS01CB04 | betamethason |
| MS01CB05 | fluormetholon |
| MS01CC | antiinflammatorika, non-steroider og antiinfektiva i kombination |
| MS01CC01 | diclofenac og antiinfektiva |
| MS01CC02 | indometacin og antiinfektiva |
| MS01E | antiglaucom-midler og miotika |
| MS01EA | sympatomimetika til glaucombehandling |
| MS01EA01 | adrenalin |
| MS01EA02 | dipivefrin |
| MS01EA03 | apraclonidin |
| MS01EA04 | clonidin |
| MS01EA05 | brimonidin |
| MS01EA51 | adrenalin, kombinationer |
| MS01EA55 | brimonidin og ripasudil |
| MS01EB | parasympatomimetika |
| MS01EB01 | pilocarpin |
| MS01EB02 | carbachol |
| MS01EB03 | ecothiopat |
| MS01EB04 | demecarium |
| MS01EB05 | physostigmin |
| MS01EB06 | neostigmin |
| MS01EB07 | fluostigmin |
| MS01EB08 | aceclidin |
| MS01EB09 | acetylcholin |
| MS01EB10 | paraoxon |
| MS01EB51 | pilocarpin, kombinationer |
| MS01EB58 | aceclidin, kombinationer |
| MS01EC | carbo-anhydrase inhibitorer |
| MS01EC01 | acetazolamid |
| MS01EC02 | diclofenamid |
| MS01EC03 | dorzolamid |
| MS01EC04 | brinzolamid |
| MS01EC05 | methazolamid |
| MS01EC54 | brinzolamid, kombinationer |
| MS01ED | beta-blokerende midler |
| MS01ED01 | timolol |
| MS01ED02 | betaxolol |
| MS01ED03 | levobunolol |
| MS01ED04 | metipranolol |
| MS01ED05 | carteolol |
| MS01ED06 | befunolol |
| MS01ED51 | timolol, kombinationer |
| MS01ED52 | betaxolol, kombinationer |
| MS01ED54 | metipranolol, kombinationer |
| MS01ED55 | carteolol, komb. |
| MS01EE | prostaglandin-analoger |
| MS01EE01 | latanoprost |
| MS01EE02 | unoproston |
| MS01EE03 | bimatoprost |
| MS01EE04 | travoprost |
| MS01EE05 | tafluprost |
| MS01EE06 | latanoprostenbunod |
| MS01EE51 | latanoprost og netarsudil |
| MS01EE52 | latanoprost og dorzolamid |
| MS01EX | andre antiglaucom-midler |
| MS01EX01 | guanethidin |
| MS01EX02 | dapiprazol |
| MS01EX05 | netarsudil |
| MS01EX06 | omidenepag |
| MS01EX07 | ripasudil |
| MS01F | mydriatika og cycloplegica |
| MS01FA | antikolinergika |
| MS01FA01 | atropin |
| MS01FA02 | scopolamin |
| MS01FA03 | methylscopolamin |
| MS01FA04 | cyclopentolat |
| MS01FA05 | homatropin |
| MS01FA06 | tropicamid |
| MS01FA54 | cyclopentolat, kombinationer |
| MS01FA56 | tropicamid, kombinationer |
| MS01FB | sympatomimetika excl. antiglaucom-midler |
| MS01FB01 | phenylephrin |
| MS01FB02 | ephedrin |
| MS01FB03 | ibopamin |
| MS01FB51 | phenylephrin og ketorolac |
| MS01G | dekongestanter og antiallergika |
| MS01GA | sympatomimetika anvendt som dekongestanter |
| MS01GA01 | naphazolin |
| MS01GA02 | tetryzolin |
| MS01GA03 | xylometazolin |
| MS01GA04 | oxymetazolin |
| MS01GA05 | phenylephrin |
| MS01GA06 | oxedrin |
| MS01GA07 | brimonidin |
| MS01GA51 | naphazolin, kombinationer |
| MS01GA52 | tetryzolin, kombinationer |
| MS01GA53 | xylometazolin, kombinationer |
| MS01GA55 | phenylephrin, kombinationer |
| MS01GA56 | oxedrin, kombinationer |
| MS01GX | andre antiallergika |
| MS01GX01 | cromoglicinsyre |
| MS01GX02 | levocabastin |
| MS01GX03 | spagluminsyre |
| MS01GX04 | nedocromil |
| MS01GX05 | lodoxamid |
| MS01GX06 | emedastin |
| MS01GX07 | azelastin |
| MS01GX08 | ketotifen |
| MS01GX09 | olopatadin |
| MS01GX10 | epinastin |
| MS01GX11 | alcaftadin |
| MS01GX12 | cetirizin |
| MS01GX13 | bilastin |
| MS01GX51 | cromoglicinsyre, kombinationer |
| MS01H | lokalanæstetika |
| MS01HA | lokalanæstetika |
| MS01HA01 | cocain |
| MS01HA02 | oxybuprocain |
| MS01HA03 | tetracain |
| MS01HA04 | proxymetacain |
| MS01HA05 | procain |
| MS01HA06 | cinchocain |
| MS01HA07 | lidocain |
| MS01HA08 | chlorprocain |
| MS01HA30 | kombinationer af lokalanæstetika |
| MS01J | diagnostika |
| MS01JA | farvestoffer |
| MS01JA01 | fluorescein |
| MS01JA02 | rose bengal natrium |
| MS01JA51 | fluorescein, kombinationer |
| MS01JX | andre oftalmologiske diagnostika |
| MS01K | kirurgiske hjælpemidler |
| MS01KA | viscoelastiske substanser |
| MS01KA01 | hyaluronsyre |
| MS01KA02 | hypromellose |
| MS01KA51 | hyaluronsyre, kombinationer |
| MS01KX | andre kirurgiske hjælpemidler |
| MS01KX01 | chymotrypsin |
| MS01KX02 | trypanblå |
| MS01L | midler mod okular vaskulær lidelse |
| MS01LA | antineovaskularisationsmidler |
| MS01LA01 | verteporfin |
| MS01LA02 | anecortav |
| MS01LA03 | pegaptanib |
| MS01LA04 | ranibizumab |
| MS01LA05 | aflibercept |
| MS01LA06 | brolucizumab |
| MS01LA07 | abiciparpegol |
| MS01LA08 | bevacizumab |
| MS01LA09 | faricimab |
| MS01X | andre ophthalmologiske midler |
| MS01XA | andre ophthalmologiske midler |
| MS01XA01 | guaiazulen |
| MS01XA02 | retinol |
| MS01XA03 | natriumchlorid, hypertonisk |
| MS01XA04 | kaliumiodid |
| MS01XA05 | natriumedetat |
| MS01XA06 | ethylmorphin |
| MS01XA07 | alun |
| MS01XA08 | acetylcystein |
| MS01XA09 | iodoheparinat |
| MS01XA10 | inosin |
| MS01XA11 | nandrolon |
| MS01XA12 | dexpanthenol |
| MS01XA13 | alteplase |
| MS01XA14 | heparin |
| MS01XA15 | ascorbinsyre |
| MS01XA18 | ciclosporin |
| MS01XA19 | limbale stamceller, autologe |
| MS01XA20 | kunstig tårevæske og andre indifferente midler |
| MS01XA21 | mercaptamin |
| MS01XA22 | ocriplasmin |
| MS01XA23 | sirolimus |
| MS01XA24 | cenegermin |
| MS01XA25 | lifitegrast |
| MS01XA26 | riboflavin |
| MS01XA27 | voretigenneparvovec |
| MS01XA28 | vareniclin |
| MS01XA29 | sepofarsen |
| MS01XA31 | pegcetacoplan |
| MS01XA32 | avacincaptad pegol |
| MS02 | otologika |
| MS02A | antiinfektiva |
| MS02AA | antiinfektiva |
| MS02AA01 | chloramphenicol |
| MS02AA02 | nitrofural |
| MS02AA03 | borsyre |
| MS02AA04 | aluminiumacetotartrat |
| MS02AA05 | clioquinol |
| MS02AA06 | hydrogenperoxid |
| MS02AA07 | neomycin |
| MS02AA08 | tetracyclin |
| MS02AA09 | chlorhexidin |
| MS02AA10 | eddikesyre |
| MS02AA11 | polymyxin B |
| MS02AA12 | rifamycin |
| MS02AA13 | miconazol |
| MS02AA14 | gentamicin |
| MS02AA15 | ciprofloxacin |
| MS02AA16 | ofloxacin |
| MS02AA17 | fosfomycin |
| MS02AA18 | cefmenoxim |
| MS02AA30 | antiinfektiva, kombinationer |
| MS02B | corticosteroider |
| MS02BA | corticosteroider |
| MS02BA01 | hydrocortison |
| MS02BA03 | prednisolon |
| MS02BA06 | dexamethason |
| MS02BA07 | betamethason |
| MS02BA08 | fluocinolonacetonid |
| MS02C | corticosteroider og antiinfektiva i kombination |
| MS02CA | corticosteroider og antiinfektiva i kombination |
| MS02CA01 | prednisolon og antiinfektiva |
| MS02CA02 | flumetason og antiinfektiva |
| MS02CA03 | hydrocortison og antiinfektiva |
| MS02CA04 | triamcinolon og antiinfektiva |
| MS02CA05 | fluocinolonacetonid og antiinfektiva |
| MS02CA06 | dexamethason og antiinfektiva |
| MS02CA07 | fludrocortison og antiinfektiva |
| MS02D | andre otologika |
| MS02DA | analgetika og anæstetika |
| MS02DA01 | lidocain |
| MS02DA02 | cocain |
| MS02DA03 | phenazon |
| MS02DA04 | cinchocain |
| MS02DA30 | kombinationer af analgetika og anæstetika |
| MS02DC | indifferente præparater |
| MS03 | oftalmologika og otologika |
| MS03A | antiinfektiva |
| MS03AA | antiinfektiva |
| MS03AA01 | neomycin |
| MS03AA02 | tetracyclin |
| MS03AA03 | polymyxin B |
| MS03AA04 | chlorhexidin |
| MS03AA05 | hexamidin |
| MS03AA06 | gentamicin |
| MS03AA07 | ciprofloxacin |
| MS03AA08 | chloramphenicol |
| MS03AA30 | antiinfektiva, kombinationer |
| MS03B | corticosteroider |
| MS03BA | corticosteroider |
| MS03BA01 | dexamethason |
| MS03BA02 | prednisolon |
| MS03BA03 | betamethason |
| MS03C | corticosteroider og antiinfektiva i kombination |
| MS03CA | corticosteroider og antiinfektiva i kombination |
| MS03CA01 | dexamethason og antiinfektiva |
| MS03CA02 | prednisolon og antiinfektiva |
| MS03CA04 | hydrocortison og antiinfektiva |
| MS03CA05 | fludrocortison og antiinfektiva |
| MS03CA06 | betamethason og antiinfektiva |
| MS03CA07 | methylprednisolon og antiinfektiva |
| MS03D | andre oftalmologika og otologika |
| MV | Diverse |
| MV01 | allergener |
| MV01A | allergener |
| MV01AA | allergenekstrakter |
| MV01AA01 | allergenekstrakt fra fjer |
| MV01AA02 | allergenekstrakt fra græspollen |
| MV01AA03 | allergenekstrakt fra husstøvmider |
| MV01AA04 | allergenekstrakt fra skimmel- og gærsvampe |
| MV01AA05 | allergenekstrakt fra træpollen |
| MV01AA07 | allergenekstrakt fra insekter |
| MV01AA08 | allergenekstrakt fra fødevarer |
| MV01AA09 | allergenekstrakt fra tekstiler |
| MV01AA10 | allergenekstrakt fra blomster |
| MV01AA11 | allergenekstrakt fra dyr |
| MV01AA20 | diverse allergenekstrakter |
| MV03 | alle andre terapeutiske produkter |
| MV03A | alle andre terapeutiske produkter |
| MV03AB | antidoter |
| MV03AB01 | ipecacuanha |
| MV03AB02 | nalorphin |
| MV03AB03 | edetater |
| MV03AB04 | pralidoxim |
| MV03AB05 | prednisolon og promethazin |
| MV03AB06 | thiosulfat |
| MV03AB08 | natriumnitrit |
| MV03AB09 | dimercaprol |
| MV03AB13 | obidoxim |
| MV03AB14 | protamin |
| MV03AB15 | naloxon |
| MV03AB16 | ethanol |
| MV03AB17 | methylthioninchlorid |
| MV03AB18 | kaliumpermanganat |
| MV03AB19 | physostigmin |
| MV03AB20 | kobbersulfat |
| MV03AB21 | kaliumiodid |
| MV03AB22 | amylnitrit |
| MV03AB23 | acetylcystein |
| MV03AB24 | digitalis antitoxin |
| MV03AB25 | flumazenil |
| MV03AB26 | DL-methionin |
| MV03AB27 | 4-dimethylaminophenol |
| MV03AB29 | cholinesterase |
| MV03AB31 | berlinerblåt |
| MV03AB32 | glutathion |
| MV03AB33 | hydroxocobalamin |
| MV03AB34 | fomepizol |
| MV03AB35 | sugammadex |
| MV03AB36 | phentolamin |
| MV03AB37 | idarucizumab |
| MV03AB38 | andexanet alfa |
| MV03AB54 | pralidoxim og atropin |
| MV03AC | jern-chelaterende midler |
| MV03AC01 | deferoxamin |
| MV03AC02 | deferipron |
| MV03AC03 | deferasirox |
| MV03AE | midler t. behandl. af hyperkaliæmi og hyperphosphatæmi |
| MV03AE01 | polystyrensulfonat |
| MV03AE02 | sevelamer |
| MV03AE03 | lanthancarbonat |
| MV03AE04 | calciumacetat og magnesiumcarbonat |
| MV03AE05 | sucroferrioxyhydroxid |
| MV03AE06 | colestilan |
| MV03AE07 | calciumacetat |
| MV03AE08 | ferricitrat |
| MV03AE09 | patiromercalcium |
| MV03AE10 | natriumzirconiumcyclosilicat |
| MV03AF | afgiftningsmidler ved cytostatikabehandling |
| MV03AF01 | mesna |
| MV03AF02 | dexrazoxan |
| MV03AF03 | calciumfolinat |
| MV03AF04 | calciumlevofolinat |
| MV03AF05 | amifostin |
| MV03AF06 | natriumfolinat |
| MV03AF07 | rasburicase |
| MV03AF08 | palifermin |
| MV03AF09 | glucarpidase |
| MV03AF10 | natriumlevofolinat |
| MV03AF11 | arginin og lysin |
| MV03AF12 | trilaciclib |
| MV03AG | midler til behandling af hypercalcæmi |
| MV03AG01 | natriumcellulosephosphat |
| MV03AG05 | natriumphosphat |
| MV03AH | midler til behandling af hypoglycæmi |
| MV03AH01 | diazoxid |
| MV03AK | vævsklæbere |
| MV03AM | midler mod embolisation |
| MV03AN | medicinske gasser |
| MV03AN01 | oxygen |
| MV03AN02 | carbondioxid |
| MV03AN03 | helium |
| MV03AN04 | nitrogen |
| MV03AN05 | medicinsk luft |
| MV03AX | andre terapeutiske produkter |
| MV03AX02 | nalfurafin |
| MV03AX03 | cobicistat |
| MV03AX04 | difelikefalin |
| MV03AZ | nerve-depressanter |
| MV03AZ01 | ethanol |
| MV04 | diagnostika |
| MV04B | urin-tests |
| MV04C | andre diagnostika |
| MV04CA | tests for diabetes |
| MV04CA01 | tolbutamid |
| MV04CA02 | glucose |
| MV04CB | tests for fedtabsorption |
| MV04CB01 | vitamin A koncentrater |
| MV04CC | tests for bile duct patency |
| MV04CC01 | sorbitol |
| MV04CC02 | magnesiumsulfat |
| MV04CC03 | sincalid |
| MV04CC04 | ceruletid |
| MV04CD | tests for hypofysefunktion |
| MV04CD01 | metyrapon |
| MV04CD03 | sermorelin |
| MV04CD04 | corticoliberin |
| MV04CD05 | somatorelin |
| MV04CD06 | macimorelin |
| MV04CE | tests for leverfunktionskapacitet |
| MV04CE01 | galactose |
| MV04CE02 | sulfobromphtalein |
| MV04CE03 | methacetin (13-C) |
| MV04CF | tuberkulose-diagnostika |
| MV04CF01 | tuberculin |
| MV04CG | tests for gastrisk sekretion |
| MV04CG01 | kation-byttere |
| MV04CG02 | betazol |
| MV04CG03 | histaminphosphat |
| MV04CG04 | pentagastrin |
| MV04CG05 | methylthioninchlorid |
| MV04CG30 | caffein og natriumbenzoat |
| MV04CH | tests for nyrefunktion og ureterlæsioner |
| MV04CH01 | inulin og andre polyfructosaner |
| MV04CH02 | indigocarmin |
| MV04CH03 | phenolsulphonphthalein |
| MV04CH04 | alsactid |
| MV04CH30 | aminohippursyre |
| MV04CJ | tests for thyroidea-funktion |
| MV04CJ01 | thyrotrophin |
| MV04CJ02 | protirelin |
| MV04CK | tests for pancreas-funktion |
| MV04CK01 | secretin |
| MV04CK02 | pancreozymin (cholecystokinin) |
| MV04CK03 | bentiromid |
| MV04CL | tests for allergiske sygdomme |
| MV04CM | tests for fertilitetsforstyrrelser |
| MV04CM01 | gonadorelin |
| MV04CX | andre diagnostika |
| MV04CX01 | indocyaningrønt |
| MV04CX02 | folsyre |
| MV04CX03 | methacholin |
| MV04CX04 | mannitol |
| MV04CX05 | 13-C-urea |
| MV04CX06 | hexaminolevulinat |
| MV04CX07 | edrophonium |
| MV04CX08 | carbonmonoxid |
| MV04CX09 | patent blue |
| MV04CX10 | pafolacianin |
| MV04CX11 | lithiumchlorid |
| MV04CX12 | xenon |
| MV06 | generelle næringsstoffer |
| MV06A | diætpræparater til fedmebehandling |
| MV06AA | lavenergi-diæter |
| MV06B | proteintilskud |
| MV06C | præparater til spædbørn |
| MV06CA | ernæringsmidler uden phenylalanin |
| MV06D | andre ernæringsmidler |
| MV06DA | kulhydrat/protein/mineral/vitamin, komb. |
| MV06DB | fedt/kulhydrat/protein/mineral/vitamin, komb. |
| MV06DC | kulhydrater |
| MV06DC01 | glucose |
| MV06DC02 | fructose |
| MV06DD | aminosyrer,incl. kombinationer med polypeptider |
| MV06DE | aminosyrer/kulhydrat/mineral/vitamin, komb. |
| MV06DF | mælkeerstatninger |
| MV06DX | andre kombinationer af næringsstoffer |
| MV07 | alle andre non-terapeutiske produkter |
| MV07A | alle andre non-terapeutiske produkter |
| MV07AA | plastre |
| MV07AB | opløsnings-og fortyndingsmidler, incl. skyllevæsker |
| MV07AC | blodtransfusion, hjælpeprodukter |
| MV07AD | blodprøver, hjælpeprodukter |
| MV07AN | inkontinens-udstyr |
| MV07AR | følsomhedstests, disk og tabletter |
| MV07AS | stomi-udstyr |
| MV07AT | kosmetika |
| MV07AV | tekniske desinfektionsmidler |
| MV07AX | midler til vaskbehandling etc. |
| MV07AY | andre non-terapeutiske hjælpeprodukter |
| MV07AZ | kemikalier og reagenser til analytisk brug |
| MV08 | kontrastmidler |
| MV08A | røntgenkontrastmidler, ioderede |
| MV08AA | vandopl.,nefrotrope,højosm. røntgenkontrastmidl. |
| MV08AA01 | diatrizoinsyre |
| MV08AA02 | metrizoinsyre |
| MV08AA03 | iodamid |
| MV08AA04 | iotalamsyre |
| MV08AA05 | ioxitalamsyre |
| MV08AA06 | ioglicinsyre |
| MV08AA07 | acetrizoinsyre |
| MV08AA08 | iocarmsyre |
| MV08AA09 | methiodal |
| MV08AA10 | diodon |
| MV08AB | vandopl.,nefrotrope,lavosm. røntgenkontrastmidl. |
| MV08AB01 | metrizamid |
| MV08AB02 | iohexol |
| MV08AB03 | ioxaglinsyre |
| MV08AB04 | iopamidol |
| MV08AB05 | iopromid |
| MV08AB06 | iotrolan |
| MV08AB07 | ioversol |
| MV08AB08 | iopentol |
| MV08AB09 | iodixanol |
| MV08AB10 | iomeprol |
| MV08AB11 | iobitridol |
| MV08AB12 | ioxilan |
| MV08AC | vandopløselige, hepatotrope røntgenkontrastmidl. |
| MV08AC01 | iodoxamsyre |
| MV08AC02 | iotroxinsyre |
| MV08AC03 | ioglycamsyre |
| MV08AC04 | adipiodon |
| MV08AC05 | iobenzamsyre |
| MV08AC06 | iopanoinsyre |
| MV08AC07 | iocetamsyre |
| MV08AC08 | natriumiopodat |
| MV08AC09 | tyropanoinsyre |
| MV08AC10 | calciumiopodat |
| MV08AD | ikke-vandopløselige røntgenkontrastmidler |
| MV08AD01 | ethylestere af ioderede fedtsyrer |
| MV08AD02 | iopydol |
| MV08AD03 | propyliodon |
| MV08AD04 | iofendylat |
| MV08B | røntgenkontrastmidler, ikke-ioderede |
| MV08BA | bariumsulfat-holdige røntgenkontrastmidler |
| MV08BA01 | bariumsulfat med suspensionsmidler |
| MV08BA02 | bariumsulfat uden suspensionsmidler |
| MV08C | kontrastmidler til magnetisk resonans imaging |
| MV08CA | paramagnetiske kontrastmidler |
| MV08CA01 | gadopentetinsyre |
| MV08CA02 | gadoterinsyre |
| MV08CA03 | gadodiamid |
| MV08CA04 | gadoteridol |
| MV08CA05 | mangafodipir |
| MV08CA06 | gadoversetamid |
| MV08CA07 | ferriammoniumcitrat |
| MV08CA08 | gadobensyre |
| MV08CA09 | gadobutrol |
| MV08CA10 | gadoxetinsyre |
| MV08CA11 | gadofosveset |
| MV08CA12 | gadopiclenol |
| MV08CB | superparamagnetiske kontrastmidler |
| MV08CB01 | ferumoxsil |
| MV08CB02 | ferristen |
| MV08CB03 | jernoxid, nanopartikler |
| MV08CX | andre kontrastmidl. til magnetisk resonans imaging |
| MV08CX01 | perflubron |
| MV08D | ultralyd kontrastmidler |
| MV08DA | ultralyd kontrastmidler |
| MV08DA01 | perflutren, human albumin mikrosfærer |
| MV08DA02 | mikropartikler af galactose |
| MV08DA03 | perflenapent |
| MV08DA04 | perflutren, phospholipid mikrosfærer |
| MV08DA05 | svovlhexafluorid, phospholipid mikrosfærer |
| MV08DA06 | perflubutan, phospholipid mikrosfærer |
| MV09 | radiofarmaka til diagnostisk brug |
| MV09A | centralnervesystemet |
| MV09AA | technetium(99m-Tc)-forbindelser |
| MV09AA01 | technetium(99m-Tc)-exametazim |
| MV09AA02 | technetium(99m-Tc)-bicisat |
| MV09AB | iod(123-I)-forbindelser |
| MV09AB01 | iod(123-I)-iofetamin |
| MV09AB02 | iod(123-I)-joloprid |
| MV09AB03 | iod(123-I)-ioflupan |
| MV09AX | andre diagnostiske radiofarmaka til centralnervesystemet |
| MV09AX01 | indium(111-In)-pentetat |
| MV09AX03 | iod (124-I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropan |
| MV09AX04 | flutemetamol (18-F) |
| MV09AX05 | florbetapir (18-F) |
| MV09AX06 | florbetaben (18-F) |
| MV09AX07 | flortaucipir (18-F) |
| MV09B | skelet |
| MV09BA | technetium(99m-Tc)-forbindelser |
| MV09BA01 | technetium(99m-Tc)-oxidronat |
| MV09BA02 | technetium(99m-Tc)-medronat |
| MV09BA03 | technetium(99m-Tc)-pyrophosphat |
| MV09BA04 | technetium(99m-Tc)-diphosphonpropandicarbonsyre |
| MV09C | renale system |
| MV09CA | technetium(99m-Tc)-forbindelser |
| MV09CA01 | technetium(99m-Tc)-pentetat |
| MV09CA02 | technetium(99m-Tc)-succimer |
| MV09CA03 | technetium(99m-Tc)-mertiatid |
| MV09CA04 | technetium(99m-Tc)-glucoheptonat |
| MV09CA05 | technetium(99m-Tc)-gluconat |
| MV09CA06 | technetium (99m-Tc) ethylendicystein |
| MV09CX | andre diagnostiske radiofarmaka til renale system |
| MV09CX01 | iod(123-I)-iodohippurat |
| MV09CX02 | iod(131-I)-iodohippurat |
| MV09CX03 | iod(125-I)-iothalamat |
| MV09CX04 | chrom(51-Cr)-edetat |
| MV09D | hepatiske og reticulo-endotheliale system |
| MV09DA | technetium(99m-Tc)-forbindelser |
| MV09DA01 | technetium(99m-Tc)-disofenin |
| MV09DA02 | technetium(99m-Tc)-etifenin |
| MV09DA03 | technetium(99m-Tc)-lidofenin |
| MV09DA04 | technetium(99m-Tc)-mebrofenin |
| MV09DA05 | technetium(99m-Tc)-galtifenin |
| MV09DB | technetium(99m-Tc), partikler og kolloider |
| MV09DB01 | technetium(99m-Tc)-nanokolloid |
| MV09DB02 | technetium(99m-Tc)-mikrokolloid |
| MV09DB03 | technetium(99m-Tc)-millimikrosfærer |
| MV09DB04 | technetium(99m-Tc)-tin-kolloid |
| MV09DB05 | technetium(99m-Tc)-svovl-kolloid |
| MV09DB06 | technetium(99m-Tc)-rheniumsulfid-kolloid |
| MV09DB07 | technetium(99m-Tc)-phytat |
| MV09DX | andre diag.radiofarm. til hep.og ret.-endothel.system |
| MV09DX01 | selen(75-Se)-tauroselcholinsyre |
| MV09E | respirationssystemet |
| MV09EA | technetium(99m-Tc), inhalation |
| MV09EA01 | technetium(99m-Tc)-pentetat |
| MV09EA02 | technetium(99m-Tc)-technegas |
| MV09EA03 | technetium(99m-Tc)-nanocolloid |
| MV09EB | technetium(99m-Tc), partikler til injektion |
| MV09EB01 | technetium(99m-Tc)-macrosalb |
| MV09EB02 | technetium(99m-Tc)-mikrosfærer |
| MV09EX | andre diagn. radiofarmaka t. respirationssystem |
| MV09EX01 | krypton(81m-Kr) gas |
| MV09EX02 | xenon(127-Xe) gas |
| MV09EX03 | xenon(133-Xe) gas |
| MV09F | thyroid |
| MV09FX | diverse thyroid diagnostiske radiofarmaka |
| MV09FX01 | technetium(99m-Tc)-pertechnetat |
| MV09FX02 | iod(123-I)-natriumiodid |
| MV09FX03 | iod(131-I)-natriumiodid |
| MV09FX04 | natriumiodid(124-I) |
| MV09G | kardiovaskulære system |
| MV09GA | technetium(99m-Tc)-forbindelser |
| MV09GA01 | technetium(99m-Tc)-sestamibi |
| MV09GA02 | technetium(99m-Tc)-tetrofosmin |
| MV09GA03 | technetium(99m-Tc)-teboroxim |
| MV09GA04 | technetium(99m-Tc)-human albumin |
| MV09GA05 | technetium(99m-Tc)-furifosmin |
| MV09GA06 | technetium(99m-Tc)-stanno-agent mærkede celler |
| MV09GA07 | technetium(99m-Tc)-apcitid |
| MV09GB | iod(125-I)-forbindelser |
| MV09GB01 | iod(125-I)-human fibrinogen |
| MV09GB02 | iod(125-I)-human albumin |
| MV09GX | andre diagnostiske. radiofarmaka til det kardiovaskulære system |
| MV09GX01 | thallium(201-Tl)-chlorid |
| MV09GX02 | indium(111-In)-imciromab |
| MV09GX03 | chrom(51-Cr)-chromat mærkede celler |
| MV09GX04 | rubidium (82-Rb) chlorid |
| MV09GX05 | ammoniak (13-N) |
| MV09H | inflammations- og infektionsdetektion |
| MV09HA | technetium(99m-Tc)-forbindelser |
| MV09HA01 | technetium(99m-Tc)-human immunoglobulin |
| MV09HA02 | technetium(99m-Tc)-exametazim mærkede celler |
| MV09HA03 | technetium(99m-Tc)-antigranulocyt antistof |
| MV09HA04 | technetium(99m-Tc)-sulesomab |
| MV09HB | indium(111-In)-forbindelser |
| MV09HB01 | indium(111-In)-oxinat mærkede celler |
| MV09HB02 | indium(111-In)-tropolonat mærkede celler |
| MV09HX | andre diagn.radiofarm.t.detekt. af inflamm.og infekt. |
| MV09HX01 | gallium(67-Ga)-citrat |
| MV09I | tumordetektion |
| MV09IA | technetium(99m-Tc)-forbindelser |
| MV09IA01 | technetium(99m-Tc)-anticarcinoembryoniskantigen antistof |
| MV09IA02 | technetium(99m-Tc)-antimelanom antistof |
| MV09IA03 | technetium(99m-Tc)-pentavalent succimer |
| MV09IA04 | technetium(99m-Tc)-votumumab |
| MV09IA05 | technetium(99m-Tc)-depreotid |
| MV09IA06 | technetium(99m-Tc)-arcitumomab |
| MV09IA07 | technetium(99m-Tc)-hydrazin nicotinsyre-octreotid |
| MV09IA08 | technetium(99m-Tc)-etarfolatid |
| MV09IA09 | technetium(99m-Tc)-tilmanocept |
| MV09IA10 | technetium (99m-Tc)-trofolastatchlorid |
| MV09IB | indium(111-In)-forbindelser |
| MV09IB01 | indium(111-In)-pentetreotid |
| MV09IB02 | indium(111-In)-satumomabpendetid |
| MV09IB03 | indium(111-In)-antiovariumcarcinom antistof |
| MV09IB04 | indium(111-In)-capromabpendetid |
| MV09IX | andre diagn. radiofarmaka til tumor detektion |
| MV09IX01 | iod(123-I)-iobenguan |
| MV09IX02 | iod(131-I)-iobenguan |
| MV09IX03 | iod(125-I)-CC49 monoclonalt antistof |
| MV09IX04 | fludeoxyglucose(18-F) |
| MV09IX05 | fluorodopa(18-F) |
| MV09IX06 | natriumfluorid(18-F) |
| MV09IX07 | fluorocholin (18f) |
| MV09IX08 | fluoroethylcholin(18-F) |
| MV09IX09 | gallium (68-Ga) edotreotid |
| MV09IX10 | fluoroethyl-L-tyrosin (18-F) |
| MV09IX11 | fluoroestradiol (18-F) |
| MV09IX12 | fluciclovin (18-F) |
| MV09IX13 | methionin (11-c) |
| MV09IX14 | gallium (68-Ga) gozetotid |
| MV09IX15 | kobber (64-Cu) dotatate |
| MV09IX16 | piflufolastat (18-F) |
| MV09IX17 | fluor (18-F) PSMA-1007 |
| MV09IX18 | flotufolastat(18-F) |
| MV09X | andre radiofarmaka til diagnostisk brug |
| MV09XA | iod(131-I)-forbindelser |
| MV09XA01 | iod(131-I)-norcholesterol |
| MV09XA02 | iod(131-I)-19-cholesterol |
| MV09XA03 | iod(131-I)-human albumin |
| MV09XX | diverse radiofarmaka til diagnostisk brug |
| MV09XX01 | cobalt(57-Co)-cyanocobalamin |
| MV09XX02 | cobalt(58-Co)-cyanocobalamin |
| MV09XX03 | selen(75-Se)-norcholesterol |
| MV09XX04 | jern(59-Fe)-ferricitrat |
| MV10 | radiofarmaka til terapeutisk brug |
| MV10A | antiinflammatorika |
| MV10AA | yttrium(90-Y)-forbindelser |
| MV10AA01 | yttrium(90-Y)-citrat kolloid |
| MV10AA02 | yttrium(90-Y)-ferrihydroxid kolloid |
| MV10AA03 | yttrium(90-Y)-silicat kolloid |
| MV10AX | andre antiinflammatoriske terap. radiofarmaka |
| MV10AX01 | phosphor(32-P)-chromphosphat kolloid |
| MV10AX02 | samarium(153-Sm)-hydroxyapatit kolloid |
| MV10AX03 | dysprosium(165-Dy) kolloid |
| MV10AX04 | erbium(169-Er)-citrat kolloid |
| MV10AX05 | rhenium(186-Re)-sulfid kolloid |
| MV10AX06 | guld(198-Au) kolloid |
| MV10B | smertepalliation (knogle-opsøgende midler) |
| MV10BX | diverse radiofarmaka til smertepalliation |
| MV10BX01 | strontium(89-Sr)-chlorid |
| MV10BX02 | samarium(153-Sm)-ethylendiamintetramethylenphosphonsyre |
| MV10BX03 | rhenium(186-Rh)-etidronat |
| MV10X | andre radiofarmaka til terapeutisk brug |
| MV10XA | iod(131-I)-forbindelser |
| MV10XA01 | iod(131-I)-natriumiodid |
| MV10XA02 | iod(131-I)-iobenguan |
| MV10XA03 | iod(131-I)-omburtamab |
| MV10XA04 | iod(131-I)-apamistamab |
| MV10XA53 | tositumomab/iod(131-I)-tositumomab |
| MV10XX | diverse radiofarmaka til terapeutisk brug |
| MV10XX01 | phosphor(32-P)-natriumphosphat |
| MV10XX02 | ibritumomab tiuxetan(90-Y) |
| MV10XX03 | radium(223-Ra)-dichlorid |
| MV10XX04 | lutetium(177-Lu)-oxodotreotid |
| MV10XX05 | lutetium(177-Lu)-vipivotid tetraxetan |
| MV20 | surgical dressings |
